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Abstract 
 
This thesis provides new insights into the recruitment mechanisms of factors 
to replicative origins that are important for helicase activation during initiation of DNA 
replication in budding yeast.  
DNA replication origins are recognised by the Origin Recognition Complex (ORC), 
which recruits, during late M-phase, Cdc6, Cdt1 and MCM2-7 to form a pre-
replication complex (pre-RC). MCM2-7 represents the core of the eukaryotic 
replicative helicase, but it is inactive within the pre-RC. In early S-phase, the pre-RC 
is converted into the pre-initiation complex (pre-IC), leading to stable 
Cdc45/GINS/MCM2-7 (CMG) complex formation and helicase activation. This 
process depends on the recruitment of a series of factors (Sld3, Cdc45, Sld2, Sld7, 
Dpb11…) and is regulated by kinases (DDK and S-CDK) but their specific function 
and mechanism of action is largely unknown. 
A systematic pairwise interaction analysis was performed using purified and in 
vitro translated proteins from Saccharomyces cerevisiae in order to understand how 
these factors interact with each other and MCM2-7, allowing helicase loading and 
activation.  
During this study a new network of interactions was identified, which is 
required for the stable recruitment of Cdc45 to MCM2-7. This was concomitant with 
the in vitro reconstitution of Cdc45 loading with purified proteins, which described 
Sld2, in addition to Sld3, as Cdc45 loading factor. Moreover, the Mcm2 subunit of the 
MCM2-7 hexamer was identified as a central player in Cdc45 recruitment, 
representing a binding surface for Sld2, Sld3 and Cdc45. The interaction sites in 
these proteins were mapped and mutants were generated to disrupt the formation of 
the complex containing Cdc45. 
The results obtained in this work constitute a comprehensive overview on the 
interactions occurring during pre-RC, and CMG formation. Additionally, they provide 
important details on the mechanisms leading to helicase activation and contribute to 
the understanding of this still poorly defined step of DNA replication. 
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Chapter 1 – Introduction  
 
DNA replication is the central process of duplication of the genetic material 
and it is essential for the survival of all living cells. DNA replication involves the 
phases of initiation, elongation and termination and these basic mechanistic steps 
are conserved among all domains of life (Bacteria, Archaea and Eukarya) (O'Donnell 
et al, 2013).  
The accurate copying of the double helix of DNA is required for inheritance of 
information that defines the phenotype of cells and ultimately organisms. Errors in 
DNA replication in higher eukaryotes are associated with a variety of serious 
consequences including birth defects, genetic abnormalities and cancer (Jackson et 
al, 2014).  
The details of chromosome replication are better understood in the budding yeast 
Saccharomyces cerevisiae than in any other eukaryotic organism, principally 
because its replicative origins contain a well defined consensus sequence, contrarily 
to other species, and because of the simplicity of its genetic manipulation. 
 
1.1 Initiation of DNA replication 
In budding yeast, the initiation process is divided in two temporally distinct 
steps (Diffley et al, 1994). Firstly, in late mitosis and early G1-phase of the cell cycle, 
a large complex of initiator proteins called the pre-Replication Complex (pre-RC) 
assembles at the replication origin. Secondly, in early S-phase when cells have 
committed to DNA replication, the pre-RC is transformed into the pre-Initiation 
Complex (pre-IC). During this reaction more than 30 factors are assembled on 
origins (Gambus et al, 2006; Zou & Stillman, 1998) leading to the establishment of 
active replication forks. Two kinases are crucial for pre-IC formation, cyclin-
dependent kinase (CDK) and Dbf4-dependent kinase (DDK), as they promote 
complex assembly and coordinate the timing of replication initiation at hundreds of 
origins (Siddiqui et al, 2013). Pre-IC formation culminates in the activation of the 
replicative helicase, which is composed of MCM2-7 and two accessory factors 
Cdc45 and GINS that together form a holoenzyme, the Cdc45/MCM2-7/GINS (CMG) 
complex (Costa et al, 2011; Gambus et al, 2006; Moyer et al, 2006). After the 
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unwinding of origin DNA, the synthesis machinery is loaded. Once the pre-IC starts 
forming, pre-RC assembly is inhibited and its reassembly is prevented until the next 
G1-phase. As a result, each origin is used once, and only once, per cell cycle. 
 
1.2 Replicative origins 
The eukaryotic origin in S. cerevisiae, called autonomously replicating 
sequence (ARS) has been defined using genetic methods. It does contain a 12-17 
bp ARS consensus sequence (ACS) constituted of a A element and three B 
elements (Marahrens & Stillman, 1992). The A element is indispensable for origin 
function, while the individual B elements are important but essential all together. In 
contrast with the rest of the genome, the sequence at replicative origins is AT rich 
and therefore allows for easier strands separation. The Origin Recognition Complex 
(ORC) binds to the A and B1 elements (Bell & Stillman, 1992; Speck et al, 2005) 
and, crucially, the replication factor Cdc6 can only form a stable complex with ORC 
on the correct DNA template. In budding yeast therefore Cdc6 functions to select for 
the correct origins, otherwise inducing ATP-hydrolysis and ORC/Cdc6 complex 
disassembly (Speck & Stillman, 2007). It is currently not known if this is true for 
higher eukaryotes, where sequence specificity has not been identified yet but 
additional initiation factors, DNA structures (G-quadruplex) and epigenetic signals 
co-operate to stimulate initiation of replication in specific genomic regions (Mechali et 
al, 2013). Interestingly, replication origins are frequently found in proximity of 
promoter regions (Cadoret et al, 2008; Cayrou et al, 2011; Sequeira-Mendes et al, 
2009) and ORC binding sites are linked with patterns of gene expression (MacAlpine 
et al, 2010; Mechali et al, 2013). One possible explanation is that both 
transcriptionally active promoters and DNA replication origins require a stretch of 
nucleosome-free DNA (Eaton et al, 2010; Papior et al, 2012; Xu et al, 2012). 
Additionally, origins are enriched for specific histone variants (H3.3 or H2AZ) and 
chromatin modifiers (histone acetylase HBO1, histone methyl transferase PR-Set7, 
chromatin-remodelling complex SNF2H) can facilitate pre-RC assembly in higher 
eukaryotes (Mechali et al, 2013). DNA structures were also recently linked to 
initiation of replication in Drosphila, where DNA supercoiling can promote ORC 
recruitment (Remus et al, 2004), although human ORC also has affinity for G-
quadruplex structures (Hoshina et al, 2013). 
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Remarkably, the recognition of the origin is not crucial for replication. In fact, 
in mammalian cells the recruitment of ORC to non-origin DNA creates an artificial 
origin (Takeda & Dutta, 2005) and, consistent, the budding yeast ORC/Cdc6 can use 
non-origin DNA for helicase loading in vitro (Evrin et al, 2009; Remus et al, 2009). 
This suggests the possibility that any DNA sequence could support replication and 
that the specific recruitment of ORC to defined genomic regions only assures even 
spacing of replication origins. Finally, not all origins fire every cell cycle, leaving 
some to the possibility to be activated in case the replication fork is blocked due to 
DNA damage (Blow et al, 2011). 
 
1.3 Pre-RC formation  
Pre-RC formation is initiated by the binding of the Origin Recognition Complex 
(ORC) to the replication origins, where it stays attached throughout the cell cycle 
(Bell & Stillman, 1992; Liang & Stillman, 1997). During late M-, early G1-phase, the 
ORC-DNA complex recruits Cdc6 to the origins (Weinreich et al, 1999). The binding 
of ORC and Cdc6 is ATP dependent (Speck et al, 2005) and it involves interactions 
between Cdc6 and the Orc1 and Orc2 subunits (Huo et al, 2012). The ORC/Cdc6 
complex in turn recruits Minichromosome maintenance (MCM2-7) helicase to origins 
with the help of Cdt1 (Coleman et al, 1996; Donovan et al, 1997; Evrin et al, 2009; 
Randell et al, 2006; Remus et al, 2009). Cdt1 is required in vivo for the nuclear 
import of MCM2-7 (Tanaka & Diffley, 2002) and the interaction of Cdt1 with Mcm6 
alleviates an inhibitory activity in the C-terminus of Mcm6 (Fernandez-Cid et al, 
2013), promoting the ORC/Cdc6/Cdt1/MCM2-7 (OCCM) complex formation (Evrin et 
al, 2013). The OCCM is an unstable intermediate and Orc1 and Cdc6 ATP 
hydrolysis is quickly activated as a consequence of its formation, resulting in the 
expulsion of Cdt1 from the complex and leaving on origins the ORC/Cdc6/MCM2-7 
(OCM) complex (Fernandez-Cid et al, 2013; Randell et al, 2006). The OCM is 
competent for the recruitment of a second MCM2-7 hexamer to DNA, leading to the 
formation of a stable MCM2-7 double-hexamer (Evrin et al, 2014). The structure of 
the double-hexamer is in fact ideally suited to set up bidirectional replication forks in 
S-phase, with each fork inheriting one MCM2-7 hexamer. A model of the pre-RC 
formation is presented in Figure 1.1. 
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Figure 1.1: Pre-RC assembly model 
1) ORC binds DNA origins. 2) Cdc6 associates with ORC. 3) Cdt1/MCM2-7 is recruited by 
ORC/Cdc6. 4) Rapid ATP-hydrolysis by Cdc6 and Orc1 leads to Cdt1 release and OCM 
formation. This reaction is blocked by CDK. 5) OCM formation results in a structural change 
in MCM2-7 to generate a dimerization competent state of the MCM2-7 helicase and 
recruitment of a second MCM2-7 complex. The recruitment of the second MCM2-7 hexamer 
is a slow reaction and may require another ORC/Cdc6 complex. 6) The MCM2-7 loading 
finishes with the formation of a stable double-hexamer encircling dsDNA. (Riera et al, 2014) 
 
It was found that all pre-RC intermediates are salt unstable, whereas the 
MCM2-7 double-hexamer that encircles dsDNA is salt resistant (Donovan et al, 
1997; Evrin et al, 2009; Evrin et al, 2014; Fernandez-Cid et al, 2013; Remus et al, 
2009). The stability of the MCM2-7 double-hexamer on chromatin is crucial to 
prevent loss of the helicase during the G1/S-phase transition, which would lead to 
inefficient DNA replication and genome instability because no reloading can occur 
during S-phase. Additionally, the MCM2-7 double-hexamer is able to slide on dsDNA 
in an ATP-hydrolysis independent manner (Evrin et al, 2009; Remus et al, 2009). 
Multiple MCM2-7 double-hexamers are loaded at replication origins in each cell cycle 
and the additional copies can potentially establish new forks in case of terminal fork 
collapse due to severe DNA damage (McIntosh & Blow, 2012). Although MCM2-7 
double-hexamer formation is crucial for DNA replication, this complex has no DNA 
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unwinding activity (Evrin et al, 2009; Ishimi, 1997; Remus et al, 2009) and MCM2-7 
needs to be activated in S-phase with the interaction with Cdc45 and GINS.  
 
1.4 Pre-IC formation 1  
Pre-IC formation is divided into two discrete steps according to the 
requirements for DDK and CDK kinases. First, during late G1-phase DDK activity 
promotes the association of Sld3, Sld7 and Cdc45 with replication origins (Heller et 
al, 2011; Kamimura et al, 2001; Kanemaki & Labib, 2006; Tanaka et al, 2011a; 
Tanaka et al, 2011b). Subsequently, Sld2, Dpb11, DNA Polymerase ε (Polε) and the 
tetramer constituted by Sld5/Psf1/Psf2/Psf3 (GINS) associate with the origins in a 
CDK dependent manner (Heller et al, 2011; Masumoto et al, 2002; Muramatsu et al, 
2010; Tanaka et al, 2007b; Zegerman & Diffley, 2007). Sld2, Dpb11, Pol  and GINS 
form a weak complex in solution that is called pre-loading complex (pre-LC) 
(Muramatsu et al, 2010) and a CDK dependent interaction between Sld3 and Dpb11 
facilitate the recruitment of GINS to the replication origin. In consequence the 
MCM2-7 double-hexamer is transformed into the CMG, which functions as the active 
helicase. Within the pre-RC MCM2-7 encircles dsDNA, but the CMG encircles single 
stranded DNA (ssDNA)(Fu et al, 2011), indicating that the MCM2-7 complex 
undergoes large conformational changes during pre-IC formation, which must 
involve MCM2-7 ring opening. Once the CMG is formed Mcm10 is likely required to 
activate the complex, since in the absence of Mcm10 the CMG cannot unwind DNA 
and stays associated with the origin (Kanke et al, 2012; van Deursen et al, 2012; 
Watase et al, 2012). Finally, with the help of Ctf4, the DNA polymerase α (Pol α) is 
recruited (Gambus et al, 2009; Kang et al, 2013; Simon et al, 2014), it binds ssDNA 
and initiates DNA synthesis by producing RNA primers prior to processive DNA 
synthesis. Polε primarily functions for leading strand DNA synthesis, while Polδ 
serves for lagging strand DNA synthesis (Kunkel & Burgers, 2008). Additional factors 
are taking part in the replisome formation and they include Replication Protein A 
(RPA) (Alani et al, 1992; Longhese et al, 1994), a trimeric highly conserved ssDNA 
binding protein, and Replication Factor C (RFC), a DNA binding protein and ATPase 
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that acts as a clamp loader of the Proliferating Cell Nuclear Antigen (PCNA) 
processivity factor for Polδ and Polε (Yao et al, 2003). 
 
Figure 1.2: Schematic representation of the initiation of replication 1 
In late G1-phase DDK promotes the recruitment of Sld3 and Cdc45 to origins where MCM2-
7 double-hexamer is loaded. Subsequently, in S-phase, Sld2, Dpb11, Polε, GINS and 
Mcm10 associate with the origins in a CDK dependent manner. The complex formed (pre-
IC) is competent for polymerases recruitment and replisome formation. 
 
 
 
1.5 The Cdc45/MCM2-7/GINS (CMG) complex 1 
MCM2-7 represents the core of the eukaryotic helicase, but this complex has 
little helicase activity on its own (Bochman & Schwacha, 2008; Ishimi, 1997; Lee & 
Hurwitz, 2000). However, once Cdc45 and GINS are associated with MCM2-7, the 
complex has a strong helicase activity (Ilves et al, 2010). Crucially, some structural 
information on the CMG complex has been obtained, giving insights into the 
organisation and function of the helicase. Moreover, as MCM2-7, Cdc45 and GINS 
are highly conserved, data obtained from various systems can be integrated, 
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resulting in a more comprehensive understanding of the complex. The low resolution 
three dimensional reconstruction of the Drosophila melanogaster CMG identified the 
arrangement of its proteins (Costa et al, 2011). The complex assumes a planar form, 
with Cdc45 and GINS binding to the side of a closed circular MCM2-7 complex, 
touching the Mcm2, Mcm5 and Mcm3 subunits. However, the structure of MCM2-7 in 
the CMG appears to differ from the structure of the MCM2-7 hexamer by itself. 
Drosophila melanogaster MCM2-7 assumes in fact two different conformations: a 
notched planar form and a gapped spiral form; in each case the MCM2-7 ring is 
broken, which was not observed within the CMG (Costa et al, 2011). This indicates 
that the MCM2-7 hexamer is unstable and that the binding of Cdc45 and GINS to 
MCM2-7 promotes stabilization of the complex, which is likely important for its 
function. Additionally, it was found that the binding of Cdc45 and GINS to MCM2-7 
generates a large channel through the CMG complex that stretches from the centre 
of the MCM2–7 pore to the inner surface of the Cdc45/GINS proteins. Moreover, 
within the CMG Cdc45 and GINS make extensive contact with each other, both seen 
in the EM structure and reported in protein-protein interaction analysis (Costa et al, 
2011; Ilves et al, 2010; Im et al, 2009). One side of Cdc45 interacts with the N-
terminal α-helical domain of Psf2, while the other side appears to contact the N-
terminus of Mcm2. On the other hand, GINS seems to interact with Mcm5. The 
structure of the CMG suggests that the complex cannot associate with dsDNA, as 
the central pore is not wide enough (Costa et al, 2011). Moreover, the CMG contains 
only a single MCM2-7 hexamer suggesting that the splitting of the double hexamer 
has to occur prior to or during CMG formation. Indeed, a biochemical analysis of the 
CMG, using strand-specific DNA roadblocks and Xenopus egg extracts, has 
suggested that the CMG is a 3' to 5' ssDNA translocase (ssDNA passing through the 
central channel), suggesting that the helicase unwinds DNA via "steric exclusion" (Fu 
et al, 2011). Moreover, during DNA damage GINS can temporarily dissociate from 
the CMG complex, demonstrating that the complex is more dynamic than previously 
assumed (Hashimoto et al, 2012). 
In contrast to bacteria, where a hexameric helicase unwinds DNA, eukaryotes 
have evolved a more complex holo-helicase, which contains in addition to the 
MCM2-7 hexamer also Cdc45 and the four subunit GINS complex. However, how 
these helicase accessory factors contribute to processive DNA unwinding and what 
the exact path of both DNA strands through the CMG complex is, are key 
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unanswered questions. Nevertheless, models that will contribute to answering these 
questions can be generated with current data. For example, it was reported that 
Cdc45 interacts tightly with ssDNA, both for budding yeast (Bruck & Kaplan, 2013) 
and human Cdc45 (Szambowska et al, 2014). Then again, in particular human 
Cdc45 seems to have a preference for 3’ protruding strands and single-
strand/double strand DNA junctions, and the protein appears to be able to slide on 
DNA with 3’-5’ polarity (Szambowska et al, 2014). Additionally, a similarity was found 
between Cdc45 and RecJ, a prokaryotic ssDNA exonuclease (Krastanova et al, 
2012; Sanchez-Pulido & Ponting, 2011). These features of Cdc45 suggest that 
ssDNA passes through Cdc45 and that it might be involved or responsible for the 
process of strands separation. Szambowska and colleagues proposed that Cdc45 in 
the CMG could act as a wedge for the separation of the two DNA strands, being 
situated in front of the complex, but this theory is not fully consistent with the three 
dimensional structure of the CMG complex (Costa et al, 2011; Krastanova et al, 
2012). Based on this model, only a restricted path of DNA through the CMG complex 
is possible.  
 
 
 
Figure 1.3: Models showing the path of DNA through the CMG 1 
C-terminal view of MCM2-7 in complex with Cdc45 and GINS. A) The leading strand passes 
right through the central channel of the CMG, whereas the lagging strand inserts in the 
lateral channel at the Mcm2/Mcm5 interface, contacting at this point Cdc45 or the 
Cdc45/GINS interface. B) The leading strand passes through the central channel of the 
CMG, while the lagging strand makes minor contact with MCM2-7 on its outer C-terminal 
surface or the Cdc45/GINS interface. The EM map of the CMG complex is based on EMDB-
1832 (Costa et al, 2011).  
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One option is that the leading strand of DNA passes through the central hole 
of MCM2-7, whereas the lagging strand inserts in the lateral channel produced 
between the N-terminal and C-terminal parts in the Mcm2/Mcm5 interface, possibly 
contacting at this point Cdc45 or Cdc45/GINS interface (Figure 1.2, model A). The 
other option is that the lagging strand does not pass through MCM2-7 at all, but 
contacts MCM2-7 on its outer C-terminal surface and/or Cdc45/GINS (Figure 1.2, 
model B).  
Both models are consistent with a recent analysis of the DNA binding properties of 
an archaeal MCM homologue and budding yeast MCM2-7, which revealed that 
residues on the surface of the N-terminal MCM2-7 OB-fold are crucial for interaction 
with the leading strand (Froelich et al, 2014), consistent with the idea that MCM2-7 
encircles ssDNA. Mutations of these residues in MCM2-7 did not have an effect on 
Cdc45 association with origins, but surprisingly impacted on GINS and RPA 
association. This could suggest that Cdc45 plays a role in the initial unwinding, 
whereas GINS is recruited as a consequence of this process. Additionally, further 
replicative factors could take part in the process of strand extrusion during CMG 
establishment or initial unwinding, such as Mcm10 and Sld2 which are reported to be 
ssDNA binding proteins (Kanter & Kaplan, 2011; Warren et al, 2008). Nevertheless, 
many more studies will be required to validate/invalidate these models and to 
conclude how the two strands of DNA pass through the CMG complex. 
 
1.6 DDK dependent regulation of DNA replication 1 
Helicase activation becomes initiated by DDK, which is targeting the MCM2-7 
double-hexamer. This reaction involves recruitment of the kinase to replication 
origins, which begins already in G1-phase of the cell cycle (Katou et al, 2006; 
Natsume et al, 2013). Here, Dbf4 interacts with Mcm2 (Ramer et al, 2013), whereas 
Cdc7 associates with both Mcm4 and Mcm5 (Ramer et al, 2013; Sheu & Stillman, 
2006). Thus, several docking sites for DDK are available within the helicase. 
However, as these sites are spread over a large surface of the MCM2-7 complex, it 
appears also possible that multiple DDK complexes are operating in the context of 
the MCM2-7 double-hexamer. Purified DDK was found to phosphorylate the Mcm2, 
Mcm4 and Mcm6 subunits, with preference for MCM2-7 in its double-hexameric form 
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(Francis et al, 2009). DDK target sequences for phosphorylation (S/T-D/E) are 
characterised by an acidic residue at the +1 position, which can be either an acidic 
amino acid or negative charge provided by a phosphoserine or phosphothreonine 
(Charych et al, 2008; Cho et al, 2006; Montagnoli et al, 2006). Indeed, the 
checkpoint kinase Mec1, and also CDK, phosphorylate chromatin-associated MCM2-
7 generating priming sites for DDK dependent phosphorylation, which contributes to 
efficient helicase activation and genomic stability (Randell et al, 2010). DDK has 
likely a large number of targets in the cell, but in budding yeast it was shown that 
MCM2-7 represents the essential target of the kinase, as mutations in subunits of the 
helicase can bypass the DDK requirement of the cell (Hardy et al, 1997; Sheu & 
Stillman, 2006). In particular the Mcm4 N-terminus contains a domain with an 
inhibitory activity that becomes alleviated upon phosphorylation (Sheu & Stillman, 
2010). Then again, a point mutation in the N-terminus of Mcm5 promotes also DDK 
independent DNA replication (Hardy et al, 1997). The structural change associated 
with DDK dependent phosphorylation of the MCM2-7 double-hexamer is unclear, 
although recently it was shown that it does not involve separation of the MCM2-7 
double-hexamer (On et al, 2014). On the other hand it appears possible that DDK 
phosphorylation of MCM2-7 generates binding sites for proteins, because Sld3, Sld7 
and Cdc45 only bind to origins upon DDK activation (Heller et al, 2011; Natsume et 
al, 2013; Tanaka et al, 2011a).  
To establish temporal control of DNA replication, the activity of DDK must be 
regulated. The Cdc7 kinase subunit is stable during the cell cycle, however the 
regulatory Dbf4 subunit becomes ubiquitinated by the APC/C and targeted for 
proteasome mediated degradation during late mitosis and G1-phase of the cell cycle 
(Ferreira et al, 2000; Oshiro et al, 1999; Weinreich & Stillman, 1999). Subsequently, 
phosphorylation of the APC/C activator protein Cdh1 by G1-CDKs prevents Cdh1 
from binding and activating the APC/C, therefore allowing S-phase kinases to 
accumulate (Jaspersen et al, 1999; Zachariae et al, 1998). This regulatory loop 
guarantees that Dbf4 activity is kept low during G1-phase of the cell cycle.  
However, this does not explain how the replication timing of individual 
chromosome domains is regulated. Several recent studies showed that DDK 
becomes modulated in a loci specific form: for example, it was found that the Ctf19 
kinetochore complex can recruit Dbf4 as early as telophase to the kinetochores to 
promote early DNA replication in S-phase (Natsume et al, 2013). Then again, origins 
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that fire late during S-phase, e.g. at the telomere, have been shown to contain a 
negative regulator of DDK activity. The Rap1-interacting factor 1 (Rif1) protein binds 
to late origins and recruits protein phosphatase 1 (PP1), which facilitates the 
dephosphorylation of the MCM complex and blocks helicase activation (Dave et al, 
2014; Hiraga et al, 2014; Mattarocci et al, 2014; Renard-Guillet et al, 2014). 
 
1.7 CDK dependent regulation of DNA replication 1 
The cell cycle of eukaryotes is controlled by the activity of CDKs, a family of 
threonine-serine protein kinases that phosphorylate specific target proteins 
promoting the activation or inhibition of cell cycle phases. The catalytic subunit of the 
kinase is regulated by cell cycle dependent association with a regulatory subunit, a 
cyclin, whose expression and/or stability is itself cell cycle dependent. Association of 
a cyclin with CDK controls the specific cell cycle transitions. For instance, G1-CDK 
promotes S-phase entry, S-CDK inhibits origins licensing and promotes DNA 
replication and finally M-CDK regulates chromosome segregation during mitosis 
(Humphrey & Pearce, 2005). Similar as for DDK, the S-CDK concentration is 
regulated by APC/C mediated degradation and therefore follows an analogous 
dynamic as described above for DDK (Ang & Wade Harper, 2005).  
 
1.7.1 Regulation of pre-RC formation 
S-CDK acts on initiation of replication in multiple ways. Firstly, relatively low 
levels of the kinase phosphorylate Orc2 and Orc6 (Nguyen et al, 2001), which 
inhibits the interaction of ORC with Cdt1 (Chen & Bell, 2011; Fernandez-Cid et al, 
2013; Frigola et al, 2013). Secondly, S-CDK dependent phosphorylation of Cdc6 
induces its degradation by the SCF complex (Drury et al, 1997; Elsasser et al, 1999; 
Perkins et al, 2001). Thirdly, phosphorylation of Mcm3 results in MCM2-7/Cdt1 
export from the nucleus (Labib et al, 1999; Liku et al, 2005; Nguyen et al, 2001). All 
these redundant mechanisms prevent pre-RC formation and thus origin licensing 
during the G1-S transition, to guarantee that no origin becomes licensed after it has 
been already fired. 
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1.7.2 Regulation of pre-IC formation 
The most important role of S-CDK is to promote helicase activation. It was 
found that Sld2 and Sld3 are the two essential targets of CDK in budding yeast 
(Masumoto et al, 2002; Tanaka et al, 2007b; Zegerman & Diffley, 2007), however if 
this is also true in higher eukaryotes is not known. S-CDK phosphorylated Sld2 and 
Sld3 bind to Dpb11 involving two pairs of BRCT domains that have phosphopeptide 
binding activity. The N-terminal pair of BRCT domains bind Sld3-P and the C-
terminal pair of BRCT domains bind Sld2-P, forming a trimeric complex. Moreover, 
recently it was shown that a flexible linker in between these two pairs of BRCT 
domains binds GINS, which is important for efficient replication (Tanaka & Araki, 
2013). In particular the binding of Sld2-P to Dpb11 is crucial for pre-LC formation, 
GINS recruitment to the replication origin and ultimately CMG formation (Muramatsu 
et al, 2010). Importantly, Sld2 becomes phosphorylated on multiple sites; however 
the phosphorylation of T84 is essential for Dpb11 binding (Tak et al, 2006). T84 
phosphorylation requires pre-phosphorylation of several other sites in Sld2, thus T84 
becomes only phosphorylated at high CDK activity. This regulatory principle could be 
important to ensure that pre-RC formation is inhibited completely at low CDK 
concentrations prior to helicase activation at high CDK concentrations. Moreover, 
hierarchical multisite-phosphorylation is predicted to allow a switch-like activation of 
Sld2 and helicase activation (Brummer et al, 2010), however how this regulatory 
principle is coordinated with the replication timing program of the cell is currently 
unclear.   
Remarkably, simultaneous bypass of the CDK and DDK pathways in G1-phase, 
using a Sld3–Dpb11 fusion (SD fusion), overexpression of a phospho-mimetic Sld2-
T84D mutation and a mcm4Δ74–174 allele allows extensive DNA synthesis in α-
factor arrested, G1 cells (Sheu & Stillman, 2010).  
Importantly, in case of DNA damage, Rad53 functions to inhibit both CDK- 
and DDK dependent activation pathways. Rad53 acts on DDK directly by 
phosphorylating Dbf4, whereas the CDK pathway is blocked by Rad53-mediated 
phosphorylation of the essential CDK substrate, Sld3 (Duch et al, 2011; Lopez-
Mosqueda et al, 2010; Zegerman & Diffley, 2010). This allows CDK to remain active 
during S-phase in the presence of DNA damage, which is crucial to prevent re-
licensing of origins that have already fired.  
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1.8 Proteins relevant to this study 
This study focuses its attention on the recruitment of Cdc45 to the loaded MCM2-7 
complex as the initial step in the process of helicase activation. Several factors were 
known to be required (MCM2-7, Sld3, Cdc45) or implicated (Sld7) in this process, 
whereas a new function was identified for Sld2 during this study. An overview of the 
features of these crucial proteins is presented below. 
 
1.8.1 MCM2-7 
MCM2-7 forms the engine of the eukaryotic replicative helicase (Labib et al, 
2000), but it has little helicase activity on its own (Bochman & Schwacha, 2008; 
Ishimi, 1997; Lee & Hurwitz, 2000) and it has to be activated by the interaction with 
Cdc45 and GINS (Araki, 2010). The MCM2-7 complex consists of six AAA+ ATPase 
proteins that assume a toroidal two-tiered structure, where the smaller ring is made 
up of the N-terminal section and the larger ring of the C-terminal ATPase domains 
(Riera et al, 2013). All Mcm subunits are highly homologous, containing a less 
conserved C-terminal AAA+ and an N-terminal domain, and their disposition in the 
heterohexamer is fixed (Mcm2/6/4/7/3/5). Only properly assembled hexamers can in 
fact enter the nucleus at the end of M-phase, where they stay throughout G1-phase 
before being released during S-phase (Labib et al, 1999; Nguyen et al, 2000). 
MCM2-7 lacks intrinsic affinity for DNA and its association with origins is 
ORC/Cdc6/Cdt1-dependent (Mendez & Stillman, 2003). 
Individual Mcm subunits have specialised functions. Mcm6 C-terminus 
contains an inhibitory domain that blocks OCCM formation in the absence of Cdt1 
and deletion of the conserved Mcm3 C-terminus (Sun et al, 2013) or even a C-
terminal V972R point mutation in Mcm3 abrogates binding of Cdt1/MCM2-7 to 
ORC/Cdc6 (Frigola et al, 2013; Sun et al, 2013). Additionally, Mcm2, Mcm3, Mcm4, 
Mcm6 and Mcm7 carry N-terminal extensions, which in vitro get phosphorylated by 
DDK (Kihara et al, 2000; Weinreich & Stillman, 1999). It has been shown that a 
deletion of the Mcm4 N-terminus bypasses the requirement of DDK activity during S-
phase (Sheu & Stillman, 2010) and  a mutation of Mcm5 called bob-1 (P83L) allows 
DNA replication and cell growth in the absence of DDK as well (Hardy et al, 1997; 
Jackson et al, 1993). Since Mcm5 is the only MCM2-7 subunit that does not become 
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phosphorylated by DDK, it is likely that it mimics a DDK-mediated structural change 
in the helicase. Importantly, it was shown that DDK phosphorylation of MCM2‐7 does 
not by itself promote separation of the double-hexamer, but it is required for the 
recruitment of firing factors and replisome components to origins (On et al, 2014). 
Additionally, pre-phosphorylation of the MCM2-7 is required for DDK to bind and 
phosphorylate the loaded MCM2–7 complex (Francis et al, 2009) and Mec1, 
facilitated by Mrc1, is one of the kinases that prime MCM2-7 for DDK 
phosphorylation (Randell et al, 2010). 
 
1.8.2 Sld3 
The replicative factor Synthetically Lethal with Dbp11-1, Sld3, (Kamimura et 
al, 1998) is considered to be a key protein for the pre-IC formation in yeast, since its 
association with origins is a prerequisite for the initiation of DNA replication. It is a 
limiting factor, as it is present with only 300 copies/cell whereas the number of 
replication origins in the genome is around 700-1000 (Tanaka et al, 2011b). It is 
essential in vivo (Kanemaki & Labib, 2006; Tanaka et al, 2007b) and it is required for 
Cdc45 association with origins (Kamimura et al, 2001). Sld3 and Cdc45 recruitment 
to origins indeed follows the same dynamics and it is weak during late G1-phase and 
stable in S-phase (Kamimura et al, 2001; Kanemaki & Labib, 2006). Work from 
Kaplan lab employing purified proteins from budding yeast showed that Sld3 binds 
MCM2-7, allegedly facilitating Cdc45 interaction with MCM2-7. Additionally, Sld3 
shows ssDNA binding properties and its interaction with the nucleic acid impairs 
binding to MCM2-7, indicating that ssDNA and MCM2-7 could compete for Sld3 
binding. Finally, it was found that Sld3 competes with GINS for binding to MCM2-7 
and ssDNA facilitates GINS-MCM2-7 interaction, possibly promoting Sld3 release 
from origins and CMG formation (Bruck & Kaplan, 2011a). This is consistent with the 
finding that in the absence of GINS, Sld3 release from chromatin is slower in vivo 
(Kanemaki & Labib, 2006). Unfortunately this in vitro data is not conclusive, because 
MCM2-7 is not loaded on DNA, but the experiments were performed with purified 
MCM2-7 in solution. Moreover, it is believed that purified MCM2-7 can assume 
different conformations, closed circular and spiral shaped complexes (Costa et al, 
2011), therefore the experiments by the Kaplan lab are not conclusive on its own. 
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Sld3 is also reported to bind the non-essential factor Sld7 throughout the cell 
cycle, which is probably involved in its stability and functionality (Tanaka et al, 
2011b). Importantly, Sld3, together with Sld2, are the essential CDK targets. The 
CDK mediated phosphorylation of Sld3 generates a binding site for the N-terminal 
BRCT repeat in Dpb11 (Tanaka et al, 2007b; Zegerman & Diffley, 2007). 12 CDK-
phosphorylation sites have been mapped in Sld3 and the phosphorylation of T600 
and S622 by CDK were shown to be crucial for the binding of Dpb11 (Tanaka et al, 
2007b; Zegerman & Diffley, 2010). Interestingly, a Cdc45 mutant (Cdc45-Jet1), 
which bypasses the requirement for S-CDK, allows Sld3-Dpb11 interaction in the 
absence of phosphorylation of T600 and S622, indicating that Cdc45 can bridge and 
stabilise the binding (Tanaka et al, 2007b). In the context of purified proteins in 
solution, S-CDK is not required for Sld3 interaction with MCM2-7 and Cdc45 (Bruck 
& Kaplan, 2011a) but the CDK-phosphorylation mediated interaction of Sld3 with 
Dpb11, which is part of the pre-LC (Muramatsu et al, 2010), could function to 
facilitate GINS recruitment to origins and helicase activation via CMG formation.  
Additionally, during DNA damage, initiation of DNA replication needs to be 
blocked to maintain genomic integrity. In budding yeast this block is operated by a 
Rad53-mediated phosphorylation of Sld3 and Dbf4 (Zegerman & Diffley, 2010), 
suggesting that Sld3 represents a key regulatory protein during pre-IC formation. 
Rad53 has the function to reduce DNA replication in response to DNA damage and, 
during the S-phase checkpoint, this is exerted by inhibiting late origin firing. Rad53 
phosphorylation of Sld3 impairs its interaction with Dpb11 and Cdc45, even when 
Sld3 had already been phosphorylated by S-CDK (Lopez-Mosqueda et al, 2010; 
Zegerman & Diffley, 2010). This mechanism appears crucial to prevent Cdc45 and 
GINS recruitment to loaded MCM2-7 on origins.  
It was recently found that Sld3 gets phosphorylated during G1-phase in a 
DDK dependent manner. Interestingly, the modification increases in the presence of 
Rif1 (a telomere-binding factor implicated in DNA replication control) mutants 
(Mattarocci et al, 2014), providing further indication that Sld3 is subject to temporal 
and locus specific control during the cell cycle. 
Based on this analysis it is clear that Sld3 is a central player in mediating 
initiation of DNA replication. The findings that the association of Sld3 with each origin 
is a prerequisite for initiation of DNA replication and its role in promoting the correct 
temporal order of chromosomal DNA replication, make Sld3 a particularly interesting 
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protein for detailed studies. Very little is known about the mechanism of its 
association with origins and MCM2-7 and about the molecular details of its function 
in promoting helicase activation. 
 
1.8.3 Cdc45 
Cdc45 is an essential replication factor and its function is conserved among 
species (Aparicio et al, 1997; Owens et al, 1997). It was found to associate weakly 
with origins already in late G1-phase together with Sld3, and their recruitment in 
budding yeast is mutually dependent (Kamimura et al, 2001). Cdc45 in fact interacts 
directly with Sld3 (Bruck & Kaplan, 2011a; Kamimura et al, 2001) and this interaction 
is believed to promote Cdc45 recruitment to the pre-RC, ultimately facilitating the 
CMG formation. Cdc45 is operating, together with GINS, for the activation of the 
MCM2-7 helicase (Costa et al, 2011; Ilves et al, 2010), but the initial association of 
Cdc45 with origins does not require the presence of GINS (Kanemaki & Labib, 
2006). Cdc45 becomes part of the CMG complex and it travels with the replisome. 
Additionally, Cdc45 has ssDNA binding properties, both in budding yeast (Bruck & 
Kaplan, 2013) and human (Szambowska et al, 2014), and this feature could be 
required for the separation of the two strands of DNA during CMG establishment or it 
could facilitate processive DNA unwinding of the CMG helicase. Consistently, a 
similarity was found between Cdc45 and RecJ, a prokaryotic ssDNA exonuclease 
(Krastanova et al, 2012; Sanchez-Pulido & Ponting, 2011). In addition to the helicase 
activation function, Cdc45 is required for the association of DNA polymerases with 
origins (Aparicio et al, 1997) and it enhances GINS and Mcm10 recruitment (Heller 
et al, 2011).  
 
1.8.4 Sld2 
The replication factor Synthetically Lethal with Dbp11-1, Sld2 (Kamimura et al, 
1998) binds to Dpb11 during S-phase in a CDK dependent manner (Tanaka et al, 
2007b; Zegerman & Diffley, 2007). Sld2 has 11 motifs suitable for phosphorylation 
by S-CDK (S/T-P) but the phosphorylation of T84 is crucial for the binding to the C-
terminal BRCT domain of Dpb11 (Araki, 2010; Tanaka et al, 2007b; Zegerman & 
Diffley, 2007). Despite the requirement of phosphorylation of one individual amino 
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acid, the phosphorylation of multiple additional residues appears to be occurring in 
vivo prior to modification of T84 (Araki, 2010; Tanaka et al, 2007b). Nevertheless, 
the introduction of a Sld3-Dpb11 fusion in addition to a S-CDK bypass mutant of 
Sld2 (Sld2T84D) allows replication in vivo in the absence of S-CDK (Zegerman & 
Diffley, 2007). 
The phosphorylation of Sld2 and its interaction with Dpb11 are essential for 
the formation of the pre-LC complex, composed by Sld2, Dpb11, Polε, GINS 
(Muramatsu et al, 2010). Consistently, Sld5 (GINS subunit) and Dpb11 form a 
complex in vitro when Sld2 is phosphorylated by S-CDK (Tanaka et al, 2007a; 
Tanaka et al, 2007b). Additionally, Sld2 and Dpb11 were found to interact with the C-
terminal portion of Pol2 (catalytic subunit of Polε) in yeast two hybrid assays 
(Muramatsu et al, 2010). Importantly, S-CDK dependent phosphorylation of Sld2 
enhances its binding to Polε and GINS interacts with Sld2 only in the presence of 
Polε. The deprivation of DDK does not impair pre-LC formation, indicating that only 
S-CDK activity is involved in this step. 
Sld2, similarly to Sld3 and Dpb11, does not move with the replication fork, therefore 
it appears possible that its function is to facilitate the recruitment of GINS via 
establishment of the pre-LC, which itself needs to be disassembled prior to initiation 
of replication (Muramatsu et al, 2010). Interestingly, Sld2 does not interact with GINS 
nor with Cdc45 (Muramatsu et al, 2010), therefore its role in promoting CMG 
formation is indirect. Consistently, the overexpression of GINS compensates for the 
individual depletion of Sld2, Dpb11 and Polε (Muramatsu et al, 2010) but in the 
absence of kinases or additional factors, Sld2, Sld3 and Dpb11 alone are unable to 
support CMG formation in vivo (Heller et al, 2011). It was recently found that a 
mutant of Sld2, which cannot bind to MCM2-7 (Sld2-m1,4), impairs DNA replication 
and stimulates CMG association already in G1-phase (Bruck & Kaplan, 2014), 
suggesting that a possible function for Sld2 is to prevent the association of GINS in 
G1-phase. Sld2 can interact in vitro with MCM2-7 in the context of purified proteins in 
solution, both in its CDK-phosphorylated form (P-Sld2) as well in the unmodified, but 
the binding of P-Sld2 and Sld3 to MCM2-7 appears to be competitive (Bruck & 
Kaplan, 2011a). Additionally, the interaction of P-Sld2 to MCM2-7 blocks in vitro the 
direct binding of GINS to MCM2-7 in a concentration dependent manner (Bruck et al, 
2011). Interestingly, (Sld2T84D), which is the phosphomimetic form of S-CDK 
phosphorylated Sld2, binds directly to ssDNA at early firing origins (ARS1 and 
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ARS305) (Kanter & Kaplan, 2011) and ssDNA inhibits Sld2T84D and Sld3 
interaction with MCM2-7 but, conversely, promotes GINS binding to MCM2-7. 
Crucially, unphosphorylated Sld2 blocks GINS-MCM2-7 interaction even in presence 
of ssDNA (Bruck et al, 2011) but, once again, the results were obtained in the 
context of purified MCM2-7 in the absence of DNA, and are not conclusive on their 
own. All these findings define Sld2 as a crucial player in CMG establishment and 
helicase activation but the mechanisms underlying its interactions and activity remain 
unclear. 
 
1.8.5 Sld7 
Following the discovery of Sld2, Sld3 and Sld5 (GINS subunit) in a screen for 
synthetically lethal mutants with Dpb11 (Kamimura et al, 1998) the Araki lab 
performed a second screen, identifying a new replicative factor, Sld7 (Tanaka et al, 
2011b). Sld7 appears to bind to the N-terminal (amino acids 60-120) of Sld3 
throughout the cell cycle and to reduce Sld3 affinity for Cdc45. It is not required for 
Sld3 interaction with origins but, in the absence of Sld7, Sld3 levels in the cells are 
reduced and there is a delay in origin firing, which is revealed by an extended 
association of GINS with origins. The role of Sld7 is not yet clear but it has been 
proposed that it helps in the stabilisation of Sld3 (Tanaka et al, 2011a; Tanaka et al, 
2011b). 
 
1.8.6 Protein interactions network 
Based on the current data, the processes of helicase loading and activation 
depend on an intricate network of protein-protein interactions. While the in vitro pre-
RC reconstitution has led to a detailed understanding of the mechanisms of helicase 
loading over the last few years, much has still to be discovered on the progression 
towards pre-IC and CMG formation and helicase activation. This is mainly due to the 
technical difficulties encountered attempting to reconstitute the pre-IC in vitro; the 
great number of factors involved and the strict kinase-mediated regulation of the 
process have been challenging the possibility to gain insights in the helicase 
activation step. Most of the recent work in this direction employed yeast extracts 
instead of purified proteins (Gros et al, 2014; Heller et al, 2011; On et al, 2014), 
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limiting the possibility to obtain information on the mechanistic details of the process. 
Nevertheless, some direct protein interactions involved have been studied over the 
years with both the two hybrid assay and immunoprecipitation with purified factors 
(full list in Appendix I, Table VI) and a schematic summary can be found in Figure 
1.4. 
 
Figure 1.4: Protein-protein interactions in helicase loading and activation 1 
Schematic representation of the interactions involved in the helicase loading A) and 
activation B) processes. Solid lines represent direct physical interactions whereas dashed 
lines stand for interactions detected with two hybrid system.  
 
A multitude of replicative factors are shown to interact with MCM2-7, 
remarking the crucial role that this complex plays during initiation of replication. In 
general, it is evident that most of the proteins involved in pre-IC formation are 
establishing contact with multiple other factors. The great number of elements 
involved and the apparent redundancy of some of the mechanisms can be explained 
with the necessity of strict regulation of DNA replication in order to avoid errors 
during the duplication of the genome and to generate a highly efficient DNA 
replication system. This is also reflected in the complicated helicase activation 
mechanism which, in eukaryotes, led to the establishment of a more sophisticated 
machinery compared to Archaea. 
 
                                               
1
 As in Tognetti, Riera and Speck, submitted 
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1.8 Differential regulation of pre-IC formation in S. pombe and 
vertebrates 1 
The core factors of the replicative helicase are conserved between Archaea 
and Eukarya (MCM2-7, Cdc45, GINS), while the pre-IC proteins (Dpb11, Sld3, Sld7, 
Sld3, Mcm10, Ctf4) have no apparent ortholog in prokaryotic or viral systems. 
Moreover, the latter factors have further evolved in higher eukaryotes and acquired 
new protein domains or functions (Tanaka & Araki, 2013). A summary of the 
replicative factors in S. cerevisiae, S. pombe and Metazoa and their function can be 
found in Appendix I, table VII. 
S. pombe and S. cerevisiae helicase activation factors have a fairly high sequence 
similarity; however their regulation is partially different. DDK is required for Sld3 
recruitment at origins, but Sld3 association, other than in budding yeast, is 
Sna41/Cdc45 independent. Instead Sna41/Cdc45 associates with chromatin in a 
CDK dependent manner (Fukuura et al, 2011; Yamada et al, 2004). Nevertheless, it 
was found in S. pombe that the Sld3-origin interaction is essential for the subsequent 
recruitment of Cut5/Dpb11, Drc1/Sld2, Sna41/Cdc45 and GINS (Yabuuchi et al, 
2006). Similarly as in budding yeast, DDK is essential for the process of helicase 
activation; though, in fission yeast DDK-bypass mutants in the MCM2-7 helicase 
have not been identified. However, the deletion of Mrc1, which is required for 
maintenance of replication fork integrity, or of Rif1 (discussed in paragraph 1.6), can 
bypass the requirement of DDK in S. pombe (Hayano et al, 2012; Matsumoto et al, 
2011). Moreover, S. pombe CDK facilitates the interaction of Drc1/Sld2 and Sld3 
with Cut5/Dpb11, similarly as in budding yeast (Fukuura et al, 2011; Nakajima & 
Masukata, 2002; Noguchi et al, 2002; Saka et al, 1994), but then again CDK 
dependent phosphorylation of Sld3 is not essential for the interaction with 
Cut5/Dpb11, probably because the Drc1/Sld2 interaction with Cut5/Dpb11 stabilizes 
the trimeric complex (Fukuura et al, 2011).  
In vertebrates the predicted homologues of Sld3, Sld2 and Dbp11 are 
Treslin/Ticrr, RecQ4 and TopBP1 respectively, but their amino acid and domain 
organisation has diverged significantly (Tanaka & Araki, 2013). As in budding yeast, 
Treslin/Ticrr/Sld3 can bind Cdc45 and it is required for its association with origins (Im 
et al, 2009; Kumagai et al, 2011; Van Hatten et al, 2002). Furthermore, it binds the 
                                               
1
 As in Tognetti, Riera and Speck, submitted 
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N-terminal BRCT domain of TopBP1/Dpb11 and it is phosphorylated by CDK on the 
same conserved residues (Boos et al, 2011; Kumagai et al, 2011). Finally, the 
checkpoint kinase 1 Chk1 can reduce the interaction of Treslin/Sld3 with 
TopBP1/Dpb11, in the same way to what was observed for Rad53 regulation of the 
interaction Sld3-Dpb11 in budding yeast (Boos et al, 2011; Kumagai et al, 2011; 
Lopez-Mosqueda et al, 2010; Zegerman & Diffley, 2010), indicating that Treslin and 
Sld3 function in an identical manner, although their sequence has diverged.  
Likewise, RecQ4 has been suggested as the homologue of Sld2, despite the 
fact that the two proteins have very limited sequence conservation. The two proteins 
share only a weak similarity in the N-terminal portion, but this region is essential for 
DNA replication (Matsuno et al, 2006; Sangrithi et al, 2005). Moreover, RecQ4 
association with origins is TopBP1/Dpb11 and pre-RC dependent, similarly as in 
budding yeast. However, RecQ4 differs from Sld2 for the following functional 
characteristics: unlike Sld2, RecQ4 contains a C-terminal helicase domain and is not 
required for TopBP1/Dpb11, Cdc45 or GINS interaction with origin DNA. 
Furthermore, RecQ4 and TopBP1/Dpb11 can bind in the absence of CDK 
phosphorylation, which is instead essential for the Sld2-Dpb11 interaction (Matsuno 
et al, 2006; Sangrithi et al, 2005). Finally, unlike Sld2, RecQ4 binds to Mcm10 and 
associates with the CMG in a Mcm10 dependent manner (Xu et al, 2009). In 
summary, although RecQ4 and Sld2 share some similarities, it is still an open 
question if RecQ4 is the functional homologue of Sld2. 
Cut5/TopBP1 is thought to be the functional homologue of Dpb11, as the 
proteins share important structural similarities (Garcia et al, 2005; Rappas et al, 
2011; Tanaka & Araki, 2013); however, some differences have been observed as 
well.  Similarly to what is known for lower eukaryotes, the association of 
Cut5/TopBP1/Dpb11 with chromatin is CDK dependent. However, other than in 
yeast, this interaction is modulated by CDK concentration: at low CDK 
concentrations Xenopus Cut5/TopBP1/Dpb11 is recruited to chromatin via an 
interaction with ORC and at high CDK concentrations via a pre-RC interaction, but 
even the recruitment at low CDK concentration is sufficient for DNA replication 
(Hashimoto et al, 2012; Van Hatten et al, 2002). Moreover, Xenopus 
Cut5/TopBP1/Dpb11 and Cdc45 interact directly (Schmidt et al, 2008), which is 
probably important, as Cdc45 association with chromatin requires 
Cut5/TopBP1/Dpb11 (Kumagai et al, 2011; Van Hatten et al, 2002). TopBP1 and its 
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counterparts share BRCT domains, even though they differ in number (Garcia et al, 
2005; Rappas et al, 2011) and only the first two pairs involved in Treslin/Sld3 binding 
are indispensable for replication  (Kumagai et al, 2010), while Dpb11 has four 
essential BRCT domains. The additional BRCT domains of TopBP1, which do not 
exist in Dpb11, function in checkpoint control of DNA replication (Garcia et al, 2005), 
indicating that this function has become more important for vertebrates. 
Homologues for Mcm10 and Pol have also been identified in vertebrates. 
While budding and fission yeast Mcm10 is believed to be involved in the CMG 
activation in a step subsequent to its assembly at the replication origins (Kanke et al, 
2012; van Deursen et al, 2012; Watase et al, 2012), human and Xenopus Mcm10 
are probably involved also in the CMG assembly process (Im et al, 2009; 
Wohlschlegel et al, 2002) together with Ctf4 and RecQ4 (Im et al, 2009). If metazoan 
Polε functions in a way similar to the yeast counterpart for pre-LC and CMG 
formation has yet to be discovered. 
Among all replication factors involved in helicase activation in budding yeast, only 
Sld7 is currently lacking homologues in higher eukaryotes. However, very recently a 
newly discovered factor, named MTBP (MDM two binding protein) was proposed as 
the functional homologue of Sld7 in human cells. It is reported to interact with 
Treslin/TICRR throughout the cell cycle and its depletion inhibits DNA replication by 
preventing assembly of the CMG during origin firing (Boos et al, 2013). Moreover, 
two metazoan factors, GEMC1 and DUE-B (Balestrini et al, 2010; Chowdhury et al, 
2010), both of which bind to TopBP1/Dpb11 and Cdc45, are required for the 
recruitment of Cdc45 to chromatin. However, they have no homologue in lower 
eukaryotes, indicating that activation of the replicative helicase in vertebrates is more 
complex than in yeast. 
DDK and CDK regulation of pre-IC formation is also essential in metazoans 
and it appears to function similarly as in S. cerevisiae with DDK operating prior to 
CDK. Moreover, DDK dependent phosphorylation of MCM2-7 (Masai & Arai, 2000a; 
Masai & Arai, 2000b; Masai et al, 2000) facilitates Cdc45 binding of chromatin 
(Masai et al, 2006), indicating that the overriding DNA replication concepts are 
conserved between lower and higher eukaryotes.  
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1.9 DNA replication and relevance for human health 
DNA replication is a fundamental biological process in all living organisms; mis- 
regulation and mutation of the factors involved cause genomic instability, growth 
defects and cancer. Given that the replicative machinery shows conserved features 
among species, the insights acquired studying any organism are useful to improve 
the understanding of basic notions that can ultimately be relevant for human health. 
Moreover, replicative proteins have proven to be good markers for detection of 
several common carcinomas and are potential targets for treatments, as their 
inhibition affects cancer cells viability (Jackson et al, 2014). 
 
1.9.1 Mutation of replicative factors 
Genes encoding for human DNA replication proteins can carry mutations 
resulting in a range of clinical disorders. These disorders share some common 
features, including reduced growth and increased risk of cancer and multisystem 
dysfunction of highly energy-dependent tissues for mitochondrial genes (Jackson et 
al, 2014). 
Mutations in genes coding for Orc1, Orc4, Orc6, Cdc6 and Cdt1 have recently been 
identified in patients with Meier-Gorlin syndrome (Bicknell et al, 2011a; Bicknell et al, 
2011b; Guernsey et al, 2011), characterised by short stature, microtia (reduced 
external ear size), hypoplasia/absence of the patella but usually normal intellect 
(Bongers et al, 2001; Gorlin et al, 1975). The general growth defect appears to be a 
result of problems during origin licensing, therefore these mutations could impair 
rather than abrogate pre-RC function. However, it has not to be forgotten that 
several replicative proteins operate also outside DNA replication therefore the 
defects caused by their mutation could impair other functionality of the cell. For 
example, in addition to regulating DNA replication, the Orc1 subunit of the human 
ORC controls centriole and centrosome copy number. Meier-Gorlin syndrome 
mutations cause in fact centrosome reduplication because of disruption of an Orc1 
CDK inhibitory domain (Hossain & Stillman, 2012).  
Finally, a specific mutation in the gene coding for Mcm4 has been linked with 
genome instability and adenocarcinomas in mice (Shima et al, 2007a; Shima et al, 
2007b). In human, a homozygous splice-site mutation in the MCM4 gene is 
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associated with a syndrome causing adrenal insufficiency, natural killer cell 
deficiency and chromosome instability (Gineau et al, 2012; Hughes et al, 2012). 
 
1.9.2 Replicative stress and cancer 
DNA replication must be strictly regulated to ensure accurate duplication of 
the genome during each cell cycle. Deregulation is a major cause of replicative 
stress and DNA damage, both occurring in tumorigenesis. Genome instability can be 
either cause or consequence of tumour progression and it has been additionally 
proposed that activated oncogenes are responsible for replicative stress (Bartkova et 
al, 2005; Gorgoulis et al, 2005).  
Replicative stress causes stalling or collapsing of replication forks, leading to DNA 
damage which in turn activates a DNA damage response (DDR) and ultimately 
senescence and apoptosis (Bartkova et al, 2006; Di Micco et al, 2006). These 
programs of cell death have the specific function to protect the cell from insults but, 
whenever additional changes occur to down regulate the DDR, tumour progression 
can take place. Cells, in order to prevent replicative stress, must avoid origin under-
usage as much as over-usage and re-usage. These crucial issues are circumvented 
by several mechanisms that prevent re-replication (i.e. oscillation of CDK activity, 
see paragraph 1.7), ensure temporally regulated origin licensing and avoid 
simultaneous firing of origins (i.e. limiting levels of firing factors) (reviewed in (Hills & 
Diffley, 2014)). Whenever some origins are not used for replication there can be both 
loss of the genetic information as well as DNA damage, possibly because of 
increased fork speed due to the greater distance that has to be covered (Burrell et al, 
2013). Over-usage of origins also promotes DNA damage in different ways: directly 
by depletion of RPA (which coats newly replicated ssDNA, protecting it from 
damage), or because of fork stalling due to depletion of dNTPs or limiting replicative 
factors, as well as possible clashes of replication and transcription (Toledo et al, 
2013). Re-replication can cause DNA damage via fork stalling (Green et al, 2010) or 
collapse (Neelsen et al, 2013), it can induce homologous recombination therefore 
altering the gene dosage and it has been proposed to play a role during cancer 
progression (Jones et al, 2013; Liontos et al, 2007; Tatsumi et al, 2006). 
The finding that cancer cells are characterised by situations of replicative 
stress could be used for the development of cancer therapies. In advanced tumours 
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for example it is possible that DDR is bypassed and the active components of the 
DDR pathway are actually actively promoting fork stability and DNA repair, helping 
the malignant cell to cope with the replicative stress. In this sense, further studies on 
replication and its regulation can be helpful to improve the understanding in the 
mechanisms cancer cells employ to circumvent death and in the future specifically 
target the de-regulated factors involved (Hills & Diffley, 2014). 
 
1.9.3 DNA replication and cancer diagnosis 
Diagnosis, essential for successful treatment of the most common cancers, is 
based on the differentiation of normal and cancer cells. DNA replication proteins 
have proved to be good markers for early detection of several common carcinomas. 
MCM2-7, in particular, appears to be a better marker than the currently used PCNA 
(DNA clamp required for the processivity of Polδ during replication) and Ki67 (a 
nuclear protein associated with ribosomal RNA transcription) (Jackson et al, 2014). 
MCM2-7 expression in fact is down regulated before normal cells are released from 
solid tissues into body fluids but this does not occur in cancer cell, therefore MCM2-7 
can be found exclusively in body fluids containing malignant and premalignant cells 
(Freeman et al, 1999; Gonzalez et al, 2005; Hiraiwa et al, 1998; Tachibana et al, 
2005; Todorov et al, 1998). This could be explained with the assumption that 
malignant cells may be constantly replicating DNA or that they have an extended 
G1/S-phase because of defects in helicase loading and activation.  
The employment of replicative proteins as markers reduces the false-negative 
results associated with conventional cytological screening and allows sensitive and 
automated detection of immunopositive cells by microscopy. MCM2-7 appeared so 
far superior to other replicative factors (PCNA, Cdc6, Cdt1, ORC) because of its high 
nuclear abundance and expression in malignant cells, for the availability of specific 
antibodies for the detection and low variability upon staining (Celis & Celis, 1985; 
Gonzalez et al, 2004; Madine et al, 2000). For all these reasons, MCM2-7 has been 
used as marker in the screening of several cancer types including cervical cancer  
(Baldwin et al, 2003), colorectal cancer (Davies et al, 2002), bladder and prostate 
cancer (Stoeber et al, 1999; Stoeber et al, 2002) and cancers of the squamous 
epithelium of the oral cavity (Scott et al, 2006) and anal canal (Scarpini et al, 2008). 
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These evidences provide further proof of the crucial importance of studying the 
process of replication. 
 
1.10 Summary and project aims 
Over the last years, thanks to the in vitro reconstitution of the budding yeast 
pre-RC (Evrin et al, 2009; Remus et al, 2009), extensive work has provided insights 
in the helicase loading process but much remains to be discovered concerning 
helicase activation. How Sld3 and Cdc45, the pre-LC components, the polymerases 
and additional replicative factors are recruited to the origins, how the CMG complex 
and the replicative fork are established and the dsDNA is melted for the extrusion of 
one ssDNA, remain open questions. Studies in vivo could not, so far, address these 
questions for several reasons. The redundancy that characterises these strictly 
regulated fundamental processes makes it difficult to discriminate the contribution of 
individual factors. Many in vivo assays allow only limited insights into the exact 
molecular mechanisms that facilitate complex formation and moreover, it is difficult to 
detect transient events in vivo.  
These problems can partially be overcome using in vitro reconstituted 
systems and purified proteins. For this reason, this project took advantage of the in 
vitro reconstitution system developed in the Speck group (Evrin et al, 2009) and 
aimed to recapitulate the initial steps following MCM2-7 double-hexamer 
establishment which lead to Cdc45 recruitment.  
Additionally, a systematic pairwise interactions analysis using purified and in 
vitro translated proteins from Saccharomyces cerevisiae was performed in order to 
understand how these factors interact with each other and MCM2-7, allowing 
helicase loading and activation.  
A new network of interactions required for the stable recruitment of Cdc45 to 
MCM2-7 was identified during this study. The interaction sites in these proteins were 
mapped and mutants were generated in order to disrupt the formation of the complex 
containing Cdc45 and finally tested in vivo in the attempt to validate the proposed 
model for Cdc45 recruitment at replicative origins. 
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Chapter 2 – Materials and Methods 
 
2.1 Materials 
 
2.1.1 General reagents 
All reagents were of molecular biology grade and obtained from Sigma Aldrich, 
except for those listed below. 
 
Category Product Brand 
Chemicals Dithiothreitol (DTT) Thermo Fisher Scientific 
Chemicals Ethanol Thermo Fisher Scientific 
Chemicals Formaldehyde Thermo Fisher Scientific 
Chemicals Iodoacetamide Thermo Fisher Scientific 
Chemicals Isopropyl ß-D-1-thiogalactopyranoside (IPTG) Thermo Fisher Scientific 
Chemicals Magnesium sulphate (MgSO4) Thermo Fisher Scientific 
Chemicals Methanol Thermo Fisher Scientific 
Chemicals Propan-2-ol Thermo Fisher Scientific 
Chemicals Silver nitrate Thermo Fisher Scientific 
Chemicals Bidistilled glycerol VWR 
Chemicals Dimethyl sulfoxide (DMSO) VWR 
Chemicals Ethylene diamine tetraacetic acid (EDTA) VWR 
Chemicals Ethylene glycol tetraacetic acid (EGTA) VWR 
Chemicals Glycine VWR 
Chemicals Potassium hydroxide (KOH) VWR 
Chemicals Sodium chloride (NaCl) VWR 
Chemicals Sodium dodecyl sulphate (SDS) VWR 
Chemicals Sodium hydroxide (NaOH)  VWR 
Chemicals Sodium thiosulphate VWR 
Cloning/mutagenesis Herculase II Fusion DNA polymerase Agilent Technologies 
Cloning/mutagenesis QuickChange II site-directed mutagenesis kit  Agilent Technologies 
Cloning/mutagenesis PfuUltra II Fusion HS DNA polymerase  Agilent Technologies 
Cloning/mutagenesis Antarctic phosphatase New England Biolab (NEB) 
Cloning/mutagenesis LongAmp polymerase New England Biolab (NEB) 
Cloning/mutagenesis Quick ligation kit New England Biolab (NEB) 
Cloning/mutagenesis Restriction enzymes  New England Biolab (NEB) 
Cloning/mutagenesis Polymerase chain reaction nucleotide mix Roche 
DNA purification Plasmid MiniPrep kit Qiagen 
DNA purification Plasmid MidiPrep kit Qiagen 
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DNA purification Plasmid MaxiPrep kit Qiagen 
DNA purification PCR purification kit Qiagen 
DNA purification Gel purification kit Qiagen 
DNA purification Nucleotide removal kit Qiagen 
Agarose gel electrophoresis 1 kb ladder Invitrogen/Life technologies 
Agarose gel electrophoresis Agarose Invitrogen/Life technologies 
Media Amino acid dropout mix (Leu
-
, Ura
-
, Trp
-
, His
-
) ForMedium 
Media L-Histidine ForMedium 
Media L-Leucine ForMedium 
Media L-Tryptophan ForMedium 
Media Uracil ForMedium 
Media Yeast extract ForMedium 
Media Yeast nitrogen base ()without amino acids) ForMedium 
Media Peptone  ForMedium 
Media Bacto-Agar Invitrogen/Life technologies 
Media D (+) galactose Thermo Fisher Scientific 
Media D (+) glucose monohydrate VWR 
Antibiotics Ampicillin disodium salt Thermo Fisher Scientific 
Antibiotics Cloramphenicol Thermo Fisher Scientific 
Beads biotinylation Long arm photoprobe biotin Vector laboratories 
Protein purification PreScission protease GE Healthcare 
Protein purification Benzonase Merck 
Protein purification Complete protease inhibitor cocktail (+/- EDTA) (PIC) Roche 
Protein purification PhosSTOP cocktail Roche 
Protein detection Bradford reagent  BioRad 
Protein detection PageRuler Plus Prestained protein ladder Thermo Fisher Scientific 
SDS-PAGE SDS-PAGE standard broad range protein marker BioRad 
SDS-PAGE Acrylamide 40 % solution GE Healthcare 
SDS-PAGE Methylenbisacrylamide 2 % solution GE Healthcare 
SDS-PAGE NuPAGE Novex 4-12% Bis-Tris Protein Gels Invitrogen/Life technologies 
SDS-PAGE NuPAGE MES running buffer (20X) Invitrogen/Life technologies 
SDS-PAGE NuPAGE MOPS running buffer (20X) Invitrogen/Life technologies 
SDS-PAGE ProtoGel (30%)  National Diagnostics 
Western blotting Bovine serum albumin (BSA) fraction V Roche 
Western blotting Restore Western Blot Stripping Buffer Thermo Fisher Scientific 
Western blotting SuperSignal kit west Pico/Dura/Femto Thermo Fisher Scientific 
Buffer RC components Adenosine-5’-triphosphate (ATP) Roche 
Buffer RC components DNase I (recombinant RNase free) Roche 
Buffer RC components Human topoisomerase I  Topogen 
Radiolabeled EasyTag™ L-[
35
S]-Methionine  PerkinElmer 
Radiolabeled γ-
32
P-ATP  PerkinElmer 
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2.1.2 Oligonucleotides 
Oligonucleotides used for cloning were obtained from Sigma Aldrich whereas those 
for in vitro transcription and translation were from Eurofins. All oligonucleotides 
produced during this study are listed in Appendix I (Table II and III, respectively). 
 
2.1.3 Plasmids 
pESC yeast epitope tagging vectors (URA-, TRP-, LEU-, HIS-) were purchased from 
Stratagene, pGEX-6P-1 from GE Healthcare, pMALC2x and pRS416 from NEB. 
The origin containing DNA substrate for the reconstituted pre-RC assays was 
pUC19-ARS1 (Evrin et al, 2009). 
 
All constructs produced in the Speck group, prior or during this study, and used 
during this work are listed in Appendix I, Table I. Constructs listed below were 
produced by me, unless differently stated. 
 
Generation of FLAG-tagged variants of MCM2-7  
For the addition of the FLAG tag at Mcm2 N-terminus, the original plasmid for 
Mcm2/Mcm7 expression (pESC-LEU-Mcm2/Mcm7 (Evrin et al, 2009)) was modified 
during this work. The tag was subcloned from another plasmid available in the lab 
using BamHI.  
MCM2-7 mutants for the N-terminal deletions of Mcm2 (Δ1-200, Δ1-238, Δ1-251) 
were produced by PCR, in pESC-LEU-Mcm2/Mcm7 or pESC-LEU-FLAG-
Mcm2/Mcm7, using the Quick Change site directed mutagenesis kit.  
Hybrid mutants of MCM2-7 (Mcm2 h1-200 sc222-868 and h1-232 sc254-868) were 
produced via subcloning (SbfI/AsiSI) of the human fragment derived from a plasmid 
available in the lab into a modified versions of expression plasmid for Mcm2 where 
the AsiSI restriction site was inserted internally in the sequence (AsiSI modified 
Mcm2 plasmids produced by Samel). 
 
Cloning of Sld3 in pESC-HIS (Zech and Speck, unpublished) 
The coding sequence of Sld3 by PCR adding BamHI and SalI restriction sites and 
cloned it into pESC-HIS for protein expression in yeast. This construct was modified 
by insertion of an N-terminal MBP tag and amplified from pMALC2x. The primers 
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also encoded for a PreScission protease site, a myc tag and the BamHI restriction 
sites. 
 
Cloning of Sld3 (wt and mutants) in pRS416  
Sld3 mutants for in vivo analysis were produced during this study as following. In first 
place the wild type plasmid was generated by PCR amplification of the coding 
sequence of Sld3 from genomic DNA (AS499 strain) preceded by 1 kb in the 
promoter region, with the simultaneous addition of SacI/BamHI restriction sites, 
which were subsequentlyused for the cloning into pRS416. Sld3 mutants were 
produced via gene synthesis (Genescript) within the coding region of Sld3 and then 
the region was subcloned into the wild type Sld3 plasmid using AatII/SphI restriction 
sites.  
For overexpression of the Sld3 mutants, the mutated region was subcloned via 
AatII/SphI restriction sites into pESC-HIS-Sld3. 
 
Cloning of Cdc45 in pESC (Zech and Speck, unpublished) 
For yeast expression, the coding sequence of Cdc45 (missing the stop codon) was 
amplified by PCR, adding NotI and SpeI restriction sites, and cloned in pESC-HIS, 
pESC-LEU, pESC-TRP and pESC-URA vectors. The stop codon was deleted in 
order to have a C-terminal FLAG tag.  
 
Cloning of Cdc45 in pGEX-6P-1 
The coding sequence of Cdc45 was amplified by PCR using an existing pESC-
Cdc45 plasmid as template, adding BamHI and NotI restriction sites and cloned in 
pGEX-6P-1 vector to obtain GST-Cdc45. 
 
Cloning of Dbf4 and Cdc7 in pESC-TRP (Zech, Clarke and Speck, unpublished) 
MBP-Prescission-Dbf4 and Cdc7 were cloned into pESC-TRP for yeast expression. 
The Dbf4 gene was amplified from genomic DNA (AS499 strain) and SmaI/NheI 
restriction sites were added at the same time. The MBP-prescission coding DNA was 
amplified from a plasmid available in the group and cloned in before the dbf4 gene 
using a BamHI site. The cdc7 gene was amplified from genomic DNA of the S. 
cerevisiae strain S288C and cloned via NotI/SpeI the vector. 
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Cloning of Dpb11, Regα and MCM2-7 N-termini in pGEX-6P-1 C-terminal 
Dpb11, Regα and the N-terminal portions of the MCM2-7 genes were amplified from 
Dpb11, Regα and MCM2-7 expression plasmids available in the Speck group and 
cloned using SphI/NotI restriction sites into a modified version of pGEX-6P-1 
carrying the GST tag on the C-terminus (Herrera and Speck, unpublished). The N-
terminal MCM2-7 truncations (covering amino acids 1-322 for Mcm2, 1-192 for 
Mcm3, 1-340 for Mcm4, 1-174 for Mcm5, 1-302 for Mcm6 and 1-253 for Mcm7)  
were designed based on the strategy of Sheu and Stillman (Sheu & Stillman, 2010) 
and taking the secondary structure prediction and the multiple alignment into 
account. 
 
Cloning of Sld2 and Sld7 in pGEX-6P-1 (Herrera and Speck, unpublished) 
The coding sequence of Sld2 was amplified by PCR with the addition NotI and EcoRI 
restriction sites. The PCR product was cloned into pGEX-6P-1 vector. The coding 
sequence of Sld7 was amplified by PCR, adding NotI and BamHI restriction sites 
and cloned into pGEX-6P-1.  
 
2.1.4 Bacterial competent cells 
DH5α competent cells (Invitrogen) were used for plasmid amplification; XL10 Gold 
ultracompetent cells (Agilent Technologies) were used for site-directed mutagenesis; 
BL21 Codon+ RIL and (DE3) RIL competent cells (Stratagene) were used for protein 
overexpression. 
 
2.1.5 Yeast strains 
AS499 (MATa bar1Δ leu2-3,112 ura3-52 his3-Δ200 trp1-Δ63 ade2-1 lys2-801 pep4) 
and S288C (MATα SUC2 gal2 mal2 mel flo1 flo8-1 hap1 ho bio1 bio6) wild type 
yeast strain were gifts by Luis Aragon (Clinical Sciences Centre, London, UK) 
whereas Sld3-7 td strain was a gift from Karim Labib (College of Life Sciences, 
Dundee, UK). 
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2.1.6 Chromatography resins and columns 
All columns, magnetic beads and resins were from GE Healthcare except for EZview 
Red anti-HA affinity gel and Glutathione agarose (Sigma-Aldrich), Amylose resin 
(NEB), Dynabeads MyOne Streptavidin T1 and Dynabeads Protein G (Invitrogen/Life 
Technologies). 
 
2.1.7 Peptides 
Peptides were purchased from LifeTein. They were all 85% purity grade or higher 
with a N-terminal biotin and two aminohexanoic acid (Ahx) spacers between biotin 
and peptide. Peptides sequences can be found in Appendix I, Table IV. 
 
2.1.8 Antibodies 
All antibodies used in this work are listed in Appendix I, Table V. 
 
2.2 Methods 
 
2.2.1 Cloning 
PCR was performed using PfuUltra II Fusion HS DNA polymerase, DNA digested 
with NEB restriction enzymes, vector dephosphorylation was carried out with 
Antarctic Phosphatase and ligation reactions were performed using the NEB Quick 
Ligation kit. PCR products and digested DNA were purified with Qiagen PCR 
purification kit and gel extraction kit respectively. 
 
2.2.2 Mutagenesis 
All mutagenesis reactions were performed using the QuickChange II Site-Directed 
Mutagenesis kit following the manufacturer’s instructions. Oligonucletides for the 
amplification were generated using the QuikChange Primer Design program 
(http://www.genomics.agilent.com/primerDesignProgram.jsp) and ordered PAGE 
purified. The oligonucleotides were designed in order to generate a unique restriction 
site using silent mutations in the sequence 
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(http://watcut.uwaterloo.ca/template.php?act=silent_new). The PCR product was 
digested with DpnI to cleave the methylated DNA template and subsequently 
transformed into XL10 Gold ultracompetent cells. The success of mutagenesis was 
verified by restriction digestion and confirmed by sequencing. 
 
2.2.3 Agarose gel electrophoresis 
DNA samples were diluted with Orange G sample buffer (0.1 % (w/v) Orange G dye, 
50% (v/v) glycerol) and analysed by electrophoresis at 100 V for the required time in 
0.8, 1 or 2 % (w/v) agarose gel according to the size. The gel was stained with 
ethidium bromide and the stained DNA was visualised by UV exposure on BioRad 
Gel Doc. 
 
2.2.4 Bacterial competent cells preparation 
Bacterial competent cells were streaked out onto a LB plate (10 g/L tryptone, 5 g/L 
yeast extract, 10 g/L NaCl, 15 g/L bacto-agar, pH adjusted to 7, sterilised by 
autoclaving) with appropriate antibiotics as required. A single colony was grown into 
500 ml LB broth at 22ºC with shaking (200 rpm) until OD600 = 0.6. When the density 
was reached, the flask was placed on ice bath for 10 min. The culture was harvested 
at 2600 g for 10 min, 4ºC. The pellet was resuspended into 80 mL ice cold sterile TB 
buffer (10 mM HEPES/KOH pH 6.7, 250 mM KCl, 15 mM CaCl2, 55 mM MnCl2) and 
placed in ice bath for 10 min. The culture was harvested and the pellet resuspended 
in 10 mL ice cold TB buffer. While swirling, 1.4 ml fresh DMSO were added and the 
mixture placed on ice bath 10 min, aliquoted, frozen in liquid nitrogen and stored at -
80ºC. 
 
2.2.5 Bacterial transformation and culture 
Competent cells were thawed on ice, mixed with DNA, incubated for 30 min on ice, 
heat shocked for 90 sec at 42°C, diluted in SOC (20 g/L tryptone, 5 g/L yeast extract, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose, pH 
adjusted to 7 and sterilised by autoclaving) and allowed to recover for 60 min at 37°C 
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while shaking (1000 rpm) before plating onto appropriate selective plates. Single 
colonies were isolated after 12 h and grown in selective liquid media. 
 
2.2.6 Plasmid DNA purification 
Plasmid DNA was purified from 5, 250 or 500 ml culture using Qiagen MiniPrep, 
MidiPrep or MaxiPrep kits respectively, following the manufacturer’s instructions. 
DNA concentration was measured using the Nanodrop ND-1000 spectrophotometer 
and sequencing was performed by the genomics core facility at the MRC Clinical 
Sciences Centre. 
 
2.2.7 DNA biotinylation and immobilisation on streptavidin beads 
Circular pUC19-ARS1 plasmid was covalently coupled with biotin by exposure to UV 
light using the Vector Laboratories Long Arm Photoprobe Biotin kit. The plasmid was 
mixed with the photoprobe, exposed to UV light, purified with sec-butanol and 
precipitated with ethanol (Evrin et al, 2009). Linear ARS1 was otherwise amplified by 
PCR using biotinylated oligonucleotides (using one or both primers biotinylated).  
DNA was subsequently immobilised overnight on streptavidin beads. 
 
2.2.8 Bacterial protein expression 
BL21 Codon+ RIL or (DE3) RIL competent cells were grown in TB liquid media (12 
g/L tryptone, 24 g/L yeast extract, 4 ml/L glycerol) supplemented with appropriate 
antibiotics at 37°C to an OD600 of 1. Protein expression was then induced by 
addition of 0.5 mM IPTG for 5h at 16°C before harvesting. 
 
2.2.9 Yeast competent cells preparation 
Yeast cells were grown over night in 500 ml YPD (20 g/L peptone, 10 g/L yeast 
extract, 2% (w/v) glucose) to OD600=0.5-0.7 at 30°C (or 24°C for temperature 
sensitive strains). The culture was harvested at 500 g for 5 min at room temperature 
and the pellet washed with 1/10 volumes (5 ml) of sterile water. The sample was 
spun again and the pellet was resuspended in 1/10 volumes (5 ml) of SORB (100 
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mM LiAc, 10 mM Tris/HCl pH 8, 1 mM EDTA/NaOH pH 8, 1 M sorbitol). After 
another centrifugation the pellet was resuspended in 360 μl SORB. 40 μl of carrier 
DNA (10 mg/ml salmon sperm DNA, denaturated at 100°C for 10 min and stored on 
ice) were added and mixed well. The mixture was aliquoted and stored at -80°C. 
 
2.2.10 Yeast transformation and culture 
30 μl of competent cells were thawed on ice. 300 ng of each plasmid to transform 
and 6 volumes (180 μl) of PEG solution (100 mM LiAc, 10 mM Tris/HCl pH 8, 1 mM 
EDTA/NaOH pH 8, 40% (w/v) PEG3350) were added and carefully mixed by 
pipetting. The mixture was incubated for 1h at 28°C (or 24°C for temperature 
sensitive strains). 1/9 volumes (3 μl) of DMSO were added and the cells were 
incubated for 15 min on 42°C. After the heat shock, the cells were harvested (2000 
rpm for 3 min), the pellet resuspended in 100 μl of minimal media and plated onto 
Kaiser plates (6.7 g/L yeast nitrogen base without amino acids, 2 g/L supplement 
amino acids mix dropout, added with  2% (w/v) glucose with selection for the 
appropriate auxotrophies). After 3 days a single colony was picked and re-streaked 
onto a new plate. After 3 days a single colony was picked and grown in SC liquid 
media (6.9 g/L yeast nitrogen base without amino acids, 0.6 g/L supplement amino 
acids mix dropout, added with 2% (w/v) glucose and selection for the appropriate 
auxotrophies) for glycerol stock or in vivo assays. Glycerol stocks were made by 
resuspending the pellet of a culture at OD600>1.5 in 50% (w/v) glycerol and stored at 
-80°C. 
 
2.2.11 Yeast growth assays 
A liquid culture grown from a single colony was diluted to OD600=0.5 in 10 ml of 
media and harvested by centrifugation at 4000 rpm for 5 min. The pellet was washed 
with 10 ml of sterile water in order to remove all glucose and subsequently 
resuspended in 10 ml of SC without carbon source with selection for appropriate 
auxotrophies and grown for at least 2h. The culture was then harvested as above 
and a 5 fold serial dilution was prepared in order to have the following OD600: 1 x 10
7, 
0.2 x 106, 0.4 x 105, 0.8 x 104, 1.6 x 104, 3.2 x 103, 6.4 x 102. 3 μl of each dilution 
were dropped onto appropriate plates to monitor differential growth.  
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2.2.12 Yeast protein expression 
A liquid culture was grown for 16 h from an isolated colony in SC liquid media added 
with 2% (w/v) glucose in the presence of appropriate auxotrophies. It was then 
diluted to OD600=0.5 in 500 ml of the same media and grown for 12 h prior dilution to 
OD600=0.5 in 12 x 500 ml cultures. After 12 h (OD600=1.4-1.9) the cultures were 
diluted with one volume each (500 ml) of Rich Media (10 g/L yeast extract, 20 g/L 
peptone, 0.1 g/L glucose, 30 g/L glycerol, 20 g/L lactic acid, pH 5.5-6) for 3 h. 
Expression was then induced with the addition of 20 g/L galactose for 6 h before 
harvesting. Whenever G1-phase arrest was required, 2.5 mg/L α-factor was added to 
the culture after 3h of induction. All cultures were grown at 30°C with the exception 
of temperature sensitive strains, which were grown at the permissive temperature of 
24°C. The harvested culture was resuspended in half a pellet volume of the 
appropriate purification buffer, frozen in liquid nitrogen and stored at -80°C. 
 
2.2.13 Yeast cells lysis 
Yeast cells were lysed using a SPEX SamplePrep 6870 freezer mill (Spex 
Certiprep). 50 g of popcorn were supplemented with 4x complete protease inhibitor 
cocktail tablets and milled by executing 15 cycles of 4 min pre-cool, 3 min grinding at 
15 cycles per second (cps) and 3 min cooling. The resulting powder was thawed at 
4°C, mixed with one powder volume of appropriate purification buffer and incubated 
for 2 h while mixing. The extract was then centrifuged at 28000 g for 1 h and the 
supernatant was collected and stored at -80°C for up to 3 days prior to purification. 
 
2.2.14 Protein purifications 
MCM2-7, CDK, DDK, Sld3, Cdc45, GST-tagged Mcm N-termini and all FLAG-tagged 
MCM2-7 versions were purified by me. I was also involved in the purification of ORC 
and Sld2, whereas all other proteins were available in the lab.  
Proteins were purified as following: 
 
ORC, Cdc6, Cdt1, MCM2-7, MCM2-7ΔC6 and CDK were purified as previously 
reported (Evrin et al, 2009; Fernandez-Cid et al, 2013).  
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MBP-Cdt1 was purified by Fernandez-Cid and Riera similarly to Cdt1 with the 
exception that the PreScission Protease cleavage step was substituted with Maltose 
elution.  
MCM2-7 FLAG-tagged mutants were purified similarly to MCM2-7 with the exception 
that the gel filtration step was substituted with incubation with anti-FLAG resin and 
elution with FLAG peptide (Genescript). 
 
Sld3 purification from yeast cells 
The lysed cells were resuspended in buffer 3A (50 mM HEPES/NaOH pH8.1, 0.5 M 
NaCl 10% (w/v) glycerol, 0.1% (w/v) NP40, 1mM DTT) plus complete protease 
inhibitor cocktail (PIC), extracted on a rotating wheel for 2h at 4°C and centrifuged at 
27,600 g for 1 h at 4°C. The extract was incubated for 2h at 4°C with Amylose Resin. 
The beads were afterwards rinsed with 10 column volumes buffer 3A + PIC and 
washed twice with 20 cv buffer 3A + PIC for 30 min and once with 20 cv buffer 3A 
without PIC for 30 min. MBP-myc-Sld3 was eluted at that stage with buffer 3A + 10 
mM Maltose. To elute myc-Sld3, instead, beads were incubated with 1 cv of buffer 
3A (without protease inhibitors) and PreScission protease for 2 h at 4 °C and more 
protein was eluted afterwards with 1 cv buffer 3A. Elutions were diluted to 0.1 M 
NaCl, bound to SP-Sepharose for 30 min. The resin was rinsed once with 10 cv 
buffer 3B (50 mM HEPES/NaOH pH8.1, 0.1 M NaCl 10% (w/v) glycerol, 0.1% (w/v) 
NP40, 1mM DTT) and once with 10 cv buffer 3C (50 mM HEPES/NaOH pH8.1, 0.2 
M NaCl, 10% (w/v) glycerol, 0.1% (w/v) NP40, 1mM DTT). The protein was eluted in 
buffer 3A (Herrera, Tognetti et al, under revision). 
 
Cdc45 purification from yeast cells 
The protein was purified as previously described (Heller et al, 2011). To remove the 
FLAG peptide the sample was incubated for 30 min with DEAE beads, the resin was 
extensively washed and the protein was eluted with bufferC45 (50 mM HEPES/KOH 
pH 7.5, 1 mM EDTA, 10% glycerol, 0.02% NP40, 0.5 mM DTT, PIC) containing 500 mM 
KCl (Herrera, Tognetti et al, under revision).  
 
DDK purification from yeast cells 
The lysed extract was incubated with amylose resin (NEB) pre-equilibrated with 
buffer DK (50 mM Hepes-KOH pH 7.5, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
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10% (w/v) glycerol, 0.02% (w/v) NP40, 1 mM DTT) and supplemented with 
proteases and phosphatases inhibitors for 2 h at 4°C. The protein was eluted by 
cleaving the MBP tag via addition of PreScission protease for 2 h at 4°C. The eluate 
was incubated with Glutathione agarose for 2 h to remove the PreScission protease. 
The GST flow-through was collected and concentrated by centricon (Millipore) 
(Herrera, Tognetti et al, under revision). 
 
For the isolation of GST tagged Mcm N-termini on Glutathione beads, cells were 
lysed by sonication in the following buffers: Mcm2 50 mM HEPES/KOH pH 7.5, 250 
mM KCl; Mcm3/4/6 50 mM TRIS/HCl pH 8, 250 mM NaCl; Mcm5/7 50 mM 
HEPES/KOH pH 7.5, 500 mM NaCl. All buffers also contained 10% (w/v) glycerol, 5 
mM ATP, 10 mM MgCl2, 1 mM DTT, 1% (v/v) Triton X-100, 25 U/ml Benzonase , 2x 
PIC, 1 mg/ml lysozyme. Dpb11 and Regα were instead resuspended from 
ammonium sulphate pellets in a buffer containing 50 mM PIPES pH 6.5, 200 mM 
NaCl, 10 mM MgCl2, 2 mM ATP, 1% (v/v) Triton X-100, 3 mM DTT, 10% (w/v) 
glycerol and 2x PIC. They were then incubated with pre-washed Glutathione beads 
and extensively washed with the appropriate buffer to remove the unbound material. 
 
Sld2 purification from bacteria (purified by Herrera) 
The cells were lysed by sonication in buffer 2A (50 mM PIPES (pH 6.5), 500 mM AS, 
10 mM MgCl2, 5 mM DTT, and 1% (v/v) Triton X-100, 10% (w/v) glycerol, 2 mM 
ATP). The fusion protein was bound to glutathione agarose in buffer 2A at 4 °C for 2 
h, and then the protein was eluted by addition of PreScission Protease for 2 h at 4 
°C. The eluate was diluted with 1 volume buffer 2A with no salt and bound to SP 
Sepharose. Sld2 was eluted with buffer 2B (50 mM PIPES (pH 6.5), 500 mM AS, 5 
mM DTT, and 0.1% (v/v) Triton X-100, 10% (w/v) glycerol) (Herrera, Tognetti et al, 
under revision). 
 
Sld7 purification from bacteria (purified by Herrera and Gardenal) 
The cells were lysed by sonication in buffer 7A (50 mM HEPES-KOH (pH 7.5), 300 
mM NaCl, 10 mM MgCl2, 1 mM DTT, and 1% (v/v) Triton X-100, 10% (w/v) glycerol, 
2 mM ATP). Ammonium sulphate was added to a final concentration of 250 mM to 
the extract. Nucleic acids are precipitated from the cell extract by the addition of 30 
μl 10 % (w/v) polymin P/HCl (pH 6.5) per ml cell extract. GST-Sld7 was precipitated 
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by adding 0.4 g fine powdered ammonium sulphate per ml of extract. The fusion 
protein was bound to glutathione agarose in buffer C at 4 °C for 2 h, and then the 
was eluted by addition of PreScission Protease for 2h at 4°C. The eluate was 
concentrated by centricon (Millipore) (Herrera, Tognetti et al, under revision).  
 
2.2.15 SDS-PAGE  
Samples were denatured for 5 min at 95°C in sample buffer (100 mM Tris-HCl pH 
6.9, 40 % (w/v) glycerol, 100 mM DTT, 6 % (w/v) SDS, 0.02 % (w/v) bromophenol 
blue) before loading onto the appropriate percentage (7.5-10-15-20%) 
polyacrylamide gel and running at 250 V at 4°C in Tris-Glycine buffer (3 % (w/v) Tris, 
14 % (w/v) glycine, 1 % (w/v) SDS). Alternatively samples were run onto NuPAGE 
Novex 4-12% Bis-Tris Protein Gels in 0.5 % (v/v) MES or MOPS. In vitro transcribed 
and translated samples were denatured for 5 min at 65°C. 
 
2.2.16 Protein staining of polyacrylamide gels 
Protein samples resolved by SDS-PAGE and the proteins were visualised by 
Coomassie Brilliant Blue or Silver staining. 
Coomassie staining was used for samples containing > 200 ng of protein. Gels were 
immersed in Coomassie Brilliant Blue solution (0.25 % (w/v) Coomassie Brilliant 
Blue, 45 % (v/v) methanol, 10 % (v/v) glacial acetic acid), heated for 1 min in a 
microwave at full power, incubated for 10 min at room temperature and then 
destained (5 % (v/v) methanol, 7.5% (v/v) glacial acetic acid) by heating for 1 min in 
a microwave at full power and then incubated at room temperature until destained as 
required. 
For samples containing a lower protein amount silver staining was performed. 
Initially the proteins were fixed by incubating the gel in fixing solution (40 % (v/v) 
methanol, 13.5 % (v/v) formaldehyde) for 10 min. The gel was washed twice with 
ultrapure water and then with 0.02 % (w/v) sodium thiosulphate before staining with 
0.1 % (w/v) silver nitrate. Proteins were revealed with a solution containing 2 % (w/v) 
sodium carbonate, 0.05 % (v/v) formaldehyde, 0.0004 % (w/v) sodium thiosulphate. 
The reaction was stopped when required with 3 % (w/v) citric acid. 
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2.2.17 Western blotting  
Samples resolved by SDS-PAGE were transferred to nitrocellulose membrane in 
transfer buffer (6 mM sodium bicarbonate, 4 mM sodium carbonate, 20 % (v/v) 
methanol, pH 9.5 or 12 if from NuPAGE Novex 4-12% Bis-Tris Protein Gels) at 500 
mA for 1 h at 4°C. Membranes were stained with Ponceau-S solution (1 % (w/v) 
Ponceau-S, 1 % (v/v) acetic acid) and destained in 0.1 % (v/v) acetic acid prior to 
blocking in appropriate blocking solution. This could be 5 % (w/v) milk or BSA in 
TBS-T (25 mM Tris-HCl pH 7.5, 140 mM NaCl, 3 mM KCl, 0.05 % (v/v) Tween 20). 
Primary antibodies were diluted in blocking solution and incubated for 1 h at room 
temperature or overnight at 4°C. Membranes were washed three times for 10 min 
with TBS-T before incubation with HRP-conjugated secondary antibody. Three 10 
min washes preceded the detection of the signal with enhanced 
Chemiluminescence.  
After immunodetection, whenever re-blotting was required, the membranes were 
washed three times for 5 min with TBS-T and incubated with Restore Western Blot 
Stripping Buffer for 15 min. Membranes were then washed three times for 10 min 
and re-probed. 
 
2.2.18 Bead based pre-RC formation assay 
Bead based pre-RC formation assays were performed as previously described (Evrin 
et al, 2009; Evrin et al, 2014; Evrin et al, 2013; Fernandez-Cid et al, 2013; Sun et al, 
2013). Briefly, 40 nM ORC, 80 nM Cdc6, 40 nM Cdt1 and 40 nM MCM2-7 were 
incubated for 10 min on ice in buffer RC (50 mM HEPES-KOH pH 7.5, 100 mM 
KGlu, 10 mM MgAc, 50 μM ZnAc, 3 mM ATP, 5 mM DTT, 0.1% (v/v) Triton X-100, 
and 5% (w/v) glycerol) followed by 10 min at 24°C. 6 nM pUC19-ARS1 magnetic 
beads were added to the sample, incubated for 15-30 min and washed with low salt 
or high salt (buffer RC with 500 mM NaCl in addition of 100 mM KGlu). 40 nM of 
additional proteins were added for 10-30 min whenever required before low salt 
washes and DNase I elution of the complex. 
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2.2.19 Gel filtration based pre-RC formation assay 
Pre-RCs were assembled in solution using a one-step reaction (Herrera, Tognetti et 
al, under revision). 50 µl reactions containing 40 nM ORC, 80 nM Cdc6, 40 nM Cdt1 
and 40 nM MCM2-7 were pre-incubated for 10 min on ice and 10 min at 24°C in 
buffer RC. 6 nM pUC19-ARS1 plasmid and 1.5 U of human topoisomerase I were 
added to the reaction and incubated for 15 min at 24°C, 950 rpm. Afterwards the 
following components were added to a final concentration of: 5 nM DDK, 40 nM 
Sld3, 40 nM Sld2, 40 nM Sld7, 40 nM Dpb11 and 40 nM Cdc45, 5 mM ATP, 250 
ng/μl BSA, 1.4 μM competitor DNA (40 bp). Competitor DNA was derived from two 
complementary oligonucleotides incubated in buffer M (100 mM Tris-HCl (pH 7.9), 
100 mM NaCl, 1 mM DTT, 10 mM MgCl2) for 5 min at 95°C and then slowly cooled 
down to RT over 30 min. The hybridized oligonucleotides were concentrated using 
Microcon (Millipore) to a concentration of 5 μM. Due to the addition of these factors 
the volume of the reaction increased by 15 μl. Then the reactions were incubated for 
1-30 min at 27°C 950 rpm. Then, KAc was added to a final concentration of 200 mM 
followed by a 3 min incubation at 24 °C and mixing at 950 rpm. Samples were 
loaded on top of a spin column, filled with 0.5 ml Sephacryl S400 HR resin. After 
loading of the samples the columns were spun for 5 min at 1000 g. Prior to the gel-
filtration step the spin columns were filled with equilibrated resin (buffer RC 
containing 200 mM KAc, but without Triton X-100 and glycerol) and pre-spun for 5 
min at 850 g. The eluate was concentrated by speed vac prior to SDS-PAGE 
analysis. 
 
2.2.20 In vitro transcription and translation 
To generate 35S-Methionine-labelled proteins, the coding sequences of the genes 
were amplified by PCR using sense and anti-sense primers, as suggested by the 
supplier’s instruction (Promega). All sense primers included at the 5’ end a spacer 
(ACTGATC), the T7 promoter sequence (TAATACGACTCACTATAGGG), a short 
spacer (CAT), the Kozac sequence (CCACCATG) and a 17-22 nucleotides 
hybridization region. The anti-sense primer included at the 3’ end a 30 nucleotides 
poli-A tail and the stop codon in addition to a 17-22 nucleotides hybridization region. 
To compensate for different methionine content additional methionines were 
57 
 
incorporated into the anti-sense primer. 400 ng of the resulting PCR product (whose 
size was verified by agarose gel electrophoresis) was used as template in the TNT-
T7 Quick for PCR DNA system (Promega), combined with 20 μl of TNT Quick Master 
Mix and 20 μCi of 35S-Methionine (Perkin-Elmer) in a total volume of 25 μl and 
incubated for 90 min at 30°C with mixing. 
 
2.2.21 Pull-down assays 
For pull-down assays with GST-tagged Mcm N-termini, Dpb11 and Regα, the 
normalised samples were immobilised on glutathione agarose (see paragraph 
2.2.14), resuspended in buffer RC and 1 µg purified Sld3 was added in buffer RC for 
15 min at 24°C (1000 rpm) before washes. Whenever CDK (20 nM) or DDK (80 nM) 
were added to the sample, they were first pre-incubated with Sld3 for 30 min at 27ºC. 
 
To generate anti-MBP/HA/FLAG/GST antibody beads, 50 µl Dyanabeads Protein G 
were washed three times with PBS-T (1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4, 
18 mM KH2PO4, 0.05 % (v/v) Tween 20). They were then resuspended with 10 µg of 
the appropriate antibody and incubated for 15 minutes at 24°C (1000 rpm) before 
washing to remove the unbound antibody and resuspension in 2 volumes PBS-T. 
Beads were washed before use with the appropriate reaction buffer. 
 
MCM2-7 pull-down reactions 
0.5 µg purified HA-MCM2-7 were immobilized on anti-HA antibody beads for 15 min 
at 24°C with mixing in 50 μl of buffer RC. In vitro translated proteins were incubated 
with HA-MCM2-7 or empty control beads for 2h with mixing at 4°C in 500 μl of buffer 
RC; afterwards the beads were washed three times and analysed by SDS/PAGE 
followed by phosphorimaging analysis. 
MBP-MCM2-7 pull-down reactions: equimolar amounts of MBP and MBP-MCM2-7 
were immobilized on anti-MBP antibody beads for 15 min at 24°C with mixing in 50 
μl of buffer RC. In vitro translated proteins were incubated with MBP or MBP-MCM2-
7 beads for 2h with mixing at 4°C in 500 μl of buffer RC; afterwards the beads were 
washed three times and analysed by SDS/PAGE followed by phosphorimaging 
analysis. 
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MBP-Cdt1 pull-down reactions 
Equimolar amounts of MBP and MBP-Cdt1 were immobilized on anti-MBP antibody 
beads for 15 min at 24°C with mixing in 50 μl of buffer RC. In vitro translated proteins 
were incubated with MBP or MBP-Cdt1 beads for 2h with mixing at 4°C in 500 μl of 
buffer RC. For the reactions in presence of Cdt1, 1 μg purified protein was added to 
the beads during the conjugation of the bait with the beads and additionally 2 μg 
purified Cdt1 were added simultaneously with the in vitro translated mixture. 
Afterwards the beads were washed three times and analysed by SDS/PAGE 
followed by phosphorimaging analysis. 
 
Sld3 pull-down reactions 
Equimolar amounts of MBP and MBP-Sld3 were immobilized on anti-MBP antibody 
beads for 15 min at 24°C with mixing in 50 μl of Sld3 buffer 3A followed by three 
washes with 100 μl of buffer RC2 (buffer RC with 225 mM KGlu and 1% (w/v) BSA). 
In vitro translated proteins were incubated with MBP or MBP-Sld3 beads for 2h with 
mixing at 4°C in 500 μl of buffer RC2 afterwards the beads were washed three times 
with 100 μl of buffer RC3 (RC2 without BSA) and analysed by SDS/PAGE followed 
by phosphorimaging analysis. For pull-down reactions with purified protein instead of 
in vitro transcribed, 0.5 μg Sld2 was incubated for 1h with mixing at 4°C in 200 μl of 
buffer RC3; afterwards the beads were washed three times with 100 μl of buffer RC3 
and analysed by SDS/PAGE followed by Western Blot. Alternatively when untagged 
Sld3 was used, 0.5 μg of Sld3 protein was immobilized on anti-Sld3 318 beads 
(protein G) for 15 min at 24°C with mixing in 50 μl of 3A and used for pull-downs as 
above, together with IgG control beads. 
 
GST-Cdc45 pull-down reactions 
The pellets of 50 ml of GST and GST-Cdc45 culture were resuspended in 2.5 ml of 
buffer C45 (50 mM KPO4 pH 7.5, 250 mM KCl, 5 mM MgCl2, 1 mM MnCl2, 10 % (w/v) 
glycerol, 1 % (v/v) Triton X-100, 1 mM DTT, 2 x PIC) added with 0.1 mg/ml lysozyme 
and incubated on ice for 30 min. The extract was sonicated and the supernatant 
separated by centrifugation and aliquoted. Equimolar amounts of GST and GST-
Cdc45 were immobilized on anti-GST antibody beads for 1h at 4°C with mixing in 
100 μl of buffer C45. Beads were washed three times with 100 μl buffer RC2. In vitro 
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translated proteins were incubated for 2h with mixing at 4°C in 500 μl of buffer RC2 
before washes and analysis by SDS/PAGE and phosphorimaging. 
 
Sld2 pull-down reactions 
The pellets of 50 ml of GST and GST-Sld2 cultures were resuspended in 2.5 ml 
buffer 2A, added with 0.1 mg/ml of lysozyme and 25 U/ml Benzonase and incubate 
on ice for 30 min. The extract was sonicated, the supernatant separated by 
centrifugation and aliquoted. Equimolar amounts of GST and GST-Sld2 containing 
extracts were immobilized on anti-GST antibody beads for 1h at 4°C with mixing in 
100 μl of buffer 2A followed by three washes with 100 μl of buffer RC2. In vitro 
translated proteins were incubated with GST or GST-Sld2 beads for 2h with mixing 
at 4°C in 500 μl of buffer RC2; afterwards the beads were washed three times with 
100 μl of buffer RC3 and analysed by SDS/PAGE followed by phosphorimaging 
analysis. 0.5 μg of purified proteins were instead incubated for 1h with mixing at 4°C 
in 200 μl of buffer RC2; afterwards the beads were washed three times with 100 μl of 
buffer RC3 and analysed by SDS/PAGE followed by Western Blot. 
 
Sld3 peptides pull-down reactions 
60 pmol of each biotinylated peptide (3 fold excess compared to beads binding 
capacity) were incubated with pre-washed streptavidin beads Dynabeads MyOne T1 
in Peptide binding buffer (PBS + 0.1% (v/v) Triton X-100 + 1 mM DTT + 1x PIC) over 
night at 4°C (1400 rpm). The morning after beads were washed with buffer RC and 
incubated with in vitro transcribed and translated proteins for 2h at 4°C (1000 rpm) in 
buffer RC prior to washes and analysis by SDS/PAGE followed by autoradiography. 
 
2.2.22 Cross-linking reaction 
Equimolar amount of proteins were incubated in 10 µl of buffer CL (50 mM 
HEPES/KOH pH 7.5, 100 mM KAc, 5 mM MgAc, 5% (w/v) glycerol, 0.1% (v/v) Triton 
X-100, 5 mM CaCl2) for 10 min on ice and 5 min at 24°C, at 950 rpm. The samples 
were then incubated with Glutaraldehyde for 10 min at 4°C, 950 rpm. The 
crosslinking reaction was blocked adding 1/10 volumes (1 µl) of 1M TRIS-HCl pH 8 
and incubated for 10 min at 24°C, 950 rpm. Sample were analysed by SDS-PAGE 
followed by silver staining or western blot. 
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2.2.23 Kinase assay 
40 nM of each protein was incubated with increasing concentrations of DDK (4 fold 
dilution series starting from 20 nM) in 10 μl final of phosphorylation buffer (50 mM 
HEPES/KOH pH 7.5, 100 mM KGlu, 10 mM MgAc, 0.05 mM ZnAc, 5% (w/v) 
glycerol, 0.1% (v/v) Triton X-100, 0.1 mM ATP, 5 mM DTT, 0.1 µCi/μl γ-32P-ATP) at 
27˚C for 15 min shaking at 950 rpm. The samples were analysed by SDS/PAGE 
followed by autoradiography. 
 
2.2.24 In silico sequence analysis 
Amino acid sequence alignments were produced using the T-Coffee server (Di 
Tommaso et al, 2011). Proteins secondary structure predictions were generated 
using a SAM-T08, HMM-based protein structure prediction (Karplus, 2009), whereas 
helical wheel projections were generated with the following online tool:   
http://rzlab.ucr.edu/scripts/wheel/wheel.cgi?sequence=ABCDEFGHIJLKMNOP&sub
mit=Submit. 
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Chapter 3 - Results 
Protein-protein interactions during pre-RC formation 
 
In eukaryotes, ORC/Cdc6 loads, with the help of Cdt1, the MCM2-7 helicase 
onto DNA (Evrin et al, 2009; Remus et al, 2009). This reaction is initiated when the 
ORC/Cdc6 complex recruits a Cdt1-MCM2-7 to the DNA replication origin.  
The work outlined in this chapter was undertaken prior to the publication of three 
papers (Fernandez-Cid et al, 2013; Frigola et al, 2013; Sun et al, 2013) that 
described the components of the Cdt1/MCM2-7 heptamer that are required for initial 
ORC/Cdc6/Cdt1/MCM2-7 complex formation. Little is still known about the subunits 
in ORC/Cdc6 that allow binding of Cdt1/MCM2-7. Initial work by the Bell lab 
investigated Orc6 and Cdt1 in this process. It was found that a degron mediated 
depletion of Orc6 inhibits pre-RC assembly in vivo, while in vitro work showed that 
ORCΔ6 (ORC complex lacking Orc6) was incapable of interacting with Cdt1 and 
forming of an ORCΔ6/Cdc6/Cdt1/MCM2-7 complex. In addition to a direct interaction 
of the N-terminal (aa 1-185) and C-terminal (aa 270-435) domains of Orc6 with Cdt1, 
Orc6 was reported to bind directly Orc3 and Orc5 (Chen et al, 2007). Furthermore, 
another study from the Bell lab (Takara & Bell, 2011) showed that the C-terminus of 
Cdt1 (aa 500-602) binds MCM2-7, whilst the N-terminus (aa 1-272) is required to 
load MCM2-7 complexes on origin DNA that are competent for CMG formation. 
These studies suggested that an Orc6-Cdt1 interaction is key to recruit Cdt1/MCM2-
7 to ORC/Cdc6 and to facilitate MCM2-7 double-hexamer formation. However two 
recent publications (Fernandez-Cid et al, 2013; Frigola et al, 2013) challenged this 
view, as they found that ORCΔ6 is sufficient to promote ORCΔ6/Cdc6/Cdt1/MCM2-7 
complex formation on origin DNA. Additional analysis of the interactions involved 
was needed to clarify how the pre-RC forms and identify the surfaces of contact 
between proteins. 
 
3.1 ORC – MCM2-7 interaction analysis 
At the beginning of the study no data was available on specific protein 
interactions of ORC and MCM2-7. Indeed an origin bound ORC complex cannot 
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interact with Cdt1/MCM2-7 (Evrin et al, 2009), suggesting that ORC and MCM2-7 
adopt a specific conformation that inhibits direct protein interactions. In consequence 
it was tested if individual purified subunits could be used for complex formation, but 
poor solubility of these proteins resulted in non-specific interactions (Uhle, Tognetti, 
Fernandez-Cid and Speck; unpublished observations). Therefore the use of in vitro 
translated ORC subunits in interactions with purified MCM2-7 was investigated first.  
 
 
Figure 3.1: Purification of MCM2-7 from yeast 
A) Coomassie blue stained gel for anti-HA purification step. Yeast extract produced via 
freezer milling was incubated with anti-HA beads, rinsed, washed twice and rinsed again 
before bound MCM2-7 (via HA-Mcm3) was eluted with HA peptide. The eluate was then 
concentrated. B) Silver stained gel showing the gel filtration fractions. The concentrated 
eluate was loaded into a Superdex 200 column and fractions corresponding to lanes 5-11 
were pooled. The elution position of known molecular weights standards is represented in 
the boxes. Arrows indicate the position of the Mcm subunits. 
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MCM2-7 was overexpressed in budding yeast arrested in G1-phase with α factor, to 
ensure that it does not carry S-phase phosphorylations, using three expression 
plasmids each containing two Mcm subunits, including Mcm3 with a N-terminal HA 
tag, as previously described (Evrin et al, 2009). Mcm3 was tagged to enrich for 
MCM2-7 at the expense of other sub-complexes. MCM2-7 was then purified in a 
two-step purification process (Figure 3.1) where MCM2-7 was bound to anti-HA resin 
and eluted using HA peptide followed by gel filtration. 
MCM2-7 was therefore used to immunoprecipitate in vitro transcribed and 
translated ORC subunits and this analysis showed that Orc2 can weakly interact with 
MCM2-7 (Figure 3.2). 
 
 
Figure 3.2: MCM2-7 interacts with Orc2 
MCM2-7 interaction analysis with ORC subunits. HA-MCM2-7 immobilized on anti-HA 
magnetic beads or IgG control beads, were incubated with 35S labelled in vitro transcribed 
translated ORC subunits, washed, separated by SDS-PAGE and analysed by 
autoradiography. Asterisks indicate full length proteins. 
 
 
Since the Orc2 interaction was rather weak we tested Cdt1, which is known to 
bind MCM2-7 (Takara & Bell, 2011), as a positive control in this pull-down assay. 
Indeed we observed that Cdt1 interacts with MCM2-7 (Figure 3.3, lane 4), as 
previously reported. Instead, when Cdc6 was tested for direct binding to MCM2-7 no 
signal was detected (Figure 3.3, lane 7).  
As the interaction of MCM2-7 with Cdc6 could be mediated by Cdt1, in this 
experiment the pull-down was also performed in the presence of purified Cdt1 as 
described paragraph 2.2.21. Purified Cdt1 competes with the in vitro translated Cdt1 
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as indicated by the reduced signal for MCM2-7 binding (Figure 3.3, compare lanes 4 
and 5), indicating that the experiment works.  
However, when purified Cdt1 was added into the Cdc6 pull-down assay, no 
increased signal was detected (Figure 3.3, compare lanes 7 and 8) indicating that 
MCM2-7 and Cdc6 do not interact directly nor in a Cdt1-mediated manner. 
 
Figure 3.3: MCM2-7 interacts with Cdt1 but not with Cdc6 
MCM2-7 interaction analysis with Cdt1 and Cdc6. HA-MCM2-7 immobilized on anti-HA 
magnetic beads or IgG control beads, were incubated with 35S labelled in vitro transcribed 
translated Cdt1 and Cdc6, washed, separated by SDS-PAGE and analysed by 
autoradiography. For samples 5 and 8, 1 μg purified Cdt1 was added to the beads during the 
conjugation with HA-MCM2-7 and additionally 2 μg purified Cdt1 were added simultaneously 
with the in vitro translated mixture. Asterisks indicate full length proteins. 
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3.4) it is evident that they share a very similar structural organisation consisting of a 
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Figure 3.4: The domain architecture of the subunits Orc1-5 and Cdc6 
Diagram of the structural domains based on sequence alignment. The functional elements 
are indicated as following: Walker A (WA), Walker B (WB) and winged-helix domain (WHD). 
 
 
Given that the C-terminal extensions of Orc1-5 are of considerable length and 
structured in a winged-helix domain, which is known to function in protein-protein 
and protein-DNA interactions (Gajiwala & Burley, 2000; Teichmann et al, 2012), they 
became interesting in the study of the binding of ORC to MCM2-7. For this reason 
MCM2-7 was used to immunoprecipitate them, both in the absence and in the 
presence of purified Cdt1 (Figure 3.5). Their length was established according to 
sequence alignment and secondary structure predictions (Gardenal and Speck, 
personal communication). The full length Orc2 was used as positive control. The C-
terminus of Cdc6 was also included in the assay despite the experiment with the full 
length protein showed no binding (Figure 3.3 lane 7) in order to exclude that an 
interaction site is present in this region but becomes exposed only under specific 
folding conditions. In the attempt of reducing the unspecific signal detected for the 
IgG control, MBP-MCM2-7 instead of HA-MCM2-7 was used in this assay. MBP-
MCM2-7 presents a MBP tag internally fused to Mcm7 (Samel and Speck, 
unpublished) and was purified by Riera (unpublished result), similarly as described 
for the wild type. 
None of the C-terminal extensions can interact with MCM2-7 under these conditions, 
not even Orc2 CT, suggesting that the interaction with the full length Orc2 (Figure 
3.2, lane 10) is mediated by a different domain or that the folding of the subunit is 
important for the binding. Furthermore, Orc6 is immunoprecipitated by MCM2-7 in 
the presence of purified Cdt1 (Figure 3.5, compare lane 25 and 26), indicating that 
Cdt1 can bridge the interaction between these proteins. Finally, the interaction 
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occurring with full length Orc2 was strengthened by the addition of Cdt1 (Figure 3.5, 
compare lane 28 and 29). 
 
 
Figure 3.5: MCM2-7 interacts with Orc2 and Orc6 in the presence of Cdt1 
MCM2-7 interaction analysis with Orc1-5 C-termini. MBP or MBP-MCM2-7 immobilized on 
anti-MBP magnetic beads, were incubated with 35S labelled in vitro transcribed translated 
proteins, washed, separated by SDS-PAGE and analysed by autoradiography. For the 
reactions in presence of Cdt1, 1 μg purified protein was added to the beads during the 
conjugation of HA-MCM2-7 with the beads and additionally 2 μg purified Cdt1 were added 
simultaneously with the in vitro translated mixture. Asterisks indicate protein constructs. 
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MCM2-7ΔC6 is a mutant of MCM2-7 which is defective for the Cdt1 binding 
domain at the C-terminus of Mcm6 (Fernandez-Cid et al, 2013). It was interesting to 
test how the interaction between MCM2-7 and ORC would change in the context of 
this mutant. For this purpose, MCM2-7ΔC6 was used to pull-down ORC full length 
subunits, together with Cdt1 and Cdc6 as controls. Again, one sample of each was 
incubated also in the presence of Cdt1 (Figure 3.6). As this mutant was not available 
with an MBP-tag the HA-tagged variant was employed, which produced less specific 
interactions based on previous tests (data not shown). 
The experiment showed similar results to the wild type MCM2-7: the only subunit of 
ORC that interacts is Orc2, which produces a very weak signal but becomes 
stronger in the presence of purified Cdt1 (Figure 3.6, compare lanes 13 and 14). This 
result indirectly shows that MCM2-7ΔC6 is still capable of interacting with Cdt1, as 
previously reported (Fernandez-Cid et al, 2013), and indicates that the C-terminal 
domain of Mcm6 is not essential for the interaction with ORC.  
 
 
Figure 3.6: MCM2-7ΔC6 interacts weakly with Orc2 
MCM2-7ΔC6 interaction analysis with ORC subunits. MCM2-7ΔC6 immobilized on anti-HA 
magnetic beads (IP-B) or IgG control beads (IP-A), were incubated with 35S labelled in vitro 
transcribed translated proteins, washed, separated by SDS-PAGE and analysed by 
autoradiography. For the reactions in presence of Cdt1 (IP-C), 1 μg purified protein was 
added to the beads during the conjugation of HA-MCM2-7Δ6 with the beads and additionally 
2 μg purified Cdt1 were added simultaneously with the in vitro translated mixture. Asterisks 
indicate full length proteins. 
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3.2 ORC – Cdt1 interaction analysis 
These results suggest that Cdt1 is contacting not only Orc6, as previously 
reported (Chen et al, 2007), but also Orc2, therefore it was interesting to further 
explore this interaction, especially as Orc6 is not required for initial 
ORC/Cdc6/Cdt1/MCM2-7 complex formation (Fernandez-Cid et al, 2013; Frigola et 
al, 2013).  
Cdt1 was used to pull-down full length Orc2 and its C-terminus. The full length Orc6 
was utilised as a positive control (Figure 3.7, lane 11). The experiment confirmed a 
direct binding only for the full length subunit of Orc2 and not for the C-terminus 
(Figure 3.7, lanes 1-6). Cdc6 full length and its C-terminus were also included in the 
experiment, in the eventuality that these two proteins could associate. Surprisingly, it 
was found that full length Cdc6 interacted with Cdt1 (Figure 3.7, lane 13). 
 
Figure 3.7: Cdt1 interacts with Orc2, Orc6 and Cdc6 
Cdt1 interaction analysis with Orc2, Orc6 and Cdc6. MBP or MBP-Cdt1 immobilized on anti-
MBP magnetic beads, were incubated with 35S labelled in vitro transcribed translated 
proteins, washed, separated by SDS-PAGE and analysed by autoradiography. Asterisks 
indicate protein constructs. 
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of the pre-RC. For this purpose, several truncations of Orc2 were produced via in 
vitro transcription and translation after the analysis of the secondary structure 
prediction (Appendix II), in order to avoid disruption of the structural elements, and 
tested in Cdt1 pull-down reactions. 
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Figure 3.8: Cdt1 interaction with Orc2 truncations 
MBP or MBP-Cdt1 immobilized on anti-MBP magnetic beads, were incubated with 35S 
labelled in vitro transcribed translated Orc2 truncations, washed, separated by SDS-PAGE 
and analysed by autoradiography. Asterisks indicate protein constructs. 
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Figure 3.9: Cdt1 interaction with Orc2 N-terminal truncations  
MBP or MBP-Cdt1 immobilized on anti-MBP magnetic beads, were incubated with 35S 
labelled in vitro transcribed translated Orc2 N-terminal truncations, washed, separated by 
SDS-PAGE and analysed by autoradiography. Asterisks indicate protein constructs. 
 
 
Figure 3.10: Cdt1 interaction with Orc2 C-terminal truncations  
MBP or MBP-Cdt1 immobilized on anti-MBP magnetic beads, were incubated with 35S 
labelled in vitro transcribed translated Orc2 C-terminal truncations, washed, separated by 
SDS-PAGE and analysed by autoradiography. Asterisks indicate protein constructs. 
 
 
 
These experiments showed that only the long fragments with the very N-
terminal portion deleted are still capable of binding Cdt1 (Figure 3.8 panel A lane 11, 
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panel B lanes 9 and 13, panel C lane 9), therefore a fine N-terminal (Figure 3.9) and 
C-terminal (Figure 3.10) mapping was performed under the same conditions.  
This would allow us to identify the minimal region required for the interaction, without 
completely disrupting the structure of the truncated fragments. 
Finally, a scheme that summarises all the detected interactions is shown in 
Figure 3.11.  
 
Figure 3.11: Summary of Cdt1 interaction with Orc2 truncations 
The interactions showed in Figures 3.7 to 3.9 are summarised and distinguished based on 
the % of binding where grey stands for poor and black for good. The functional elements are 
indicated as following: Walker A (WA), Walker B (WB) and winged-helix domain (WHD). 
 
 
The results show that no single motif in Orc2 is sufficient for the interaction 
with Cdt1. Instead it was found that the interaction is independent of the very N-
terminal and C-terminal portions of Orc2. Any further shortening leads to a loss of 
binding. That could mean that a central region is required for binding or folding. To 
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explore this further, the fragment (Orc2 aa 126-620) could be shortened from the C-
terminus and the fragment (Orc2 aa 1-461) could be shortened from the N-terminus.  
 
3.3 Discussion 
When this project started, very little was known on the interactions occurring 
during pre-RC formation and it was unclear how the ORC/Cdc6 complex, formed 
onto replicative origins, is contacting MCM2-7/Cdt1. The only details available were 
that Orc6 is crucial for the recruitment of Cdt1 (Chen et al, 2007) and that the C-
terminus of Cdt1 binds MCM2-7 whilst the N-terminus is required to load pre-RC 
complexes that are competent for CMG formation (Takara & Bell, 2011). An 
impressive amount of work and publications led to an improved understanding of the 
pre-RC formation process (Fernandez-Cid et al, 2013; Frigola et al, 2013; Sun et al, 
2013). These findings will be discussed in this paragraph together with the new 
results presented in this chapter. 
During this study ORC and MCM2-7 were analysed at first. The isolated ORC 
subunits were used instead of the full length protein to maximise the chance of 
detecting an interaction, given that it seems plausible that ORC assumes a specific 
conformation upon DNA binding which could allow MCM2-7 binding. The use of in 
vitro transcribed and translated proteins was an important technical break-through, 
as it allowed the detection of specific interactions in a rapid process. This approach 
could lead to false positive results, exposing domains that are generally buried in the 
structure of the full length protein, but it is still a valuable tool for initial screening of 
interactions. 
The pull-down proved to work, revealing the known interaction of MCM2-7 with Cdt1 
(Figure 3.2, (Takara & Bell, 2011)). The full length MCM2-7 appears to interact 
exclusively with the Orc2 subunit (Figure 3.2), but it is also possible that the binding 
site is produced by the folding of more subunits other than Orc2. The interaction 
between MCM2-7 and Cdc6 was also analysed (Figure 3.3), but no binding was 
detected. This could suggest that the two proteins do not directly contact each other, 
or more likely that MCM2-7 has to be in a different conformation which could be 
achieved after a first contact with the DNA or ORC. The interaction would be then 
hindered by a change in MCM2-7 structure, similarly as observed for Cdc6 
interacting with Mcm3 (Sun et al, 2013). Surely Cdt1 does not sufficiently alter the 
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structure of MCM2-7, as the pull-down of Cdc6 with Cdt1/MCM2-7 did not give any 
signal (Figure 3.3, lanes 7-8). 
At the time of analysis it appeared reasonable to investigate the involvement 
of the C-terminal extensions of Orc1-5 and Cdc6 (Figure 3.4) in the binding to 
MCM2-7, as these represented one potential interaction surface. Sun and colleagues 
proved the hypothesis wrong; they indicated that the C-terminal part of the ORC 
subunits contact DNA, but are distal to MCM2-7 (Sun et al, 2013). The data on the 
interaction of MCM2-7 with Orc1-5 and Cdc6 C-terminal domains shows indeed no 
binding, both in absence and presence of Cdt1 (Figure 3.5). Interestingly, a signal 
was detected for the full length Orc6 in the presence of Cdt1, suggesting that these 
two proteins do interact as previously reported (Chen et al, 2007) and that Cdt1 
could bridge an interaction with MCM2-7. However, in contrast to the initial report, 
Orc6 is required for OCM, but not OCCM,formation (Fernandez-Cid et al, 2013). 
The relation between MCM2-7 and ORC was further analysed in the context 
of the MCM2-7ΔC6 mutant, which has a defective Cdt1 binding domain (Takara & 
Bell, 2011), showing no significant difference compared with the wild type. The 
increased signal for the interaction of MCM2-7ΔC6 with Orc2 in the presence of Cdt1 
(Figure 3.6, compare lanes 13-14) is consistent with previous reports where it was 
shown that the mutant is still capable of interacting with Cdt1 and indicating that 
MCM2-7 has more than one binding site for Cdt1 (Fernandez-Cid et al, 2013). 
The surface of contact between MCM2-7 and ORC surely deserves to be better 
investigated and the work of Sun and colleagues (Sun et al, 2013) provides some 
important hints on the direction to follow. In the current study though the interaction 
ORC-Cdt1 appeared more promising, therefore a series of Cdt1 pull-downs was 
performed. As already expected from MCM2-7 interacting with Orc2 stronger in the 
presence of Cdt1 (Figure 3.5, compare lanes 38 and 39), a direct interaction analysis 
confirmed the binding of Cdt1 to the full length Orc2 (Figure 3.7, lane 4), and 
consistently reproduced the literature for Cdt1 with Orc6 interaction (Asano et al, 
2007; Chen et al, 2007). Surprisingly the assay also showed an interaction between 
Cdt1 and Cdc6 which has not been observed in before (Figure 3.7, lane 13) and will 
need further exploration. 
An extensive number of different Orc2 truncations was examined for binding to Cdt1 
(Figures 3.7 to 3.10, summarised in 3.11), indicating that the putative binding site 
must be in the central portion of Orc2, in the AAA+ region, with a minimum fragment 
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comprising amino acids 225-461. Unfortunately Cdt1 was not capable of pulling 
down this fragment, suggesting that the structural context is important as well. 
Overall the data presented in this chapter provides some interesting 
contributions to the understanding of the pre-RC formation process.  
 
 
Figure 3.12: Cryo EM structure of the pre-RC complex 
A) Proximity of Cdc6 and Mcm3, but no direct interaction. DNA appears loaded. B) Close up 
of the putative Mcm2/Mcm5 gate that could function for DNA entry. Adapted from Riera et al, 
2013. 
 
 
From the structure proposed by Sun and colleagues (Sun et al, 2013) and 
presented in Figure 3.12, it appears possible that the surface of contact between 
MCM2-7 and ORC involves Orc2, and also that Cdt1 and Orc2 can interact with 
each other, but that this interaction is potentially more important for initial 
ORC/Cdc6/Cdt1/MCM2-7 complex formation.  
It is more difficult to find an explanation for the newfound interaction of Cdt1 with 
Cdc6, because the two proteins seem to be located far away from one other, at least 
in the structure of the OCCM. It is still possible to speculate that this interaction could 
find an importance during the recruitment of the second MCM2-7 hexamer for the 
formation of the double-hexamer. Additional studies are required to better 
understand the complicated and dynamic structure of the pre-RC complex. 
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Chapter 4 – Results 
Analysis of the interaction of Sld3 with the pre-RC 
 
The transition between pre-RC, which presents a loaded but inactive form of 
MCM2-7 helicase, and the pre-IC, a complex competent for initiation of replication, is 
believed to result in the formation of the CMG, where Cdc45 and GINS are recruited 
to MCM2-7 to activate the helicase (Costa et al, 2011; Ilves et al, 2010). 
How the CMG is formed has been under analysis for several years and it is known 
that Cdc45 associates with origins before GINS, already in G1-phase, with the same 
timing as Sld3 (Kamimura et al, 2001).  
Sld3 is an essential protein in yeast, it is a limiting factor present with only 300 
copies/cell (Tanaka et al, 2011b) and it is required for Cdc45 recruitment to origins 
(Kamimura et al, 2001; Kanemaki & Labib, 2006). Its S-CDK dependent 
phosphorylation generates a binding site for Dpb11 and their interaction is essential 
for initiation of replication (Tanaka et al, 2007b; Zegerman & Diffley, 2007), but it is 
believed to be a recruiting factor since it does not move with the replicative fork 
(Kanemaki & Labib, 2006). Furthermore during DNA damage, a Rad53 mediated 
phosphorylation of Sld3 and Dbf4 blocks CMG formation (Lopez-Mosqueda et al, 
2010; Zegerman & Diffley, 2007), thus origin firing is blocked until the damage has 
been repaired.  
For all these reasons, Sld3 appears to be one of the most important factors during 
initiation of DNA replication and therefore its interaction with the pre-RC will be 
analysed in detail in this chapter. 
 
4.1 Analysis of Sld3 recruitment to the pre-RC 
Kamimura and colleagues showed that, in vivo, Sld3 and Cdc45 associate 
simultaneously with replication origin in G1-phase and with late-firing origins in late 
S-phase (Kamimura et al, 2001). A temperature sensitive mutant of Cdc45 was used 
to analyse the association of Sld3 with origins in chromatin immunoprecipitation 
assays, finding a reduction compared to the wild type strain, suggesting that Sld3 
requires Cdc45 for stable recruitment. In fission yeast the recruitment of Sld3 to 
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origins does not depend on Cdc45 (Yamada et al, 2004). This indicates that Sld3 is 
potentially one of the first proteins binding to the pre-RC, which was tested in this 
project. 
Sld3 was purified from budding yeast using a method developed in the group 
(Herrera, Tognetti et al, under revision). An MBP-PS-Myc-Sld3 construct was 
overexpressed in yeast from a galactose-inducible promoter, the culture was 
harvested and disruption with a cryogenic method prior to binding to amylose resin. 
Bound MBP-Myc-Sld3 was rinsed, washed and eluted with PreScission protease, 
whose recognition site was added between the MBP and Myc tags. The eluted 
material was incubated with SP sepharose to concentrate it and remove the 
protease (Figure 4.1) and eluted using 0.5 and 1 M NaCl. For simplicity, from now on 
MBP-PS-Myc-Sld3 will be called MBP-Sld3 whereas Myc-Sld3 just Sld3 because of 
the small size of the tag (203 Da). All purified Sld3 used in this work is Myc-Sld3. 
 
Figure 4.1: Purification of Sld3 from yeast 
Coomassie stained gel showing the purification of Sld3 from yeast overexpressing MBP-PS-
Myc-Sld3. Cells were lysed by freezer milling and the extract incubated with amylose resin. 
Bound MBP-Sld3 was washed three times and Sld3 eluted after cleavage with PreScission 
protease. The elutions were pooled, diluted to decrease the salt concentration and incubated 
with SP sepharose beads. Sld3 was then eluted using elution buffer containing 0.5 or 1 M 
NaCl. The relevant fractions determined by Bradford were pooled (lanes 21 and 22). Arrows 
indicate the position of MBP-Sld3 (120.3 kDa), Sld3 (77.3 kDa) and PreScission protease 
(46 kDa). 
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The pre-RC was initially reconstituted by incubating the purified pre-RC 
proteins with biotinylated origin DNA linked to streptavidin beads, as previously 
described (Evrin et al, 2009), the unbound proteins were then washed away and 
Sld3 added to the sample in a second step. The experiment was unsuccessful 
because of the high non-specific binding of Sld3 to the streptavidin beads used in the 
assay. A series of variations was performed in order to improve the amount of Sld3 
available for the interaction with the pre-RC and a summary is presented in Table 
4.1. Unfortunately none of these changes resulted in a sufficient decrease of the 
unspecific binding of Sld3 to the beads. 
 
Parameter changed Conditions tested Result 
Beads 
Different streptavidin beads 
(Dynabeads, Magnalink, 
Nanolink, PEGylated) and 
neutravidin beads. 
PEGylated streptavidin 
beads appeared promising 
Beads blocking prior to  
pre-RC reconstitution 
20 mg/ml BSA or milk 20 mg/ml milk improved 
Beads blocking time 1 h or overnight Overnight improved 
Salt concentration washes 100, 200, 300 mM KGlu No improvement 
Additional proteins DDK, Cdc45, MCM10, RPA No improvement 
Proteins ratio Different Sld3/Cdc45 ratios No improvement 
Different Sld3 Sld3 purified from bacteria No improvement 
 
Table  4.1: Optimisation of the recruitment of Sld3 to the reconstituted pre-RC 
Summary of parameters tested during the optimisation. Starting condition was pre-RC 
reconstituted as described in Evrin et al, 2009, added with 40 nM Sld3 for 15 min at 27°C 
before washes. 
 
 
One of the unsuccessful experiments is presented in Figure 4.2. In this case the 
recruitment of Sld3 was tested in the presence of Cdc45 and DDK in the bead based 
assay. No Sld3 was detected bound to the Pre-RC in any of the conditions (Figure 
4.2, panel A) but a very strong signal was instead sensed when the beads were 
analysed (Figure 4.2, panel B), suggesting that Sld3 is interacting non-specifically 
with the solid matrix. Cdc45 was behaving in a similar manner, despite a weak, non 
stoichiometric signal was detected as pre-RC bound (Figure 4.2, panel A), especially 
in the presence of Sld3 and DDK. 
79 
 
 
Figure 4.2: Bead based assay for Sld3 recruitment to the pre-RC 
Analysis of the recruitment of Sld3 to the pre-RC reconstituted as previously described 
(Evrin et al, 2009). 40 nM Sld3, 40 nM Cdc45 and a 3 fold dilution (6-20-60 nM) DDK were 
added for 15 min at 27°C to the pre-RC prior to salt wash and elution with DNase I. The 
samples were analysed by SDS-PAGE followed by Western Blotting using specific 
antibodies against Mcm2, Sld3 and FLAG (Cdc45). 
 
 
 
A novel method was developed in the lab for the reconstitution of the pre-RC 
in solution, followed by gel filtration (Herrera, Tognetti et al, under revision). This 
method, in contrast to the method involving a solid matrix(DNA coupled to 
streptavidin coated magnetic beads) which previously depleted the proteins from 
solution, allowed a successful analysis. In this assay, the pre-RC was assembled 
using a one-step reaction. Fifty microliter reactions containing 40 nM ORC, 40 nM 
Cdc6, 40 nM Cdt1 and 40 nM MCM2-7 were pre-incubated for 10 min on ice and 10 
min at 24°C. 6 nM pUC19-ARS1 plasmid and 1.5 U of human topoisomerase I were 
added to the reaction and incubated for 15 min at 24°C 950 rpm. Afterwards the 
additional components were added (in this case Sld3 to a final concentration of 40 
nM Sld3), together with 5 mM ATP, 250 ng/µl BSA, 1.4 µM competitor DNA (40 bp). 
Then the reactions were incubated for the required time at 27°C 950 rpm and finally 
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KAc was added to a final concentration of 200 mM followed by a 3 min incubation at 
24°C and mixing at 950 rpm. Samples were loaded on top of a spin column, filled 
with 0.5 ml of resin (Sephacryl S400 HR, GE). After loading of the samples the 
columns were spun for 5 min at 1000 g. Prior to the gel-filtration step the spin 
columns were filled with equilibrated resin and pre-spun for 5 min at 850 g. The 
eluate was concentrated by speed-vac prior to SDS-PAGE analysis. 
The pre-RC was therefore reconstituted with this method and is shown in 
Figure 4.3 (panel A, lane 4). In Figure 4.3, lane 2, the DNA was left out, whereas in 
lane 3 the pre-RC proteins (ORC, Cdc6, Cdt1 and MCM2-7) were not added into the 
reaction, showing that the signal detected in lane 4 is DNA dependent and 
corresponds to the reconstituted complex. The salt wash performed in this assay 
removes most ORC, Cdc6, Cdt1 and associated MCM2-7 leaving on DNA only 
loaded MCM2-7 complexes. This system was afterwards used to test Sld3 
interaction with the pre-RC. 
 
 
Figure 4.3: Sld3 recruitment to the pre-RC 
A) Silver stained gel showing the reconstitution of the pre-RC using the gel filtration method. 
B) Analysis of the recruitment of Sld3 to the pre-RC reconstituted as in panel A. 40 nM Sld3 
was added for 1 min at 27°C to the pre-RC reconstituted in solution prior to salt wash and 
gel filtration. After gel filtration, the samples were analysed by SDS-PAGE followed by 
Western Blotting using specific antibodies against Mcm2 and Sld3. 
 
To analyse the recruitment of Sld3, 40 nM Sld3 was added to the pre-RC 
reconstituted in solution for 1 min at 27°C prior to salt wash and gel filtration. Under 
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these conditions, Sld3 was capable of binding to the DNA in a pre-RC dependent 
manner. In the absence of additional proteins a nearly stoichiometric complex 
between MCM2-7 and Sld3 was observed (Figure 4.3, panel B, lane 2). 
 
4.2 Analysis of direct interaction between Sld3 and MCM2-7 
Knowing that Sld3 and Cdc45 interact with one another (Kamimura et al, 
2001), Cdc45 associates with MCM2-7 to form the CMG (Costa et al, 2011; Ilves et 
al, 2010) and Sld3/Cdc45/MCM2-7 can form a ternary complex in vitro (Bruck & 
Kaplan, 2011a), it was hypothesized that Sld3 directly binds to MCM2-7. 
MBP-MCM2-7 was used for the interaction analysis because it performs in 
immunoprecipitations better than the wild type protein, as described in chapter 3.  
The interaction between purified Sld3 and MCM2-7 was tested first (Figure 4.4), 
showing a specific binding of Sld3 to MBP-MCM2-7, but not to the MBP control. 
 
Figure 4.4: Direct interaction of Sld3 with MCM2-7 
MCM2-7 interaction analysis with Sld3. MBP or MBP-MCM2-7 immobilized on anti-MBP 
magnetic beads, were incubated with 0.5 μg purified Sld3, washed, separated by SDS-
PAGE and analysed by western blot against MBP (upper) or Sld3 (lower). The western blot 
probed against MBP in the immunoprecipitation for MBP-MCM2-7 reveals, together with a 
band corresponding to MBP-Mcm7 (137 kDa), one of the size of MBP (42.5 kDa) possibly 
due to C-terminal degradation of the protein. 
 
 
One possible surface on MCM2-7 for interaction with Sld3 was hypothesised to be at 
the N-termini, where the MCM2-7 subunits contain non-conserved extensions of 
various lengths (Figure 4.5, in red).  
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Figure 4.5: The domain architecture of the subunits of MCM2-7 
Diagram of the structural domains based on sequence alignment. Archaeal MCM (MtMCM) 
is included. The functional elements are indicated as following: Walker A (WA), Walker B 
(WB) and Arginine Finger (RF). 
 
 
A structure of the MCM2-7 hexamer comprising the non-conserved N-termini has yet 
to be defined, but these regions are believed to be flexible and therefore suitable for 
protein-protein interactions.  
Before investing time into the cloning and isolation of tagged MCM2-7 N-
termini, a test was performed with controls for Sld3 binding to check if the 
experimental controls could work. Dpb11, a known interacting partner of Sld3 
(Zegerman & Diffley, 2007), was chosen as a positive control. In vivo though Sld3 
and Dpb11 interact only after CDK dependent phosphorylation of Sld3, therefore 
their interaction in vitro needed to be tested. Regα was instead used as a negative 
control, being an unrelated protein involved in proteasome activation. 
These proteins, GST-tagged at their N-terminus, were conjugated to Glutathione 
beads (Figure 4.5, panel E) and used in a pull-down assay with Sld3, alone or in 
combination with CDK, DDK or both (Figure 4.5, panel F). CDK is known to 
phosphorylate Sld3 and thus allows its binding to Dpb11 (Zegerman & Diffley, 2007); 
Whether DDK affects this interaction has not been tested, but as DDK is important 
for the transition of the pre-RC into pre-IC it was interesting to analyse (Heller et al, 
2011). Initially, CDK was overexpressed in insect cells as HA-Clb5/Cdc28 
(Fernandez-Cid et al, 2013), bound to anti-HA resin and eluted using HA peptide 
(Figure 4.6, panel A). The activity of CDK was then verified using Cdc6 as substrate 
for phosphorylation (Chen & Bell, 2011). Upon addition of increasing concentrations 
of CDK, a clear shift of Cdc6 is visible (Figure 4.6, panel B, lane 3 onwards), 
indicating that the kinase is active. 
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Mcm4
Mcm5
Mcm6
Mcm7
MtMCM
Zinc finger N-C linker WA WB RF
N-terminus C-terminusAAA+
83 
 
DDK was instead overexpressed in yeast as MBP-PS-Dbf4/Cdc7 from a galactose-
inducible promoter. MBP-Dbf4/Cdc7 was bound to amylose resin, rinsed, washed 
and eluted with PreScission protease to cleave off the MBP tag. The eluted material 
was incubated with Glutathione resin to trap the GST-tagged protease and finally 
pooled and concentrated (Figure 4.6, panel C). DDK was then examined for its ability 
to phosphorylate loaded MCM2-7 (Kihara et al, 2000; On et al, 2014; Randell et al, 
2010; Sheu & Stillman, 2010; Weinreich & Stillman, 1999), showing a clear shift of 
Mcm6 at the concentration tested (Figure 4.6, panel D). 
In the absence of kinases, Sld3 was able to bind Dpb11 (Figure 4.5, panel F 
lane 3), suggesting that, either Sld3 is already phosphorylated by CDK when purified 
from asynchronous cells, or that Sld3 and Dpb11 can interact in vitro in the absence 
of modifications. Regα showed no interaction (Figure 4.5, panel F lane 2) as 
expected. The addition of CDK successfully resulted in a phosphoshift of Sld3 in the 
input (Figure 4.5, panel F, compare lane 4 to 1) and did not alter the binding of Sld3 
to Dpb11 (Figure 4.5, panel F lane 6), whereas DDK slightly weakened the 
interaction (Figure 4.5, panel F lane 9).  
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Figure 4.6: Test of Sld3 interaction with controls and kinases purification and testing 
A) CDK was overexpressed in insect cells as HA-Clb5/Cdc28, bound to anti-HA resin and 
eluted with HA peptide B) CDK activity test on Cdc6. 1.3 µM of Cdc6 was incubated with 
increasing concentrations of CDK C) MBP-PS-Dbf4/Cdc7 was bound to amylose resin, 
rinsed, washed and eluted with PreScission protease. The eluted material was incubated 
with Glutathione resin, pooled and concentrated D) DDK activity test: reconstituted pre-RC 
was high salt washed to produce loaded MCM2-7 and incubated with 40 nM DDK for 15 min 
at 27°C. E) The E. coli extracts overexpressing GST-Regα (54.7 kDa) and GST-Dpb11 (113 
kDa) were incubated with Glutathione beads, washed, analysed on a SDS-PAGE gel 
together with 20% input of Sld3 and stained with Coomassie Brilliant Blue. They represent 
the loading controls for the immunoprecipitations in panel B. F) Samples prepared as 
described in panel A were incubated with 1 µg of purified Sld3 alone or pre incubated with 
20 nM CDK (lanes 4, 5, 6) or 100 nM DDK (lanes 7, 8, 9). The samples were analysed by 
SDS-PAGE followed by Western Blotting using a specific antibody against Sld3. The 
Ponceau-S stained membrane shows equal loading of GST-Dpb11 and GST-Regα on 
Glutathione beads. 
 
 
 
To analyse the interaction of Sld3 with the MCM2-7 N-termini, each N-
terminal region preceding the Zinc finger (see Figure 4.5) was fused at its C-terminus 
with GST tag and overexpressed in bacteria. A range of different buffers, pH, and 
salt concentrations were analysed to elucidate a good condition for binding to 
Glutathione resin and the purification. Finally, a normalisation of the protein amount 
was performed, which is shown in Figure 4.7, panel A. The MCM2-7 N-termini are 
highly negatively charged therefore they separate in SDS-PAGE gel not at the 
expected molecular weight but significantly higher. The identity of the proteins was 
verified by Mass Spectrometry. 
The Glutathione beads presenting the GST-fused N-termini, together with Dpb11 
and Regα as controls, normalised for the amount of protein bound, were then used 
to pull-down purified Sld3 (Figure 4.7, panel B). 
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Figure 4.7: Interaction of Sld3 with GST-tagged MCM2-7 N-termini 
A) The E. coli extracts overexpressing GST-tagged MCM2-7 N-termini, GST-Regα and 
GST-Dpb11 were bound to Glutathione beads, washed, analysed on a SDS-PAGE gel and 
stained with Coomassie Brilliant Blue. Dilutions that represent equal protein amount, and are 
used in panel B, are marked with black rectangles. All dilutions were run in the same gel and 
stained together. The identity of the proteins was verified by Mass Spectrometry; they are 
indicated with arrows. Molecular weights of the domains fused to GST: Mcm2 (aa 1-322) 65 
kDa, Mcm3 (aa 1-192) 48 kDa, Mcm4 (aa 1-340) 65 kDa, Mcm5 (aa 1-174) 47 kDa, Mcm6 
(aa 1-302) 60 kDa, Mcm7 (aa 1-253) 56 kDa, Dpb11 113 kDa, Regα 54.7 kDa. B) The 
samples indicated in panel A were incubated with 1 µg of Sld3, washed and analysed by 
SDS-PAGE followed by Western Blotting using a specific antibody against Sld3. 
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The pull-down confirmed an interaction between Sld3 and Dpb11 (Figure 4.7, panel 
B lane 9) and none to Regα (lane 2), consistent with what was previously observed. 
When the GST-tagged MCM2-7 N-termini were used, instead, Sld3 was 
immunoprecipitated by Mcm2, Mcm7 and to a lesser extent by Mcm5 and Mcm6 
(Figure 4.7, panel B).  
Several optimisations were performed in order to decrease the non-specific 
interactions. The variations included a bigger volume and extended time for the 
washes, increased salt concentrations or addition of 0.1 mg/ml BSA to the buffer 
used for the washes. None of these conditions appeared to improve the quality of the 
assay as presented in Figure 4.7, panel B, in a consistent way. It was concluded that 
the difficulty in handling Glutathione agarose (see paragraph 4.6 for Discussion) 
could significantly affect the reproducibility of the experiment and, for this reason, it 
was decided to use a different approach to study this interaction, similarly to what is 
described in Chapter 3. MBP-Sld3 was therefore employed to immunoprecipitate in 
vitro transcribed and translated MCM2-7 subunits. In this case, the binding of the 
same protein (MBP-Sld3) to magnetic beads significantly reduces the variability 
among samples. 
 
 
Figure 4.8: Sld3 interaction analysis with MCM2-7 subunits.  
A) Coomassie stained gel showing MBP (42 kDa) and MBP-Sld3 (120.3 kDa) immobilized 
on anti-MBP magnetic beads. B) MBP or MBP-Sld3 immobilized on anti-MBP magnetic 
beads were incubated with 35S labelled in vitro transcribed translated proteins, washed, 
separated by SDS-PAGE and analysed by autoradiography. Asterisks indicate full length 
proteins. 
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MBP-Sld3 was purified as described for Sld3 (Figure 4.1), with the exception 
that the protein was eluted with maltose instead of MBP cleaved with PreScission 
Protease. It was immobilised on anti-MBP beads and used to precipitate the full 
length subunits of MCM2-7. Once again, Dpb11 was used as a positive control while 
purified MBP was used as negative control during the immunoprecipitation assays 
(Figure 4.8). 
The experiment confirmed the interaction of Sld3 with Dpb11 (Figure 4.8, lane 20) 
and also showed a specific interaction with the Mcm2 subunit of MCM2-7 (Figure 
4.8, lane 8), consistent with the preliminary result obtained from the GST pull-downs 
of the N-termini (Figure 4.8, lane 3), but with the added advantage that the 
background was reduced. 
Given that Mcm2 appeared as the only subunit of MCM2-7 to interact with 
Sld3 in this assay, it was decided to focus attention on this subunit. To confirm that 
the interaction involves the N-terminal domain of Mcm2, three truncations were 
produced after the analysis of the secondary structure prediction and tested in the 
pull-down with Sld3 (Figure 4.9).  
 
 
 
Figure 4.9: Sld3 interacts with the N-terminal of Mcm2 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated truncations of Mcm2, washed, separated by SDS-
PAGE and analysed by autoradiography. 
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The prediction (Appendix II) would suggest the position of helixes and sheets 
therefore the truncation could be produced in order to minimise disruption of these 
elements. The experiment confirmed the binding between MBP-Sld3 and Mcm2 full 
length (Figure 4.9, lane 11), as well as with the N-terminus of Mcm2 (Figure 4.9, lane 
5). The central and C-terminal domains of Mcm2 were instead not precipitated by 
MBP-Sld3 (Figure 4.9, lanes 7 and 9 respectively). 
MBP-Sld3 appears to interact with the N-terminal region of Mcm2 therefore it 
was interesting to map the minimal region of binding. A series of N-terminal and C-
terminal truncations of the region of interest were produced and tested in the assay, 
while Mcm2 full length and aa 1-322 were used as positive controls. 
Interestingly the fragment corresponding to aa 1-200 does not interact with MBP-
Sld3 (Figure 4.10, panel A lane 11; panel B lane 12), whereas all other fragments 
tested are still immunoprecipitated. All C-terminal truncations, excluding 1-200, and 
all N-terminal truncations analysed can bind MBP-Sld3, suggesting that the minimal 
binding site is comprised between the amino acids 200-250 of Mcm2. 
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Figure 4.10: Sld3 interaction with Mcm2 truncations 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated truncations of Mcm2, washed, separated by SDS-
PAGE and analysed by autoradiography. 
  
M
c
m
2
 1
-8
6
8
 (
F
L
)
M
c
m
2
 1
-3
2
2
M
c
m
2
 1
-2
0
0
M
c
m
2
 1
-2
5
0
M
c
m
2
 1
-3
0
0
M
c
m
2
 1
-3
5
0
5 % input
IP - MBP
IP - MBP-Sld3
+
+
M
c
m
2
 1
-8
6
8
 (
F
L
)
+
+
M
c
m
2
 1
-3
2
2
+
+
M
c
m
2
 1
-2
0
0
+
+
M
c
m
2
 1
-2
5
0
+
+
M
c
m
2
 1
-3
0
0
+
+
M
c
m
2
 1
-3
5
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
A
M
c
m
2
 1
-8
6
8
 (
F
L
)
M
c
m
2
 1
-3
2
2
M
c
m
2
 1
-2
0
0
M
c
m
2
 5
0
-3
5
0
M
c
m
2
 1
0
0
-3
5
0
M
c
m
2
 1
5
0
-3
5
0
M
c
m
2
 2
0
0
-3
5
0
IP - MBP
IP - MBP-Sld3
+
+
M
c
m
2
 1
-8
6
8
 (
F
L
)
+
+
M
c
m
2
 1
-3
2
2
+
+
M
c
m
2
 1
-2
0
0
+
+
M
c
m
2
 5
0
-3
5
0
+
+
M
c
m
2
 1
0
0
-3
5
0
+
+
M
c
m
2
 1
5
0
-3
5
0
+
+
M
c
m
2
 2
0
0
-3
5
0
1 2 3 4 5 6 7 8 9 10111213 141516 1718 1920 21
5 % input
B
91 
 
In order to further characterise this potentially crucial region, the sequence 
comprised between amino acids 190-290 was submitted to the Quark server (Xu & 
Zhang, 2012) to predict the structure and then refined with ModRefiner (Xu & Zhang, 
2011) (Riera, personal communication).  
 
Figure 4.11: 3D structure prediction of amino acids 190-290 of Mcm2 
The sequence comprised between amino acids 190-290 was submitted to the Quark server 
to predict the structure and then refined with ModRefiner.  
  
 
 
In the prediction shown in Figure 4.11, several helixes can be identified and this 
information was used to produce additional truncations in the region between aa 
200-250. The logic was to avoid the disruption of the structure, and therefore affect 
the interaction with Sld3. These truncations were then tested in an 
immunoprecipitation assay with MBP-Sld3 (Figure 4.12).  
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Figure 4.12: Fine mapping of the binding site on Mcm2 for Sld3 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated truncations of Mcm2, washed, separated by SDS-
PAGE and analysed by autoradiography. 
 
Mcm2 full length and 1-250 were used as positive controls, while Mcm2 1-200 was 
used as negative control. From this experiment it appears that the fragment 1-218 is 
already capable of interaction but the 1-250 is otherwise required to achieve a 
stronger binding. This suggests that a binding site is contained in the region 200-218 
and another in 241-250 or that a defined structure is required for this interaction. 
 
4.3 Analysis of Mcm2 N-terminal deletion mutants  
In order to prove that the region 1-250 of Mcm2 is indeed responsible for the 
interaction of MCM2-7 with MBP-Sld3, a deletion mutant including these amino acids 
was cloned, expressed and purified employing the same strategy as for the wild type 
(Figure 3.1). 
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Figure 4.13: Purification of MCM2-7 2Δ1-250 
Coomassie blue stained gel of the purification of the MCM2-7 deletion mutant. Yeast extract 
produced by freezer milling was incubated with anti-HA beads, rinsed, washed twice and 
rinsed again before bound MCM2-7 2Δ1-250 was eluted with HA peptide. The eluate was 
concentrated and loaded into a Superose 6 column for gel filtration and fractions 
corresponding to lanes 11-13 and 14-15 were pooled separately. Arrows indicate the 
position of the Mcm subunits. 
 
 
The purified mutant was tested in first place for the ability to form a complex 
with the other components of the pre-RC on origin DNA and salt stable MCM2-7 
loading. The pre-RC was reconstituted as previously described (Evrin et al, 2009) 
with either wild type MCM2-7 or MCM2-7 2Δ1-250 (Figure 4.14, panel A). Both forms 
of MCM2-7 appeared to be recruited onto DNA (Figure 4.14, panel A, lanes 6 and 8) 
and also to be stably loaded after high salt wash (Figure 4.14, panel A, lanes 7 and 
9), although the deletion mutant appeared to be less efficient than the wild type in 
this condition. The high salt wash removes ORC, Cdc6 and Cdt1, leaving MCM2-7 
encircling the DNA, with only very small amounts of ORC left behind. 
MCM2-7 2Δ1-250 was produced following the strategy described in chapter 3, 
using three expression plasmids each containing two Mcm subunits, including Mcm3 
with a N-terminal HA tag, therefore there is the possibility of contamination with wild 
type Mcm2, expressed from its genomic promoter. The purification using an anti-HA 
resin followed by gel filtration would in fact not be able to discriminate between the 
deletion mutant and contaminating wild type protein. Given the low yield of MCM2-7 
E
x
tr
a
c
t 
1
/1
0
F
T
 1
/1
0
R
in
s
e
 1
/5
W
a
s
h
 1
W
a
s
h
 2
H
A
 E
lu
ti
o
n
 1
H
A
 E
lu
ti
o
n
 2
H
A
 E
lu
ti
o
n
 3
P
o
o
le
d
 e
le
u
ti
o
n
s
C
o
n
c
e
n
tr
a
te
d
 H
A
 p
o
o
l 
1
/1
0
C
1
C
2
C
3
C
4
C
5
C
6
C
7
C
8
C
9
C
1
0
C
1
1
C
1
2
Pool 
A
200 -
116 -
97 -
66 -
45 -
Pool 
B
kDa
Mcm4/Mcm7
Mcm6
Mcm3
Mcm2 Δ1-250
Mcm5
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
94 
 
complex obtained in the purification, it appears possible that wild-type Mcm2 could 
be contaminating the MCM2-7 2Δ1-250 complex. To exclude this possibility, wild 
type MCM2-7 and MCM2-7 2Δ1-250 were analysed by western blot, probed with a 
specific antibody anti-Mcm2. The epitope of this antibody is in the first 250 amino 
acids of the protein therefore it should not produce a signal for the deletion mutant. 
Nevertheless a signal at the same molecular weight as for the wild type could be 
detected in the case of the mutant (Figure 4.14, panel B), indicating that wild type 
Mcm2 is present in the sample. The loading obtained (Figure 4.14, panel A lane 9) 
could be therefore due to the contamination and not to MCM2-7 2Δ1-250 itself, 
rendering the result non-conclusive 
To further analyse this mutant, a growth assay was performed comparing the 
wild type protein with the mutant (Figure 4.14, panel C), while the empty vectors 
were used to generate a control strain that does not express proteins. Each strain 
was spotted in a 5 fold serial dilution on a selective plate containing either glucose 
(no protein expression) or galactose (protein expression) and grown at 30°C. The 
strains grew in a comparable manner on the glucose plate and no dominant lethality 
was observed in galactose for the deletion mutant strain compared to the wild type. 
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Figure 4.14: Activity test for MCM2-7 2Δ1-250 
A) Silver staining gel showing the reconstituted pre-RC formed with MCM2-7 wild type or 
MCM2-7 2Δ1-250. The assay was performed as previously described (Evrin et al, 2009). B) 
20% inputs of MCM2-7 wild type and mutant were analysed by SDS-PAGE followed by 
western blot and probed with a specific antibody anti-Mcm2. C) Yeast growth assay showing 
the effect of overexpression of the control strain (transformed with empty pESC-LEU, pESC-
TRP and pESC-URA), wild type MCM2-7 or MCM2-7 2Δ1-250 mutant. A 5 fold serial dilution 
of cells (starting from 1 x 107) was spotted onto selective Kaiser plates with either 2% 
glucose or 2% galactose. Plates were incubated for 3 days at 30°C. 
 
 
Taken all together, the results obtained with MCM2-7 2Δ1-250 suggest that the 
mutation could affect proper Mcm2 folding. This would explain the poor yield of the 
purification and the lack of an effect in the growth assay. It is still possible that the 
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mutant is indeed capable of loading and that the disruption of the interaction of Sld3 
with Mcm2 1-250 is not dominant-lethal, as other Sld3 binding sites are present in 
MCM2-7. It is otherwise possible that this interaction is bypassed in vivo by the 
presence of other factors, or that the wild type MCM2-7 present in the strain is 
sufficient to support growth. 
In order to produce a mutant protein complex that is not contaminated with the 
wild type, it was decided to add a FLAG tag to the Mcm2 subunit. In this way the 
FLAG-mediated purification would yield a sample that predominantly contains the 
deletion mutant. Furthermore, as the deletion of 250 amino acids could affect the 
stability of the mutant MCM2-7 complex, shorter deletion mutants were included as 
well, based on the findings shown in Figure 4.12. 
Initially, a growth assay was performed to establish if the FLAG tag at the N-
terminus of Mcm2 affects the protein function and whether dominant-lethality could 
be observed the Δ1-200 and Δ1-238 mutants (Figure 4.15). 
 
 
Figure 4.15: Growth assay for FLAG-tagged MCM2-7 
Yeast growth assay showing the effect of overexpression of the control strain (transformed 
with empty pESC-LEU, pESC-TRP and pESC-URA), MCM2-7 wild type, wild type FLAG and 
FLAG-tagged deletion mutants. A 5 fold serial dilution of cells (starting from 1 x 107) was 
spotted onto selective Kaiser plates with either 2% glucose or 2% galactose. Glucose plates 
were incubated for 2 days whereas galactose plates for 3 days at 30°C. 
 
 
The experiment indicates that the FLAG tag at the N-terminus of Mcm2 is causing 
dominant lethality, suggesting that the protein cannot fold or function in an optimal 
way. One possibility is that an N-terminal extension causes a specific defect, while 
the removal of the N-terminus is tolerated. It is interesting to note that 1-238 caused 
weak dominant lethality; this could suggest that this construct affects MCM2-7 
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function. Nevertheless, as the control wt FLAG was altered it was decided to analyse 
the mutants in more detail. 
 
4.4 MCM2-7 hybrid mutant 
The previous analysis of the deletion mutants suggests that the loss of the N-
terminal portion of Mcm2 affects the stability of the MCM2-7 complex. It was 
hypothesised that the corresponding region of the human Mcm2 could stabilise 
MCM2-7, but that the human Mcm2 N-terminus would not support interaction with 
Sld3. 
To test this possibility, the human and yeast sequences were aligned using 
the T-Coffee server (Di Tommaso et al, 2011), the portion of human sequence that 
aligned to the yeast Mcm2 1-250 (alignment in Appendix III) was used for in vitro 
transcription and translation and tested in a pull-down with MBP-Sld3. Also, a hybrid 
version of Mcm2 1-250 containing an important section of the yeast binding site for 
Sld3 was tested in this assay (Figure 4.16). 
 
Figure 4.16: Test of human Mcm2 N-terminus for Sld3 binding 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated variants of Mcm2 N-terminus, washed, separated by 
SDS-PAGE and analysed by autoradiography. 
 
 
Both, yeast Mcm2 1-250 and the hybrid human 1-200 fused to S. cerevisiae 222-
250, were immunoprecipitated by MBP-Sld3 (Figure 4.16, lanes 5 and 9 
respectively). Interestingly, human 1-232 did not interact with Sld3 (Figure 4.16, lane 
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7). This suggests that the interaction between Sld3 and MCM2-7 has diverged 
among species, consistently with the fact that Sld3 and Treslin show little homology 
in some stretches.  
Remarkably, the hybrid h1-200 sc222-250 is immunoprecipitated by MBP-Sld3, 
confirming that the region 222-250 contributes significantly to the interaction (Figure 
4.16, lane 9). 
It was then decided to purify a FLAG-tagged version of MCM2-7 presenting 
the human N-terminus covering the binding site for Sld3 (MCM2-7 FLAG h1-232 
sc254-868). MCM2-7 wild type FLAG-tagged was also purified to use as a control for 
the following experiments, keeping in mind that the tag appeared to cause a slight 
growth defect. 
 
Figure 4.17: Purification of FLAG-tagged MCM2-7 wild type and human hybrid 
Silver stained gel showing the purification of MCM2-7 wild type FLAG and hybrid mutant. 
Yeast extracts produced via freezer milling were incubated with anti-HA beads, rinsed, 
washed twice and rinsed again before bound MCM2-7 was eluted with HA peptide. The 
eluate was incubated with anti-FLAG beads, rinsed, eluted from the resin with FLAG peptide 
and concentrated. Final samples are shown in lane 29 and 30, together to the wild type 
purified with the standard protocol (lane 31). 
 
 
The proteins were overexpressed in budding yeast cells arrested with α factor in G1-
phase of the cell cycle, to ensure that the proteins are not carrying S-phase 
phosphorylations, using three expression plasmids each containing two Mcm 
subunits, including Mcm3 with a N-terminal HA tag and Mcm2 with a N-terminal 
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FLAG tag. They were then purified in a two-step purification process (Figure 4.17) 
where MCM2-7 was bound to anti-HA resin and eluted using HA peptide followed by 
a passage onto an anti-FLAG resin. The samples were finally eluted using FLAG 
peptide and concentrated. This protocol allowed the removal of a Mcm3/5 sub 
complex as well as any Mcm2 wild type contaminants. 
These MCM2-7 complexes were then tested in the pre-RC assay for 
recruitment and loading onto origin DNA. A standard pre-RC reconstitution assay 
was performed as previously described (Evrin et al, 2009), using either wild type 
MCM2-7, the FLAG-tagged version or the hybrid mutant (Figure 4.18, panel A). The 
FLAG-tagged MCM2-7 appeared to be recruited and loaded similarly as the standard 
wild type version (Figure 4.18, panel A, compare lanes 9-10 with 7-8), indicating that 
the FLAG tag does not have an effect on pre-RC formation. This also indicates that 
the growth defect seen previously (Figure 4.15) must be due to the interference of 
the tag with other functionalities of the MCM2-7 protein. When the hybrid mutant 
MCM2-7 FLAG h1-232 sc254-868 was used, it showed poor recruitment and 
extremely weak loading compared to the wild type versions (Figure 4.18, panel A 
lanes 11 and 12), indicating that the human N-terminus of Mcm2 is not able to 
restore the functionality of the yeast counterpart. 
This hybrid mutant, together with another one where a shorter portion of 
human Mcm2 is fused to the yeast Mcm2 preserving the binding site for Sld3, was 
also tested in vivo for dominant lethality (Figure 4.18, panel B). 
Again MCM2-7 wild type FLAG showed a slight growth defect compared to its 
untagged version. Both hybrid mutants appeared to further impact the viability, 
suggesting that if they can form a stable MCM2-7 complex, it is not fully functional. 
This data underlines how difficult it is to manipulate MCM2-7. The risk of 
disrupting the structure of the complex or affecting other interactions in addition to 
the one studied is very high.  
 
100 
 
 
Figure 4.18: Analysis of the MCM2-7 hybrid mutants 
A) Silver staining gel showing the reconstituted pre-RC formed with MCM2-7 wild type or 
FLAG-tagged versions. The assay was performed as previously described (Evrin et al, 
2009). A longer staining was applied to lanes 11 and 12 in order to detect minimal amount of 
protein. B) Yeast growth assay showing the effect of overexpression of the control strain 
(transformed with empty pESC-LEU, pESC-TRP and pESC-URA), MCM2-7 wild type, 
FLAG-tagged wild type and two forms of hybrid mutants. A 5 fold serial dilution of cells 
(starting from 1 x 107) was spotted onto selective Kaiser plates with either 2% glucose or 2% 
galactose. Glucose plates were incubated for 2 days whereas galactose plates for 3 days at 
30°C. 
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For these reasons it was decided to focus the attention on the residues in the 
region 200-250 of Mcm2 that differ between yeast and human and could be 
potentially crucial for the interaction with Sld3. As shown before in fact the human 
sequence 1-232, corresponding to the first 250 amino acids in yeast, could not 
interact with Sld3. An alignment was therefore performed with the two sequences 
(Figure 4.19 and Appendix III) and the most conserved residues in the fungal 
alignment but different from the human sequence were selected for mutation.  
All the amino acids chosen were mutated to the human counterpart. Some of them 
were also mutated to the opposite charge or to alanine (in case they were serine or 
threonine that could be phosphorylated), in order to maximise the effect. 
 
 
 
Figure 4.19: Alignment of S. cerevisiae and H. sapiens Mcm2 
An alignment of yeast and human Mcm2 was performed and the region comprising the first 
250 amino acids is shown. Regions that appeared crucial and important for the interaction 
with Sld3 (based on Figure 4.12) are marked in orange and yellow respectively. Residues 
marked in red were only changed with the human amino acid, in green the ones that were 
additionally changed in alternative ways. 
 
 
The mutants were produced using in vitro transcription and translation system either 
with wild type S. cerevisiae Mcm2 aa 1-250 or with the hybrid version human 1-200 
S. cerevisiae 222-250 as a template and tested in the pull-down assay with MBP-
Sld3. 
As a positive control, the non-mutated domain was used. The mutants 
T233D+S239R and E236K+R247E+H248D appeared to slightly suppress the 
scMcm2          MSDNRRRRREEDDSDSENELPPSSPQQHFRGGMNPVSSPIGSPDMINPEGDDNEVDDVPD 60 
hMcm2           MASSPAQRRRGNDP------LTSSPGRSSRR----TDALTSSPGRDLPPFEDESEGLLGT 50 
                *:..  :**. :*.       .*** :  *     ..:  .**.   *  :*:. . :   
 
scMcm2          IDEVEEQMNEVDLMDDNMYEDYAADHNRDRYDPD--QVDDREQQELSLSERRRIDAQLNE 118 
hMcm2           EGPLEEEEDGEELIGDGMERDYRAIPELDAYEAEGLALDDEDVEELTASQREAAERAMRQ 110 
                 . :**: :  :*:.*.* .** *  : * *:.:   :**.: :**: *:*.  :  :.: 
 
scMcm2          RDR-LLRNVAYIDDEDEEQEGAAQLDEMGLPVQRRRRRRQYEDLENSDDDLLSDMDIDPL 177 
hMcm2           RDREAGRGLGRMRRG--LLYDSDEEDEERPARKRRQVERATEDGEE-DEEMIES------ 161 
                ***   *.:. :        .: : **   . :**: .*  ** *: *::::..       
 
scMcm2          REELTLESLSNVKANSYSEWITQPNVSRTIARELKSFLLEYTDETGRSVYGARIRTLGEM 237 
hMcm2           -----IENLEDLKGHSVREWVSMAGPRLEIHHRFKNFLRTHVDSHGHNVFKERISDMCKE 216 
                     :*.*.::*.:*  **:: ..    * :.:*.**  :.*. *:.*:  **  : :  
 
scMcm2          NSESLEVNYRHLAESKAILALFLAKCPEEMLKIFDLVAMEATELHYPDYARIHSEIHVRI 297 
hMcm2           NRESLVVNYEDLAAREHVLAYFLPEAPAELLQIFDEAALEVVLAMYPKYDRITNHIHVRI 276 
                * *** ***..**  : :** **.:.* *:*:*** .*:*..   **.* ** ..***** 
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binding to MBP-Sld3 compared to the wild type, mainly in the context of the hybrid 
background (Figure 4.20, panel B, lanes 11 and 15 respectively). 
 
 
Figure 4.20: Analysis of the interaction between Sld3 and Mcm2 mutants 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated variants of Mcm2 N-terminus, washed, separated by 
SDS-PAGE and analysed by autoradiography (A). In green are labelled the mutants that 
were not changed to the human amino acid (B). 
 
 
The single mutants of the most promising multiple mutants analysed in Figure 4.20 
(T233D+S239R and E236K+R247E+H248D) were produced in the hybrid 
background and tested for binding to MBP-Sld3. The non-mutated version was again 
used as control. Unfortunately the mutant T233D was not efficiently transcribed and 
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translated (Figure 4.21, panel A lane 3), probably because of degradation of the 
DNA used in the reaction, therefore it was not possible to establish if it had an impact 
on the binding to Sld3. However, the mutant S239R alone was not able to produce a 
reduction comparable to the double mutant (Figure 4.21, panel A lane 12). The 
quantified radioactive signal of the double mutant T233D+S239R was around 30% of 
the wild type whereas S239R 45%, suggesting that T233D plays a role in the 
interaction. 
 
 
Figure 4.21: Test of the interaction of Sld3 with Mcm2 mutants 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated variants of Mcm2 N-terminus, washed, separated by 
SDS-PAGE and analysed by autoradiography. 
 
 
When the residues modified in the mutant E236K+R247E+H248D were analysed 
separately (Figure 4.21, panel B) instead a contribution from H248D could be 
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detected. This mutation alone produced the same signal reduction detected as for 
the triple mutant.  
This series of experiments resulted in the identification of three residues on the N-
terminus of Mcm2 (T233, S239 and H248) that could be involved in the interaction of 
MCM2-7 with Sld3. These amino acids need to be analysed separately and in 
combination in the context of the MCM2-7 hexamer to confirm their importance. 
 
 
4.5 Analysis of the binding site on Sld3  
The previous paragraphs showed how challenging the handling of a big 
hetero hexamer such as MCM2-7 can be. One reason for the observed problems 
could be the instability of the complex as a result of manipulations. Therefore the 
study on the interaction between MCM2-7 and Sld3 proceeded with the analysis on 
the binding site of Sld3. 
At first, the same approach employing a tagged form of MCM2-7 to pull-down 
in vitro transcribed and translated subunits of Sld3 was followed. After a series of 
non conclusive experiments, showing a very high non-specific interaction of all Sld3 
domains tested with the control (both anti-IgG and anti-MBP were tried at this stage), 
it was decided that it was not the right approach to study this interaction. Sld3 in fact 
is predicted to lack a defined structure (secondary structure prediction in Appendix 
II), therefore it is possible that its domains mis-fold and become sticky.  
To overcome this problem, the sequence of Sld3 was analysed in order to 
identify the most conserved regions in fungi (fungal alignment in Appendix III) and 
also in higher eukaryotes, taking advantage from the work of Sanchez-Pulido and 
colleagues (Sanchez-Pulido et al, 2010). This data was then integrated with a 
secondary structure prediction. As a result, seven conserved regions were identified 
which also contained structural elements that could be important for protein-protein 
interaction. They were used to generate a series of biotinylated peptides (Appendix I, 
Table IV) that cover the most relevant regions of Sld3 according to this analysis to be 
used to immunoprecipitate Mcm2 in order to identify minimal fragments of Sld3 that 
are responsible for the binding. This approach is similar to what previously described 
in few reports (Ball et al, 1997; Rolef Ben-Shahar et al, 2009). The purpose of this 
assay was to screen for putative regions of interaction of Sld3 therefore no mutated 
control peptides were included at this stage. 
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The biotinylated peptides were conjugated to streptavidin beads and then incubated 
with in vitro transcribed translated Mcm2 and two N-terminal domains (aa 1-250 and 
1-322) that previously showed interaction with Sld3 (Figure 4.22). Three peptides 
appeared to bind to all three proteins examined and corresponded to amino acids 
170-195 (CR1b), 196-226 (CR2) and 286-311 (CR3b) of Sld3, whereas peptides 
CR1a (152-175), CR3a (249-287), CR4 (333-355), CR5 (384-419) and CR6 (518-
546) showed no interaction. Interestingly, all portions of Mcm2 tested interacted with 
CR3b which is conserved in lower eukaryotes but not in higher organisms (see 
Appendix III), consistently with the fact that the interaction of Sld3 with MCM2-7 may 
have diverged during evolution. 
 
Figure 4.22: Interaction analysis of Sld3 peptides with Mcm2 
Biotinylated peptides of Sld3 bound to streptavidin beads were incubated with 35S labelled in 
vitro transcribed translated Mcm2 full length (A), aa 1-250 (B) and 1-322 (C), washed, 
separated by SDS-PAGE and analysed by autoradiography. 
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This approach provided a rapid and effective tool to screen a protein-protein 
interaction and identified a specific region of Sld3 that can bind Mcm2 and an in vivo 
analysis will be presented in chapter 6.  
 
4.6 Discussion 
Sld3 is believed to be one of the first factors recruited to the pre-RC essential 
for the progression into the pre-IC and CMG (Kamimura et al, 2001; Kanemaki & 
Labib, 2006). In this chapter the interaction occurring between Sld3 and MCM2-7 
was analysed in detail.  
All previous data on the matter had been produced via in vivo studies (Kamimura et 
al, 2001; Kanemaki & Labib, 2006; Tanaka et al, 2007b; Zegerman & Diffley, 2007) 
or employing yeast extracts that were used for in vitro assembly and DNA replication 
assays (Heller et al, 2011). However, these studies have the limitation of not being 
able to discriminate the contribution of each individual factor involved in the process 
and can therefore not uncover the detailed molecular mechanism of pre-IC 
assembly. The few studies performed in vitro on Sld3 (Bruck et al, 2011; Bruck & 
Kaplan, 2011a; Bruck & Kaplan, 2011b) were based on the analysis of purified 
proteins combined in solution in the absence of DNA and not in the context of the 
pre-RC, therefore the obtained results are not fully conclusive. 
Consequently, it was tested whether Sld3 can be recruited in vitro to the pre-
RC. The reconstitution of a complex containing Sld3 bound to the pre-RC proved to 
be challenging as Sld3 is predicted to be an unstructured protein with the tendency 
of becoming sticky on solid surfaces. Furthermore streptavidin (used for biotinylated-
DNA conjugation) is negatively charged whereas Sld3 is a highly positively charged 
protein (the charge at pH 7 is around 40) and therefore the two are very likely to 
interact. The standard pre-RC reconstitution system (Evrin et al, 2009) was therefore 
not ideal for the purpose. Several attempts were made (Table 4.2) in order to 
overcome the non-specific binding of Sld3 to the beads, but they were not 
successful. The difficulty in optimising an in vitro assay capable of reconstituting 
complexes that are more elaborated than the pre-RC (i.e. pre-IC and CMG) is 
reflected in recent publications on the matter that employ yeast extracts instead of 
purified proteins (Gros et al, 2014; Heller et al, 2011; On et al, 2014). 
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A novel method was therefore developed in the lab for the reconstitution of 
the pre-RC in solution, followed by gel filtration, which separates proteins in solution 
from DNA bound complexes (Herrera, Tognetti et al, under revision). This system, 
despite presenting some limitations such as the impossibility of performing reactions 
that require multiple washes, has the advantage of significantly enhancing complex 
formation, as the proteins do not bind to the solid matrix. 
The interaction of Sld3 with the pre-RC, thus, was reconstituted using this novel 
method and showed that Sld3 is in fact able to interact with the pre-RC in a nearly 
stoichiometric fashion and in the absence of additional factors. This finding appears 
to contradict the literature, were Sld3 was only recruited to the pre-RC upon DDK 
phosphorylation (Heller et al, 2011) and in a Cdc45-dependent manner (Kamimura et 
al, 2001). It seems reasonable to argue that the initial recruitment can be 
independent from other factors but it is too weak to be detected in in vivo studies, 
whereas it can still be sensed using a more sensitive in vitro assay. Alternatively, it 
appears possible that other factors binding to Sld3 might inhibit its interaction in the 
absence of Cdc45. The contribution of DDK and Cdc45 to this interaction is not in 
any way proved wrong and it will be analysed and discussed in chapter 6. 
The study followed with an interaction analysis of Sld3 and MCM2-7. The 
direct binding of these two proteins in vitro, already shown by Bruck and Kaplan 
(Bruck & Kaplan, 2011a), was confirmed (Figure 4.4) and it was subsequently 
hypothesised to involve the non-conserved N-terminal extensions of MCM2-7 (Figure 
4.5). These regions are in fact flexible, involve sites for post-translational 
modifications and are therefore suitable for protein-protein interactions. 
The strategy used for the initial analysis involved the generation of the N-terminal 
MCM2-7 extensions, C-terminally fused to a GST tag, which can be conjugated to a 
Glutathione resin and employed in a pull-down with Sld3. The assay was validated 
with Dpb11 (binding reported in Zegerman & Diffley, 2007) as a positive control and 
Regα (an unrelated protein) as a negative control (Figure 4.6). However when the N-
terminal sections of MCM2-7 were tested (Figure 4.7), the experiment identified 
some crucial difficulties with the approach. In the first place, extensive work was 
required to find the best condition for the purification and binding to the Glutathione 
resin for each subunit. Secondly, a careful normalisation of the beads, based on 
amount of bound protein, had to be carried out. Finally, the handling of the agarose 
Gluthatione resin itself was more challenging than expected because the beads 
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could be easily lost. Obviously all these variables could impact very strongly on the 
reliability of the assay; therefore a new strategy was developed for further studies. 
The reverse pull-down, using MBP-Sld3 conjugated to anti-MBP beads, was 
performed with in vitro transcribed and translated subunits of MCM2-7, showing a 
clear prevalence for interaction with Mcm2 (Figure 4.8).  
Interestingly, Mcm2 is located on the putative “gate” of opening of MCM2-7 for the 
entry of the dsDNA during pre-RC formation and exit of ssDNA during helicase 
activation (Bochman & Schwacha, 2007; Bochman & Schwacha, 2008; Bochman & 
Schwacha, 2010; Costa et al, 2011; Samel et al, 2014; Sun et al, 2013) and it is 
shown that it interacts with Cdc45 in the CMG structure (Costa et al, 2011; Ilves et 
al, 2010). Sld3, which is known to interact with Cdc45 (Bruck & Kaplan, 2011a; 
Kamimura et al, 2001; Kanemaki & Labib, 2006), is therefore in the perfect position 
to take part in the binding with both Mcm2 and Cdc45. It is also possible to speculate 
that Sld3 executes the function of keeping the “gate” closed until GINS is recruited to 
the complex. 
To confirm that its N-terminal portion was involved, Mcm2 was divided in three 
domains and tested in the same way (Figure 4.9), showing that the region comprised 
between aa 1-322 is necessary to support binding to Sld3. This is consistent with 
what reported in fission yeast, where the Mcm2 fragment containing aa 1-280, but 
not 1-204, was interacting with Sld3 (Fukuura et al, 2011) (see alignment in 
Appendix III). 
A series of experiments was carried out at this point to map the binding site, which 
suggested that the region 200-250 is the most important for the interaction (Figure 
4.10). This fragment was then further analysed, but it was not possible to effectively 
produce shorter domains that were still able to interact with Sld3 as much as the 1-
250 (Figure 4.12). This suggests either that several important residues are contained 
between aa 200-250 or that the folding of the region is important. 
A mutant version of MCM2-7, deleted of the first 250 amino acids was 
expressed,  purified and tested in the pre-RC reconstitution assay, as well as tested 
in vivo for dominant lethality (Figure 4.13 and 4.14). The attempt of producing an 
MCM2-7 hexamer in the absence of such a long stretch of Mcm2, despite similar 
work was done on other subunits without a drastic effect on the stability (Sheu & 
Stillman, 2006), appeared to be too optimistic. MCM2-7 2Δ1-250 yielded in fact an 
extremely small amount of protein when overexpressed and purified, and the sample 
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seemed contaminated with the wild type Mcm2 subunit naturally expressed in S. 
cerevisiae. Furthermore, when the mutant was expressed in vivo, it did not show any 
dominant lethality, suggesting that the MCM2-7 2Δ1-250 complex does not form 
accurately and thus wild type MCM2-7 can complement the function of the mutant. 
The analysis of the N-terminal region of Mcm2 followed with the test in vivo of 
shorter FLAG-tagged deletion mutants for a growth effect, but these did not show 
differential growth compared to the control strain (Figure 4.15).  
To overcome the potential instability of the MCM2-7 complex due to the 
deletion of a long stretch of Mcm2, another approach involved the design of versions 
of Mcm2 that were a hybrid between human and yeast. The N-terminal portion of 
human Mcm2, corresponding to S. cerevisiae aa 1-250 in fact was not able to 
interact with Sld3 in vitro (Figure 4.16). The mutant MCM2-7 FLAG h1-232 sc254-
868, when overexpressed and purified, showed a defect in the recruitment and 
loading to DNA (Figure 4.17, panel A) in vitro and, when tested in vivo, appeared to 
slightly slow the growth compared to the control (Figure 4.18, panel B). 
Taken together these findings indicate that first 250 amino acids at the N-terminus of 
Mcm2 play an important role in the stability of the complex and are required for 
protein-protein interactions. 
Unfortunately this data did not validate in a conclusive way the hypothesis of 
Sld3 interacting with the region 200-250 of Mcm2, therefore it was decided to focus 
on the residues in the region 200-250 of Mcm2 that differ between yeast and human 
and could be potentially crucial for the binding. Several alignments were run (Figure 
4.19 and fungal alignment in Appendix III) to identify the most important amino acids 
in the region of interest. They were subsequentlymutated to the human counterpart 
in the yeast 1-250 peptide and tested for binding to Sld3 (Figure 4.20 and 4.21). 
Three amino acids (T233, S239 and H248) were identified for their role in the 
interaction with Sld3. It cannot be excluded that these amino acids are only 
contributing to the creation of the binding site for Sld3 and that other binding sites 
are required, but it would still be extremely interesting to test them separately and in 
combination, both in vivo and in vitro. 
The analysis of the interface of contact on MCM2-7 for Sld3 required an extensive 
amount of work and did not end with a definitive result. It was still useful to explore 
different techniques for the analysis of a protein-protein interaction. 
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Another approach to prove that the interaction between MCM2-7 and Sld3 
was occurring and it was essential for initiation of DNA replication, was to study the 
binding site on Sld3. For this purpose, the sequence of Sld3 was analysed for its 
conservation in fungae and in higher eukaryotes and this data was then integrated 
with a secondary structure prediction to identify stretches that could support protein-
protein interactions. A series of peptides of Sld3 were thus designed to cover these 
interesting regions and tested for interaction with Mcm2, identifying the most 
important regions of Sld3 as 170-195 (CR1b), 196-226 (CR2) and 286-311 (CR3b). 
This is consistent with the work of Fukuura and colleagues in fission yeast (Fukuura 
et al, 2011), who identified the region comprises between aa 201 and 601 of Sld3 for 
the interaction with Mcm2 (see annotated alignment in Appendix III). 
This strategy was much faster and more promising than the ones adopted for the 
analysis of the binding site on Mcm2. The regions of interest are sufficiently small to 
allow careful analysis and systematic mutagenesis, which most likely would result in 
the generation of a mutant that is indeed defective for the binding. Other essential 
interactions for initiation of replication were tested in this work and a comprehensive 
in vivo analysis will be presented and discussed in chapter 6. 
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Chapter 5 – Results 
Analysis of the interaction of Cdc45 with the pre-RC 
and Sld3 
 
Cdc45 is a conserved protein required for the activation of the MCM2-7 
helicase; together with GINS, it is involved in the formation of the CMG complex 
(Costa et al, 2011; Ilves et al, 2010) upon activation of the pre-RC by DDK and S-
CDK (Labib, 2010), and it is essential for the progression of the replicative fork 
(Aparicio et al, 1997; Labib, 2010; Tercero et al, 2000). As explained in chapter 4, 
Cdc45 can be detected in vivo upon addition of a cross-linking reagent together with 
Sld3 as weakly chromatin bound already in late G1-phase (Aparicio et al, 1999; 
Kamimura et al, 2001) as one of the first factors to interact with the pre-RC. 
Nevertheless, its interaction with chromatin becomes more stable only during S-
phase, concomitantly with GINS recruitment to origins (Kanemaki & Labib, 2006). 
Cdc45 association with the pre-RC has been under investigation for several 
years. Kamimura and colleagues (Kamimura et al, 2001) reported that the 
recruitment of Cdc45 to origins is Sld3 dependent, whereas Kanemaki and Labib 
(Kanemaki & Labib, 2006) showed that GINS is required for its stable engagement 
with the nascent replisome. The Bell lab confirmed these findings using a new in 
vitro system, which employs a G1-phase extract for pre-RC formation and an S-
phase extract, where a number of limiting factors are overexpressed, to promote 
helicase activation. Cdc45 or other factors were removed from the extract to 
understand the pre-IC assembly process (Heller et al, 2011). Using this method they 
proved that Cdc45 association to origin DNA is DDK dependent. 
These systems have the disadvantage of not being able to discriminate the 
contribution of each individual factor involved in the process and even the depletion 
of one protein at the time could result in compensation by the others, as the limiting 
factors were overexpressed. For this reason the recruitment of Cdc45 to the pre-RC 
was here studied in vitro using purified proteins, allowing the analysis of interactions 
that could be obscure to more complex assays. 
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5.1 Analysis of the recruitment of Cdc45 to the pre-RC 
To study the recruitment of Cdc45 to the pre-RC in vitro, Cdc45 was purified 
in the first place as a C-terminal FLAG-tagged fusion protein overexpressed in S. 
cerevisiae from a galactose-inducible promoter. The yeast extract was bound to anti-
FLAG resin and the protein was eluted by competition with the FLAG peptide, pooled 
and concentrated (Figure 5.1). Whenever the FLAG peptide had to be removed (i.e. 
for immunoprecipitation using anti-FLAG beads), the sample was diluted and 
incubated with DEAE beads. The resin was then extensively washed and the protein 
was eluted with purification buffer containing high salt (protocol as in Herrera, 
Tognetti et al, under revision). Unless differently stated, all Cdc45 used in this work 
is Cdc45-FLAG. 
  
Figure 5.1: Purification of Cdc45-FLAG from yeast 
Silver stained gel showing the purification of Cdc45 from yeast overexpressing Cdc45-FLAG. 
Cells were lysed by freezer milling and the extract incubated with anti-FLAG resin. Bound 
Cdc45-FLAG was washed three times and eluted using elution buffer containing FLAG 
peptide. The elutions were pooled (lanes 8-9). Arrow indicates the position of Cdc45-FLAG 
(75 kDa). 
 
 
Initially, the bead based pre-RC assay was used to analyse if Cdc45 could 
associate on its own with the pre-RC. The pre-RC was formed as previously reported 
(Evrin et al, 2009) and 40 nM of Cdc45 (equimolar to the input of MCM2-7) were 
added for 30 minutes in a second step. A sub stoichiometric amount of Cdc45 was 
bound to the pre-RC if compared to MCM2-7 (Figure 5.2, panel A) indicating that 
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Cdc45 cannot directly interact with the pre-RC under these conditions. Several 
changes were performed to improve Cdc45 binding: Cdc45 concentration, time and 
temperature of incubation and salt concentration of the reaction buffer. None of 
these changes showed a better result. Cdc45 recruitment was also tested in the 
presence of Sld3 and DDK, which could chaperone the interaction (Heller et al, 
2011; Kamimura et al, 2001; Kanemaki & Labib, 2006), as shown in Figure 4.2, 
panel A, proving unsuccessful. 
In order to exclude the fact that Cdc45 gets depleted because of non-specific 
interactions with the beads, a series of experiments were performed by Carmen 
Herrera using the gel filtration based pre-RC assay. Initially 40 nM of Cdc45 were 
added to the pre-RC for either 1 or 30 minutes to capture both quick and transient or 
slow type of association (Figure 5.2, panel B). Only after 30 minutes of incubation, a 
weak association of Cdc45 was detected (Figure 5.2, panel B lane 4). 
To exclude that the amount of Cdc45 used in the assay is suboptimal, and to test the 
influence of Sld3 on the reaction, which is known to bind to Cdc45 (Heller et al, 2011; 
Kamimura et al, 2001; Kanemaki & Labib, 2006), or that the purified protein is 
inactive because of the tag or the purification process, Cdc45 was titrated on top of 
the pre-RC where Sld3 was also present. Under these conditions though, only a 
small amount of Cdc45 was detected at the highest concentration tested (Figure 5.2, 
panel C).  
The recruitment of Cdc45 to the pre-RC was finally tested in the presence of 
both Sld3 and DDK, reported to be essential in vivo (Heller et al, 2011; Kamimura et 
al, 2001; Kanemaki & Labib, 2006). Equimolar amount of Sld3 and Cdc45 were 
incubated with the pre-RC for 1 minute in the presence of DDK. Sld3 was interacting 
with the pre-RC both in the absence and in the presence of Cdc45 (Figure 5.2, panel 
D, compare lanes 2 and 4), consistent with what is shown in figure 4.3 (panel B). The 
signal of Sld3 appears slightly reduced in the presence of Cdc45 suggesting that the 
two proteins could interact in solution, diminishing the amount of Sld3 available for 
binding to the pre-RC. Cdc45 signal was extremely weak, both in the absence and in 
the presence of Sld3 (Figure 5.2, panel D, compare lanes 3 and 4). 
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Figure 5.2: Analysis of Cdc45 recruitment to the pre-RC 
A) 40 nM Cdc45 were added for 30 min at 27°C to the pre-RC reconstituted with the bead 
based assay. The samples were analysed by SDS-PAGE followed by Western Blotting using 
specific antibodies against Mcm2 and FLAG (for detection of Cdc45). B) 40 nM Cdc45 were 
added for 1 or 30 min at 27°C to the pre-RC reconstituted with the gel filtration system. The 
samples were analysed by SDS-PAGE followed by Western Blotting using specific 
antibodies against Mcm2 and FLAG. C) 40 nM Sld3 and 40-60-80 nM Cdc45 were added for 
1 min at 27°C to the pre-RC reconstituted with the gel filtration system. The samples were 
analysed by SDS-PAGE followed by Western Blotting using specific antibodies against 
Mcm2, Sld3 and FLAG. D) 40 nM Sld3 and 40 nM Cdc45 were added in the presence of 5 
nM DDK for 1 min at 27°C to the pre-RC reconstituted with the gel filtration system. The 
samples were analysed by SDS-PAGE followed by Western Blotting using specific 
antibodies against Mcm2, Sld3 and FLAG. Experiments shown in panels B, C and D were 
performed by Herrera (Herrera, Tognetti et al, under revision). 
 
 
These experiments show that Cdc45 associates in vitro very poorly with the pre-RC 
and that Sld3 and DDK are not sufficient to support this interaction. 
 
5.2 Analysis of direct interactions between Cdc45 and MCM2-7 
Several publications suggested that Cdc45 and MCM2-7 can directly contact 
each other on origins (Gambus et al, 2009; Kamimura et al, 2001; Kanemaki & 
Labib, 2006; Sheu & Stillman, 2006; Zou & Stillman, 1998; Zou & Stillman, 2000) 
and form the CMG (Costa et al, 2011; Gambus et al, 2006; Ilves et al, 2010; Moyer 
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et al, 2006), but only Bruck and Kaplan used purified proteins to study the interaction 
in the context of Sld3 or GINS trimeric complexes (Bruck & Kaplan, 2011a).  
In order to answer the question of whether Cdc45 and MCM2-7 can directly 
associate one with another in the absence of other factors and origin DNA, 
immunoprecipitations were performed using GST-Cdc45 or MBP-MCM2-7.  
GST-Cdc45 and GST (negative control) were overexpressed in bacteria and the 
lysate extract bound to anti-GST magnetic beads (Figure 5.3, panel A). The samples 
were used to immunoprecipitate purified MCM2-7 (chapter 3, Figure 3.1) but no 
interaction was detected (Figure 5.3, panel C). To exclude that the N-terminal GST 
tag of Cdc45 could impair the binding, purified MBP-MCM2-7 was used to 
immunoprecipitate Cdc45 (purified as in Figure 5.1, FLAG-tagged at the C-terminal) 
but once again, no signal was observed (Figure 5.3, panel D). 
These interaction assays show that Cdc45 is not able to bind to MCM2-7 
directly, suggesting that either other factors or the DNA are required to bridge the 
interaction or that the conformation assumed by these two proteins in solution does 
not support a direct contact. The latter hypothesis is reinforced by the knowledge 
that MCM2-7 undergoes several conformational changes during initiation of 
replication (Costa et al, 2011; Evrin et al, 2009; Remus et al, 2009). The discrepancy 
between this result and what reported by Kaplan lab (Bruck & Kaplan, 2011a), where 
an interaction was observed between Cdc45 and MCM2-7 that would be stimulated 
by the addition of Sld3 to the reaction, could be explained with the different 
sensitivity of the detection methods employed. The radiolabelled proteins employed 
in their work in fact are most likely easier to detect compared to the method used in 
this study. 
Given that a functional assay is not yet available for Cdc45, it was not known 
if the tagged purified protein was folded in a physiological way and therefore if it was 
able to exert its roles. In the case of MCM2-7, it has been shown that the protein 
purified following the same protocol is capable of interacting with the DNA and to 
support pre-RC formation (Evrin et al, 2009; Evrin et al, 2014; Evrin et al, 2013; 
Fernandez-Cid et al, 2013; Sun et al, 2013). 
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Figure 5.3: Cdc45 and MCM2-7 direct interaction analysis 
A) Coomassie stained gel showing GST (26.6 kDa) and GST-Cdc45 (100.8 kDa) 
immobilized on anti-GST magnetic beads. Asterisks indicate contaminant proteins. B) Silver 
stained gel showing MBP (42 kDa) and MBP-MCM2-7 immobilized on anti-MBP magnetic 
beads. C) GST or GST-Cdc45 immobilized on anti-GST magnetic beads were incubated 
with purified MCM2-7, washed, separated by SDS-PAGE and analysed by western blot with 
a specific anti-Mcm2 antibody. D) MBP or MBP-MCM2-7 immobilized on anti-MBP magnetic 
beads were incubated with purified Cdc45, washed, separated by SDS-PAGE and analysed 
by western blot with a specific anti-FLAG antibody to detect Cdc45. 
 
 
To exclude that the purified sample of Cdc45 was not functional, or that the 
binding site for MCM2-7 was masked by other parts of Cdc45 (auto-inhibited), MBP-
MCM2-7 was used to immunoprecipitate in vitro transcribed and translated Cdc45 
full length and individual domains. The truncations were designed after analysis of 
the secondary structure of Cdc45 (Appendix II) in order to minimise disruptions of the 
structural elements of the protein. Purified MBP was used as negative control (Figure 
5.4). Full length Cdc45 did not bind to MCM2-7 (Figure 5.4, lane 12), consistent with 
what was previously seen with purified proteins (Figure 5.3, panel C), as well as 
none of the fragments analysed did bind MCM2-7.  
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Figure 5.4: MCM2-7 interaction analysis with Cdc45 truncations 
MBP or MBP-MCM2-7 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated truncations of Cdc45, washed, separated by SDS-
PAGE and analysed by autoradiography. Asterisks indicate protein constructs. 
 
 
This result suggests that MCM2-7 and Cdc45 do not interact with each other, 
contrarily to what previously reported. However, as Cdc45 is known to interact with 
MCM2-7 in the context of the CMG, it is likely that the Cdc45 binding site in the 
purified MCM2-7 is hidden. In order to facilitate the exposure of the hidden domains, 
the reverse experiment was performed using GST-Cdc45 to pull-down in vitro 
transcribed and translated MCM2-7 subunits, similarly to what was previously shown 
for Sld3 (Figure 4.8, panel B). Interestingly, GST-Cdc45 immunoprecipitated weakly 
but specifically Mcm2, similarly to Sld3 (Figure 5.5, lane 8), supporting the idea that 
Sld3 and Cdc45 can form a complex with MCM2-7 (Bruck & Kaplan, 2011a). This 
also suggests that the binding site for Cdc45 on MCM2-7 is not exposed in the 
hexamer in solution and that a conformational remodelling is required prior to the 
interaction. A partial mis-folding of the MCM2-7 protein sample employed in Bruck 
and Kaplan’s analysis could therefore explain their positive result for the interaction 
analysis of the full length MCM2-7 and Cdc45 (Bruck & Kaplan, 2011a). 
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Figure 5.5: Cdc45 interaction analysis with MCM2-7 subunits 
GST or GST-Cdc45 immobilized on anti-GST magnetic beads were incubated with 35S 
labelled in vitro transcribed translated proteins, washed, separated by SDS-PAGE and 
analysed by autoradiography. Asterisks indicate full length proteins. 
 
 
A series of experiments was performed at this point in order to map the 
binding site for Cdc45 in Mcm2, using N- or C-terminal truncations similarly to what 
was described in chapter 4 for Sld3, but the results were not conclusive. A weak 
non-specific interaction with GST was detected and all fragments analysed 
interacted to some extent with GST-Cdc45, indicating that either the 
immunoprecipitation with the GST-tagged protein produces too much non-specific 
signal or that the binding site on Mcm2 involves several regions that cannot be 
separated without impacting on the interaction. 
Further studies would be required to try to determine the surface of interaction, but a 
different approach, such as peptide arrays, should be used in place of the pull-down 
approach. 
This work instead continued with the characterisation of the interaction of Cdc45 with 
Sld3, which appeared equally relevant and less challenging to achieve. 
 
5.3 Analysis of direct interaction between Cdc45 and Sld3 
The interaction of Cdc45 with Sld3 was shown in several publications, both in 
vivo (Kamimura et al, 2001; Kanemaki & Labib, 2006; Tanaka et al, 2011b) and, 
while this project was already undertaken, also in vitro (Bruck & Kaplan, 2011a; 
Bruck & Kaplan, 2011b). Sld3 is considered a Cdc45 loading factor, as it is required 
for CMG formation, but not for CMG maintenance. The possibility to create mutants 
that interfere with the interaction with Cdc45 could offer precious insights into the 
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contribution of these two essential proteins for the following steps of replication 
initiation, especially when analysed with a reconstituted system. 
The initial attempt was to determine which domain of Cdc45 was responsible 
for the interaction. MBP-Sld3 was therefore used to immunoprecipitate in vitro 
transcribed and translated Cdc45 full length and truncations (Figure 5.6). MBP was 
used as a negative control.  
Consistent with the literature (Bruck & Kaplan, 2011a; Bruck & Kaplan, 2011b; 
Kamimura et al, 2001; Kanemaki & Labib, 2006; Tanaka et al, 2011b), MBP-Sld3 
immunoprecipitated full length Cdc45 (Figure 5.6, lane 12). Two other Cdc45 
truncations were specifically and reproducibly precipitated: aa 1-456 (lane 18) and 
333-456 (lane 22). Fragments 165-456, 333-650 and 165-650, which all contain the 
333-456 domain, gave inconsistent results with a weak signal or no signal in different 
experiments. This could indicate that the binding site has to be located in a 
specifically folded region or that some portions of the protein can mask the binding 
domain. Obviously it could also indicate that aa 333-456 can interact with Sld3 
because of their charge (Cdc45 fragment is weakly negatively charged, whereas 
Sld3 is positively charged) and that this interaction would not occur physiologically 
when the protein is correctly folded. 
 
Figure 5.6: Sld3 interaction analysis with Cdc45 subunits 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed translated Cdc45 full length and truncations, washed, separated 
by SDS-PAGE and analysed by autoradiography. 
 
 
Despite the partially discordant result of this interaction analysis, it would still be 
worthwhile trying to examine in detail the sequence of Cdc45 to define some 
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stretches in the fragment 333-456 that could be mutated in order to disrupt the 
interaction with Sld3 and then test these mutations both in vitro and in vivo. In 
particular, a sequence analysis of Cdc45 showed that the fragment 333-456 is fairly 
well conserved (see alignment in Appendix III), suggesting that the interaction 
between Sld3 and Cdc45 could also be evolutionary conserved.  
This study instead followed with the characterisation of the binding site for 
Cdc45 on Sld3, employing the peptide strategy described in paragraph 4.5. An initial 
attempt involved the use of GST-Cdc45 to immunoprecipitate in vitro transcribed and 
translated Sld3 domains but proved to be unsuccessful because of the high non-
specific signal detected for the GST control (similarly to what discussed in paragraph 
5.2). Peptides were therefore designed to cover the most conserved regions of Sld3 
and their biotinylated version was used to immunoprecipitate in vitro transcribed and 
translated Cdc45 (Figure 5.7).  
 
Figure 5.7: Interaction analysis of Sld3 peptides with Cdc45 
Biotinylated peptides of Sld3 bound to streptavidin beads were incubated with 35S labelled in 
vitro transcribed translated full length Cdc45, washed, separated by SDS-PAGE and 
analysed by autoradiography 
 
 
Mainly three peptides of Sld3 resulted in a clear interaction with Cdc45: 170-195 
(CR1b), 196-226 (CR2) and 249-287 (CR3a), but 170-195 (CR1b) bound best. This 
is consistent with the findings from the Araki lab (Tanaka et al, 2007b), where, using 
a two hybrid system, mapped the region 150-430 of Sld3 as responsible for 
interaction to Cdc45. 
These regions are sufficiently small to allow for a careful sequence analysis which 
can result in the identification of mutants that are defective for the interaction. A more 
detailed in vivo analysis on these regions was performed and it will be described in 
chapter 6.  
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5.4 Discussion 
In this chapter the recruitment of Cdc45 to the pre-RC, as well as its 
interaction with MCM2-7 and Sld3, was analysed. Cdc45 is a conserved protein, 
essential for the progression of the replicative fork (Aparicio et al, 1997; Labib et al, 
2000; Tercero et al, 2000) and one of the first factors to interact with the pre-RC after 
its formation on origin DNA already in late G1-phase (Aparicio et al, 1999; Kamimura 
et al, 2001).  
The direct recruitment of Cdc45 to the reconstituted pre-RC was attempted in the 
first place, using both bead based and gel filtration based methods. A reconstituted 
system offers in fact the possibility to conclusively prove the mechanism of the 
reaction. When Cdc45 was added alone to the pre-RC no interaction was detected 
(Figure 5.1, panels A and B). This is consistent with previous reports (Kamimura et 
al, 2001; Kanemaki & Labib, 2006), where Cdc45 could not stably associate with the 
origins in the absence of Sld3.  
The contribution of Sld3 to the recruitment of Cdc45 to the pre-RC was 
therefore analysed, but once again no interaction was detected (Figure 5.1, panel C).  
Moreover, DDK was also added to the reaction, according to Heller’s finding (Heller 
et al, 2011) that showed that Sld3 and Cdc45 recruitment to the origin is DDK 
dependent. Surprisingly DDK did not allow Cdc45 binding to the pre-RC, indicating 
that Sld3 and DDK are not sufficient to support stable interaction of Cdc45 with the 
pre-RC in vitro. The discrepancy of this result with the literature could be explained 
with the fact that all previous work was performed in vivo or using yeast extract. 
These experimental conditions are not fully controllable and mechanisms of 
compensation could occur without being able to detect them.  
In the absence of any observed recruitment it was hypothesized that an interaction 
occurs in vivo as suggested in several publications (Costa et al, 2011; Gambus et al, 
2006; Gambus et al, 2009; Ilves et al, 2010; Kamimura et al, 2001; Kanemaki & 
Labib, 2006; Moyer et al, 2006; Sheu & Stillman, 2006; Zou & Stillman, 1998; Zou & 
Stillman, 2000), but that something abrogates the stable Cdc45/MCM2-7 complex 
formation in other cases. Alternatively, it was possible that one of the proteins used 
in the reconstituted assay was not active, possibly because of the position of the tag, 
despite previous work showing that the fusion at the N-terminal of Cdc45 and Sld3 
does not affect their interaction in vitro (Bruck & Kaplan, 2011a) nor in two hybrid 
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assay (Kamimura et al, 2001). It remaines to be elucidated if the tags could affect 
Cdc45 recruitment to the pre-RC, maybe impairing its interaction with MCM2-7. 
Purified Cdc45 and MCM2-7 were therefore tested for direct binding and they 
appeared to be unable to interact in solution (Figure 5.3, panels C and D), 
independently from the position of the tag on Cdc45 (C-terminal GST in panel C and 
N-terminal FLAG in panel D). 
This result indicates that either they do not bind directly, require additional factors or 
DNA to bridge them, or that the binding site on MCM2-7 is hidden under these 
conditions. In recent work, Bruck and Kaplan suggested that Cdc45 and MCM2-7 
directly interact and that this interaction is disrupted by the addition of ssDNA (Bruck 
& Kaplan, 2013). For their experiment they used GST-Cdc45 (N-terminal tag) and 
MCM2-7 purified from bacteria. It is possible to speculate that the expression in 
bacteria of a large complex such as MCM2-7 could result in mis-folding, causing the 
exposure of Cdc45 binding site. 
It is known that MCM2-7 changes its conformation to adapt to the different 
steps of helicase recruitment and activation (Costa et al, 2011; Evrin et al, 2009; 
Remus et al, 2009) therefore it appears reasonable to think that the binding site of 
some MCM2-7 interaction factor could be hidden in the purified MCM2-7 hexamer. 
Indeed, MBP-MCM2-7 was unable to immunoprecipitate Cdc45 or Cdc45 truncations 
(Figure 5.4). This supports the idea that MCM2-7 adopts a conformation that cannot 
sustain the interaction with Cdc45. 
To test this model further, individual MCM2-7 subunits were used for 
immunoprecipitation assays with Cdc45. In this case a weak but specific interaction 
with Mcm2 was detected (Figure 5.5). The fact that the subunit involved in this 
binding is Mcm2 is interesting for multiple reasons. In first place, Mcm2 was shown 
in this work to interact with Sld3 (Figure 4.8, panel B) and this is fully consistent with 
the fact that MCM2-7/Cdc45/Sld3 can form a trimeric complex in solution (Bruck & 
Kaplan, 2011a). Furthermore, Mcm2 is part of the putative “gate” for opening of 
MCM2-7 for DNA entry (Bochman et al, 2008; Bochman & Schwacha, 2007; 
Bochman & Schwacha, 2008; Bochman & Schwacha, 2010; Costa et al, 2011; 
Samel et al, 2014; Sun et al, 2013) and the CMG structure showed that Mcm2 
interacts with Cdc45 in the context of the complex (Costa et al, 2011; Ilves et al, 
2010). 
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It was not possible during this project to further map the binding site, possibly 
because of technical limitations conferred by the use of GST-tagged proteins such 
as protein amount variability during immobilisation and unspecific interactions with 
other proteins. The investment of time in the optimisation of an assay for the fine 
mapping of the binding site on Mcm2 appeared risky considering the difficulties 
encountered during the study of Sld3 association (chapter 4). The focus was 
therefore switched to the interaction of Cdc45 with Sld3, equally important and 
possibly easier to manipulate. The binding of Cdc45 with Sld3 is commonly accepted 
and it has been shown both in vivo and in vitro (Bruck & Kaplan, 2011a; Bruck & 
Kaplan, 2011b; Kamimura et al, 2001; Kanemaki & Labib, 2006; Tanaka et al, 
2007b; Tanaka et al, 2011b). An attempt to identify a region of interaction small 
enough to be susceptible for analysis by point mutations was made at first using 
MBP-Sld3 to immunoprecipitate Cdc45 truncations (Figure 5.6). This experiment 
resulted in a partially conclusive result, given that a small fragment of Cdc45 (aa 
333-456) was precipitated, but not all fragments were performing in a consistent way 
in this assay, indicating  that the folding of some of them was not correct or optimal 
or that aa 333-456 can interact with Sld3 because of their charge. This region is still 
too large to allow the identification of residues that are important for the interaction 
but attempts can be made analysing the sequence conservation among species.  
At the same time as this work was ongoing, the peptide approach was used to 
identify conserved domains in Sld3 that are involved in the interaction with Mcm2, 
and seemed an appealing and fast alternative to use. The biotinylated peptides of 
Sld3 were therefore used to immunoprecipitate in vitro transcribed and translated 
Cdc45 (Figure 5.7), resulting in the identification of three regions involved in the 
interaction: 170-195 (CR1b), 196-226 (CR2) and 249-287 (CR3a). An in vivo 
analysis on these regions and their mutations was performed and it will be described 
in chapter 6.  
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Chapter 6 – Results 
Analysis of the interactions involved in Cdc45 
recruitment to the pre-RC 
 
At the time when the recruitment of Cdc45 to the pre-RC was under 
investigation my colleague Carmen Herrera was working on the reconstitution of the 
pre-IC and identified a salt stable complex containing Cdc45 (Herrera, Tognetti et al, 
under revision). The assay was performed differently from the standard bead based 
assay to enhance complex assembly. The pre-RC was assembled in solution and 
additional factors were added to promote Cdc45 assembly, prior to the addition of 
salt and gel filtration mediated purification of DNA associated complexes, as 
described in chapter 4 (Herrera, Tognetti et al, under revision). The newly identified 
complex formed in the presence of DDK and contained in addition to Cdc45, also 
Sld3, Sld7 and Sld2 (Figure 6.1, panel A). Given that Sld7 is a non-essential factor 
(Tanaka et al, 2011b), its contribution to the complex formation was analysed by 
Herrera, showing that Sld7 is dispensable for this reaction (Figure 6.1, panel B). In 
order to verify what components are essential for Cdc45 recruitment, an assay was 
performed where individual factors were left out from the reaction. The participation 
of Sld2 in recruitment of Cdc45 had not been observed before and therefore required 
further investigation.  
The analysis of Cdc45 recruitment offered interesting insights. In the first 
place it was found that Cdc45 recruitment to the pre-RC required Sld3, Sld2 and 
DDK (Figure 6.1, panel C, lane 6). In the absence of individual factors much less 
Cdc45 can be detected (Figure 6.1, panel C, lanes 2,3 and 5), but a stoichiometric 
Sld2/Sld3/Cdc45-pre-RC complex is only observed upon the addition of all factors. In 
the absence of individual factors sub-stoichiometric amounts of Sld3 were detected 
(Figure 6.1, panel C, compare lane 6 to 3, 4 and 5). Sld2 instead appeared to 
interact better in the absence of Sld3 (Figure 6.1, panel C, lane 2) than in the 
absence of Cdc45 and DDK (Figure 6.1, panel C, lanes 4 and 5).  
 
125 
 
 
Figure 6.1: Reconstitution of Cdc45 recruitment to the pre-RC 
A) Efficient Cdc45 recruitment to the pre-RC by Sld2, Sld3, Sld7 and DDK. B) Sld7 is not 
required for Sld2/Sld3/Cdc45-pre-RC complex formation. This experiment was performed in 
the presence of DDK. C) Sld2, Sld3 and DDK are required for optimal Cdc45 recruitment to 
the pre-RC. This experiment was performed in the presence of Sld7. In all experiments 40 
nM of each protein was used, besides DDK (5 nM), and added for 1 minute at 27°C to the 
pre-RC reconstituted in solution. A salt wash was added before samples were purified by gel 
filtration, separated by SDS-PAGE and analysed by western blot. Dilution series represent % 
of total proteins (40 nM), which were added into the reaction. All experiments shown in this 
figure were performed by Herrera (Herrera, Tognetti et al, under revision). 
 
 
These experiments provide a new and interesting way to study the transition of the 
pre-RC to the CMG and represent the first in vitro reconstitution of Cdc45 binding to 
the pre-RC using purified proteins. Thus, Herrera and I worked together in order to 
characterise the complex and analyse the mechanism of its formation. 
 
6.1 Analysis of Sld2 interactions 
Sld2 is an essential factor, whose phosphorylation by S-CDK creates a 
binding site for Dpb11 (Tanaka et al, 2007b; Zegerman & Diffley, 2007) and is 
required to facilitate the recruitment of GINS, and therefore CMG formation. Sld2 in 
pre-RC
ORC
Sld2
Sld3
Cdc45
- +
1     2
Sld7
7
.8
1
 %
3
.1
2
 %
1
.2
5
 %
0
.5
0
 %
3      4      5     6
1 min
+ DDK
Cdc6
Mcm2
Sld7
Mcm2
Sld2
Sld3
Cdc45
- +
1     2
Sld7
pre-RC
1 min
7
.8
1
 %
Mcm2
Sld2
Sld3
Cdc45
-
+
+
+      
+
+
-
+
+      
+
+
+
-
+      
+
+
+
+
-
+
+
+
+
+      
-
+
+
+
+      
+ 3
.1
2
 %
1
.2
5
 %
0
.5
0
 %
DDK
Sld3
Cdc45
Sld2
1       2      3      4      5     6 7     8      9     10
A B
C
126 
 
fact is a member of a transient complex called pre-Loading Complex (pre-LC), 
together with Dpb11, Polε and GINS (Muramatsu et al, 2010). Moreover, Sld2 
interaction with purified hexameric MCM2-7 was shown by the Kaplan lab (Bruck et 
al, 2011). No function is reported for Sld2 outside S-phase in the absence of CDK 
activity, therefore the finding that it is required for the stable recruitment of Cdc45 to 
the pre-RC deserved further investigation. 
The analysis of Sld2 involvement in the process under study started with the 
examination of its recruitment to the pre-RC. Herrera reconstituted the pre-RC in 
solution and added 40 nM of purified Sld2 (equimolar to MCM2-7) for either 1 or 30 
minutes to capture both quick and transient or slow type of association, prior to salt 
addition and gel filtration (Figure 6.2, panel A). The association appeared efficient 
already at 1 minute (Figure 6.2, panel A, lane 3), increased over time (Figure 6.2, 
panel A, lane 4) and did not require any additional factor nor kinases. 
Therefore the surface of contact between MCM2-7 and Sld2 was analysed in 
this work. GST-Sld2 and GST (negative control) were overexpressed in bacteria and 
the lysate extract was incubated with anti-GST magnetic beads (Figure 6.2, panel B). 
The beads were then used to immunoprecipitate in vitro transcribed and translated 
MCM2-7 subunits (Figure 6.2, panel C). Interestingly, GST-Sld2 immunoprecipitated 
weakly but specifically Mcm2, similarly as observed for Sld3 (Figure 4.8, lane 8) and 
Cdc45 (Figure 5.5, lane 8). 
The finding that Sld2 interacts with Mcm2 supports the concept that Sld2 is 
involved in Cdc45 recruitment to the pre-RC. Sld2 could in fact directly interact with 
Cdc45 or alternatively remodel the pre-RC/Sld3 complex. However, the binding site 
for Sld3, Cdc45 and Sld2 could be only partially formed by Mcm2 and additionally 
involve adjacent subunits.  
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Figure 6.2: Sld2 recruitment to the pre-RC and interaction with MCM2-7 
A) 40 nM Cdc45 were added for 1 or 30 min at 27°C to the pre-RC reconstituted with the gel 
filtration system. The samples were analysed by SDS-PAGE followed by Western Blotting 
using specific antibodies against Mcm2 and Sld2. This experiment was performed by 
Herrera. B) Coomassie stained gel showing GST (26.6 kDa) and GST-Sld2 (78.8 kDa) 
immobilized on anti-GST magnetic beads. C) GST or GST-Sld2 immobilized on anti-GST 
magnetic beads were incubated with 35S labelled in vitro transcribed translated proteins, 
washed, separated by SDS-PAGE and analysed by autoradiography. Asterisks indicate full 
length proteins. 
 
 
In addition, Herrera found that Sld2 and Sld3 by themselves become recruited 
to the pre-RC and, when added in combination, the interaction of both proteins did 
not improve, but the binding of Sld2 was decreased (Figure 6.3, panel A, compare 
lane 2 and 3 with 4). This indicates that the two proteins cannot bind simultaneously 
to the pre-RC and suggests that either the pre-RC undergoes a conformational 
change in the presence of Cdc45 and DDK (Figure 6.1 shows in fact that Sld3 and 
Sld2 are recruited in a stoichiometric fashion) or that Cdc45 stabilises the complex, 
perhaps bridging some interactions. 
Interestingly, Herrera also found that DDK could resolve the competition occurring 
between Sld3 and Sld2 and the two proteins could be again stoichiometrically 
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recruited to the pre-RC when the kinase was added to the reaction (Figure 6.3, panel 
B). 
 
 
Figure 6.3: DDK regulates Sld2 and Sld3 interactions with the pre-RC 
A) Sld2 and Sld3 binding to the pre-RC. Sld2, Sld3 or the combination of both was incubated 
with the pre-RC reconstituted in solution. B) DDK stabilizes Sld2 within the Sld2/Sld3-pre-RC 
complex reconstituted in solution. After the salt wash, the samples were purified by gel 
filtration and analysed by SDS-PAGE followed by Western Blotting using specific antibodies 
against Mcm2, Sld3 and Sld2. Both experiments were performed by Herrera (Herrera, 
Tognetti et al, under revision). 
 
 
The intriguing finding that Sld3 and Sld2 can both interact with Mcm2 but 
cannot be simultaneously associated to the pre-RC unless DDK is added to the 
reaction warranted a more detailed analysis of the Sld2-Mcm2 interaction, especially 
as this could help to understand how the kinase could stabilise an Sld2/Sld3-pre-RC 
complex. If DDK phosphorylation would merely generate the binding site for Sld2, 
then Sld2 should not interact with the pre-RC when no kinase is added (Figure 6.2, 
panel A). To test if Sld3 and Sld2 are binding the same portion of Mcm2 or 
alternative sites, GST-Sld2 was used to immunoprecipitate in vitro transcribed and 
translated truncations of Mcm2. Considering that the binding site of Sld3 and Sld2 
could overlap, and knowing that Sld3 binds the N-terminal region of Mcm2 (Figure 
4.9), a series of C-terminal truncations were tested together with the three domains 
that cover the whole Mcm2 (Figure 6.4). As expected, GST-Sld2 weakly 
immunoprecipitated full length Mcm2 (Figure 6.4, lane 15), although the interaction 
appeared weaker than before (Figure 6.2, panel C). The in vitro transcribed and 
translated full length protein appears in fact degraded. This phenomenon was 
observed sometimes during this work, especially when full length proteins were in 
vitro transcribed and translated and then used in a pull-down. 
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Surprisingly, none of the Mcm2 fragments containing the N-terminus 
interacted with GST-Sld2 and, instead, a good interaction was observed with the C-
terminal portion of the protein (aa 666-868, Figure 6.4, lane 24) and a weak signal 
was also observed with the central part of Mcm2 (aa 322-665).  
 
Figure 6.4: Sld2 interacts with Mcm2 C-terminus 
GST or GST-Sld2 immobilized on anti-GST magnetic beads were incubated with 35S labelled 
in vitro transcribed and translated truncations of Mcm2, washed, separated by SDS-PAGE 
and analysed by autoradiography. 
 
 
The data suggest that Sld3 and Sld2 do not compete for the binding site on Mcm2. 
Nevertheless, Sld3 interaction with the Mcm2 N-terminus hindered Sld2 binding to 
the C-terminus. DDK dependent phosphorylation of MCM2-7 could therefore 
produce a conformational change in the complex allowing simultaneous binding of 
Sld2 and Sld3 (Figure 6.5). 
It has to be pointed out that the N-termini of the MCM2-7 subunits are 
unstructured regions and therefore it seems reasonable to think that this region could 
be flexible and assume, upon Sld3 binding, a folding that obstructs the Sld2 binding 
site at the C-terminus. This finding allows us to draw a model where DDK regulates 
Cdc45 recruitment to the pre-RC in multiple ways, one of which being the 
simultaneous interaction of Sld3 and Sld2. Further structural analysis is required in 
order to prove this theory.  
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Figure 6.5: Model of Sld3 and Sld2 interaction with Mcm2 
Sld3 interacts with the N-terminus of Mcm2 and, in the absence of DDK, the hindrance 
impairs Sld2 interaction with the C-terminus. Upon DDK phosphorylation, MCM2-7 
undergoes a conformational change that exposes again Sld2 binding side and therefore 
Sld3 and Sld2 can be simultaneously associated with the pre-RC. 
 
 
For the purpose of this study, however, the interaction of Sld2 with the other 
components of the Cdc45 containing complex was carried out. No data was 
available on Sld2 interaction with Sld3 or Sld7. In vivo work by the Araki lab 
(Muramatsu et al, 2010) indicated that Sld2 and Cdc45 do not interact but that Sld2, 
upon CDK dependent phosphorylation, interacts with Dpb11, as also shown by 
Zegerman and Diffley (Zegerman & Diffley, 2007). 
GST-Sld2 was therefore used to immunoprecipitate Sld3, Sld7 as well as Cdc45. 
Moreover, it was tested if Dpb11 could bind to Sld2 in vitro in the absence of CDK 
kinase (Figure 6.6). Here a new interaction of Sld2 with Sld3 and Sld7 was observed 
(Figure 6.6, lanes 5 and 7 respectively). It was also confirmed that Sld2 and Cdc45 
cannot interact (Figure 6.6, lane 10) and, surprisingly, a weak interaction was found 
with Dpb11, although previous data suggested that this interaction required CDK 
(Figure 6.6, lane 12). 
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Figure 6.6: Sld2 interacts with Sld3, Sld7 and Dpb11 but not with Cdc45. 
GST or GST-Sld2 immobilized on anti-GST magnetic beads were incubated with 35S labelled 
in vitro transcribed and translated Sld3, Sld7, Cdc45 and Dpb11, washed, separated by 
SDS-PAGE and analysed by autoradiography. Asterisks indicate full length proteins. 
 
 
 
Figure 6.7: Sld2-Sld3 interaction analysis 
A) In vitro transcribed translated Sld3 interacts with Sld2. GST-Sld2 (400ng) and an 
equimolar amount of GST, immobilized on magnetic beads, were incubated with 35S labeled 
in vitro transcribed translated Sld3, washed, separated by SDS-PAGE and analyzed by 
autoradiography. B) In vitro transcribed translated Sld2 interacts with Sld3. Sld3 (150 ng) 
immobilized on anti-Sld3 magnetic beads or control beads, were incubated with 35S labeled 
in vitro transcribed translated Sld2, washed, separated by SDS-PAGE and analyzed by 
autoradiography. C) Purified Sld3 interacts with Sld2. GST-Sld2 (400ng) and an equimolar 
amount of GST, immobilized on magnetic beads, were incubated with purified Sld3 (500 ng), 
washed, separated by SDS-PAGE and analyzed by western-blot. Lanes 3-6; a dilution series 
representing % of total Sld3 input is shown. D) Purified Sld2 interacts with Sld3. Sld3 (150 
ng) immobilized on anti-Sld3 magnetic beads or IgG control beads, were incubated with 
purified Sld2 (500 ng), washed, separated by SDS-PAGE and analyzed by western-blot. 
Lanes 3-6; a dilution series representing % of total Sld2 input is shown. 
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Given that the interaction between Sld3 and Sld2 is of major importance in the 
context of this work, their binding was confirmed by immunoprecipitating purified 
Sld3 with GST-Sld2 (Figure 6.7, panel C) as well as using Sld3 to capture purified 
(Figure 6.7, panel D) and in vitro transcribed and translated Sld2 (Figure 6.7, panel 
C). This analysis proved an interaction between the two proteins and showed that 
the interaction is independent of the N-terminal GST tag on Sld2, or the N-terminal 
Myc on Sld3. 
The analysis proceeded with the mapping of the binding site on Sld2 using 
MBP-Sld3 to immunoprecipitate in vitro transcribed and translated portions of Sld2. 
These truncations were produced after the analysis of the secondary structure 
prediction (Appendix II), which was performed in order to minimise disruption of α-
helixes and β-sheets. Full length Sld2 bound to MBP-Sld3 (Figure 6.8, lane 17), but it 
appeared to be partially degraded similarly to what was previously observed (Figure 
6.4) The very N-terminal region of Sld2 did not interact with Sld3 under these 
conditions (fragments 1-148 and 1-249, Figure 6.8, lanes 11 and 13 respectively). All 
truncations containing the amino acids 250-327, instead, appeared to bind, but some 
unspecific signal was also detected for the MBP control in some cases (lanes 14-15, 
22-23 and 24-25).  
 
Figure 6.8: Sld2 interaction with Sld3 
MBP or MBP-Sld3 immobilized on anti-MBP magnetic beads were incubated with 35S 
labelled in vitro transcribed and translated truncations of Sld2, washed, separated by SDS-
PAGE and analysed by autoradiography. Asterisks indicate protein constructs. 
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Unfortunately the fragment 250-327 was too short to be analysed under the same 
conditions because even the high percentage acrylamide gel used in the SDS-PAGE 
for these assays could not resolve peptides smaller than 100 amino acids. An 
alignment of fungal Sld2 amino acid sequences (Appendix III) was therefore 
prepared and a limited number of residues were found to be highly conserved in this 
small region. These amino acids could be mutated in the future in order to identify a 
version of Sld2, which is defective for the interaction with Sld3. 
This analysis however continued with the study of the binding site for Sld2 on 
Sld3, employing Sld3 peptides as described in paragraph 4.5 and 5.3. The 
biotinylated peptides (Appendix I, Table IV) were conjugated to streptavidin beads 
and incubated with in vitro transcribed and translated Sld2. Five peptides appeared 
to bind to Sld2 and corresponded to amino acids 170-195 (CR1b), 196-226 (CR2), 
249-287 (CR3a), 286-311 (CR3b) and 333-355 (CR4) of Sld3, while peptides CR1a 
(152-175), CR5 (384-419) and CR6 (518-546) did not show an interaction (Figure 
6.9).  
 
 
Figure 6.9: Interaction analysis of Sld3 peptides with Sld2 
Biotinylated peptides of Sld3 bound to streptavidin beads were incubated with 35S labelled in 
vitro transcribed translated full length Sld2, washed, separated by SDS-PAGE and analysed 
by autoradiography. 
 
 
Contrarily to what was observed for Mcm2 and Cdc45, a greater number of peptides 
interacted with Sld2, suggesting that in vitro transcribed and translated Sld2 could 
interact non-specifically with some of them, or that the binding site on Sld3 involves 
multiple residues or regions covering amino acids 170-355 of Sld3. The Sld3 peptide 
CR3a (aa 249-287) however appeared to interact very well with Sld2, indeed 
stronger than with any other peptide, therefore it was decided to analyse its 
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sequence starting from the sequence alignment of Sanchez-Pulido and colleagues 
(Sanchez-Pulido et al, 2010) in order to identify conserved residues that could be 
responsible for the interaction. The region comprising amino acids 259 and 287 
contains a cluster of very conserved residues (Figure 6.10, panel A). The sequence 
was analysed for a secondary structure prediction as well (Figure 6.10, panel B) and 
this analysis predicts a helix within the amino acids 269-282. A helical wheel 
projection of the sequence corresponding to CR3a was therefore performed (Figure 
6.10, panel C), as it could help to identify clusters of amino acids with similar charge 
or hydrophobicity. Indeed, the most conserved residues obtained from the sequence 
alignment were clustered in four groups based on their characteristics and proximity 
in the helical projection. They were subsequently mutated following the strategy 
adopted by Frigola and colleagues (Frigola et al, 2013), where several amino acids 
were substituted simultaneously, in order to maximise the disruption. Positively 
charged amino acids were changed for negative charge and vice versa and the ones 
containing a long side chain were altered for a short side chain and vice versa. The 
mutations produced are indicated in Figure 6.10, panel A. Two mutants (mut3 and 
mut4) were produced altering the hydrophobic residues positioned in proximity, 
whereas mut2 targeted the conserved lysines, which were changed for aspartic acid, 
finally mut1 altered the remaining conserved amino acids. 
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Figure 6.10: Sequence analysis of Sld3 CR3a (aa 249-287) 
A) Representative multiple sequence alignments of Treslin/Sld3 family adapted from 
Sanchez-Pulido’s work (Sanchez-Pulido et al, 2010) of the most conserved region of CR3a 
(amino acids 259-287). The mutated residues are marked. B) Secondary structure prediction 
of the region 250-290. A helix is predicted for the residues 269-282. C) Helical wheel 
projection for the sequence corresponding to CR3a. The most conserved residues were 
clustered based on their characteristics and proximity in four groups to produce the following 
mutants: mut1 (wild type mixed) R269E_E270R_Q274A_E280R, mut2 (wild type positively 
charged) K267D_K272D, mut3 (wild type hydrophobic) L273E_L277E_L248E, mut4 (wild 
type hydrophobic) I275K_L278E_I282K. 
 
 
The indicated mutations were produced in the context of the peptide CR3a. The 
biotinylated peptides (Appendix I, Table IV) were conjugated to streptavidin beads 
and then incubated with in vitro transcribed and translated Sld2. It was found that 
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mut1 (R269E_E270R_Q274A_E280R) and mut3 (L273E_L277E_L248E) 
suppressed very strongly the interaction with Sld2 (Figure 6.11, lanes 4 and 6 
respectively compared to lane 3). On the other hand, mut2 did not alter the binding 
compared to the wild type (Figure 6.11, compare lanes 5 and 3) and mut4 showed 
only a reduced signal (Figure 6.11, compare lanes 7 and 3). 
 
Figure 6.11: Interaction analysis of mutated Sld3 peptides with Sld2 
Biotinylated peptides of mutated Sld3 bound to streptavidin beads were incubated with 35S 
labelled in vitro transcribed translated full length Sld2, washed, separated by SDS-PAGE 
and analysed by autoradiography. 
 
 
The result of this assay appeared promising, as mutations in a conserved region of 
Sld3 were suppressing the interaction of Sld2; therefore it was decided to test these 
mutations in vivo. It appears possible that the binding of Sld2 with Sld3 could be 
essential for its stable interaction with the pre-RC and could facilitate Cdc45 
recruitment. 
 
6.2 In vivo analysis of Sld3 mutants 
The screen with the mutants of CR3a gave some promising results, as some 
mutants affected the interaction with Sld2 and, in order to perform a comprehensive 
in vivo analysis, more mutants were generated in the peptides CR1b and CR2 
following the same strategy described in paragraph 6.1. The peptides covering these 
two regions in fact were found to interact with Mcm2 and Cdc45 (Figure 4.22 and 5.7 
respectively). The CR3b peptide interacted with Mcm2 (Figure 4.22) but this region 
does not contain well conserved residues that could be targeted for mutation (see 
Appendix III) therefore it was decided to focus on the other regions during this 
analysis.  
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Three of the most conserved residues of CR1b were mutated to produce Sld3 
F179R_K181D_R186E (Sld3 CR1b mut) whereas four residues in CR2 were 
changed to generate Sld3 L213R_F218R_R221E_H222D (Sld3 CR2 mut). The 
variations are shown in figure 6.12. 
 
 
Figure 6.12: Representation of mutants of CR1b and CR2 
Representative multiple sequence alignments of Treslin/Sld3 family adapted from Sanchez-
Pulido et al (Sanchez-Pulido et al, 2010) for the most conserved region of CR1b (amino 
acids 170-195) and CR2 (amino acids 196-226). The mutated residues are marked.  
 
 
To test the Sld3 mutants in vivo it was decided to use the Sld3-7td strain 
developed by the Labib lab (Kanemaki & Labib, 2006). Sld3-7 contains a 
temperature sensitive mutation that affects the ability of MCM2-7 and Cdc45 to 
interact during initiation (Kamimura et al, 2001). Cells with this mutation grow well at 
24°C, but their growth is reduced at 37°C, therefore this mutant version of Sld3 was 
combined with the heat-inducible degron cassette (Kanemaki et al, 2003; Sanchez-
Diaz et al, 2004) producing a strain that grows almost as well as the control strain at 
24°C and exhibits severe growth defect at 37°C (Kanemaki & Labib, 2006). The 
addition of the degron cassette to wild type Sld3 on the contrary does not prevent 
growth at 37°C (Kanemaki & Labib, 2006). Indeed, Sld3 is a limiting factor for DNA 
CR1b CR2
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replication (Tanaka et al, 2011a), therefore it is possible that even a small amount of 
functional Sld3 in the cell is sufficient to support growth. For this reason a 
temperature sensitive allele of Sld3 was combined by the Labib lab with the degron 
technology. 
The degron cassette is recognised by the Ubr1 protein that is associated with an 
ubiquitin-conjugating enzyme, and proteolysis is stimulated at higher temperatures, 
because the unfolding of the degron exposes lysines that are sites of ubiquitylation 
(Dohmen et al, 1994). Efficient proteolysis of the degron requires increased 
expression of the Ubr1 protein (Labib et al, 2000) therefore the only copy of the 
UBR1 gene was expressed under the control of the galactose-inducible promoter 
CUP1. The CUP1 promoter additionally requires the addition of CuSO4 to the 
medium. In this way the cells can be grown at the permissive temperature of 24°C 
with normal Ubr1 protein levels and after a temperature shift to the restrictive 
temperature (37°C) galactose addition triggers strong expression of Ubr1 and rapid 
degradation of the target protein (Sanchez-Diaz et al, 2004). This strain allows the 
phenotypic analysis of Sld3 mutants in the absence of its wild type copy.  
For the expression of the mutant versions of Sld3 a yeast centromere plasmid 
was chosen (pRS416). These vectors have both a replication origin and a 
centromere sequence and are propagated at a very low copy-number, autonomously 
replicating due to the presence of a yeast replication origin and efficiently segregated 
as the plasmid contains a yeast centromere sequence, in addition to a selectable 
marker (Stearns et al, 1990). 
The SLD3 gene with mutations in CR1b, CR2, CR3a mut1 and mut3, 
preceded by the natural promoter, were cloned into the yeast centromere plasmid 
and transformed into the Sld3-7td strain described above. Moreover, the Sld3-7td 
strain transformed with the empty vector that does not express any protein served as 
a negative control, while the transformation of the plasmid containing non modified 
SLD3 gene served as positive control, as this plasmid should effectively rescue the 
lethality conferred by the degradation of the endogenous protein. 
The strains were grown in selective media and spotted in a 5 fold serial 
dilution series on a selective plate containing either glucose (no Ubr1 expression) or 
galactose (Ubr1 expression) in the presence of CuSO4 and incubated at the 
permissive temperature of 24°C, a condition in which the Sld3-7 mutant does not 
show growth defects. The strains were also spotted on a selective plate containing 
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either glucose and CuSO4 (no Ubr1 expression) or galactose (Ubr1 expression) and 
incubated at the restrictive temperature of 37°C, condition in which the Sld3-7 mutant 
shows severe growth defect.  CuSO4 is omitted from the galactose plate incubated at 
37°C because it stimulates the transcription of the degron fused protein from the 
CUP1 promoter and in this condition the degradation of the Sld3-7 is instead 
wanted(Kanemaki et al, 2003; Sanchez-Diaz et al, 2004).  
All strains analysed appeared to grow similarly well at the permissive 
temperature and with inactivated Ubr1 (glucose plate at 24°C, Figure 6.13 panel A). 
The strains expressing CR1b mut, CR2 mut and CR3a mut1 show a slightly reduced 
growth of colonies compared to the other strains. This could be due to a weak 
dominant lethal effect of these mutants. Indeed, overexpression of Ubr1 at the 
permissive temperature revealed a strong dominant lethality of the mutants CR1b 
mut, CR2 mut and CR3a mut1, suggesting that in these conditions the Sld3 
concentrations dropped sufficiently to reveal the observed effect (galactose plate at 
24°C, Figure 6.13 panel B). When the strains were analysed at the restrictive 
temperature with inactivated Ubr1 (glucose plate at 37°C, Figure 6.13 panel C), they 
all appeared to be able to grow. Strains expressing CR1b mut, CR2 mut and CR3a 
mut1 showed again slightly reduced growth under these conditions, consistent with 
what was observed at the permissive temperature. 
At the restrictive temperature and in case of Ubr1 overexpression, namely 
when endogenous Sld3 is degraded, only the strain transformed with the plasmid 
containing wild type Sld3 could grow (galactose plate at 37°C, Figure 6.13 panel D). 
This indicates that the lethal effect of the degron (observed for the control strain 
transformed with the empty vector) can effectively be rescued by the addition of Sld3 
and also, importantly, that all mutants analysed cannot complement the strain.  
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Figure 6.13: Growth assay for Sld3 mutants 
Yeast growth assay showing the effect of expression of the indicated proteins in the Sld3-7td 
strain. A 5 fold serial dilution of cells (starting from 1 x 107) was spotted onto Kaiser plates 
lacking uracil with either 2% glucose or 2% galactose and 0.1 mM CuSO4 as indicated. 
Plates were incubated for 3 days at the specified temperature. 
 
 
This assay shows that the mutations affect an essential function of Sld3, likely 
involving DNA replication. Unfortunately, it is not possible to claim with this 
experiment only, that the growth defect observed is indeed due to disruption of one 
of the interactions studied in this project and described in this and the previous 
chapters.  
To analyse the effect of the mutations on pre-IC assembly, these strains were 
therefore grown in liquid media and arrested in G1-phase before synchronous 
release into S-phase, chromatin fractionation of the samples and western blot 
analysis for the essential proteins involved in initiation of DNA replication (MCM2-7, 
Sld3, Sld2, Cdc45, GINS). The purpose of this experiment was to prove that 
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mutations in Sld3, which affect in vitro the interaction with Mcm2, Cdc45 or Sld2, had 
an impact on pre-IC assembly during initiation of replication in vivo.  
The experimental setting was a variation of what was previously described by 
Kanemaki & Labib (Kanemaki & Labib, 2006) and Sheu & Stillman (Sheu & Stillman, 
2006). Briefly, it included the growth of the culture in selective liquid media in the 
presence of raffinose as a carbon source (to facilitate the subsequent switch to 
galactose), the arrest in G1-phase with α factor in raffinose for 3 hours at the 
permissive temperature (to maintain the repression of Ubr1) followed by 40 
additional minutes in galactose (to induce Ubr1 expression while still in G1-phase), 
the shift to the restrictive temperature in galactose for 1 hour in presence of α factor 
(to boost the degradation of the degron cassette and therefore of endogenous Sld3) 
before the release in S-phase in presence of hydroxyurea, which allows the firing of 
early replication origins, but then slows the cell cycle progression due to dNTPs 
starvation. A sample was collected before the release in S-phase and at 90 and 120 
minutes into S-phase. The samples were spheroplasted to degrade the cell wall and 
finally the chromatin was isolated by centrifugation through a sucrose cushion. The 
chromatin bound and soluble fractions were analysed by SDS-PAGE followed by 
western blot and probed against the essential proteins for initiation of replication 
(MCM2-7, Sld3, Sld2, Cdc45, GINS).  
Unfortunately the arrest/release conditions, as well as the chromatin 
fractionation, required some optimisation and a conclusive result was not obtained in 
the timeframe of this project. It remains a very valuable experiment to perform in the 
future in order to achieve a final proof of the relevancy of the newly identified 
mutants of Sld3. 
 
6.3 Analysis of the trimeric complex Sld3/Sld2/Sld7 
During the characterisation of the complex containing Cdc45 (Figure 6.1), 
Herrera observed that Sld3 and Sld2 could interact with the pre-RC in the presence 
of DDK and they were rapidly displaced from the complex when incubated longer 
(Figure 6.14, panel A). Interestingly, it was also found that the addition of Sld7 to this 
reaction would result in the lack of recruitment of Sld3, Sld2 and Sld7 to the pre-RC 
(Figure 6.14, panel B), suggesting that these three proteins could form a complex in 
solution that inhibits its interaction with the pre-RC. Finally, a striking recruitment of 
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Sld3, Sld2 and Sld7 in the presence of Cdc45 was observed (Figure 6.14, panel C) 
that was much more stable over time compared to what was observed for Sld3 and 
Sld2. Over time Sld3, Sld2 and Sld7 would get displaced from the complex, leaving 
only Cdc45 at this point stably bound to the pre-RC (Figure 6.14, panel C, lane 8).  
 
Figure 6.14: Sld3, Sld2, Sld7 release from the pre-RC 
A) Time course analysis of Sld2 and Sld3 association with the pre-RC in the presence of 
DDK (5 nM). B) Time course analysis of Sld2, Sld3 and Sld7 association with the pre-RC in 
the presence of DDK (5 nM) C) Time course analysis of Cdc45, Sld2, Sld3 and Sld7 
association with the pre-RC in the presence of DDK (5 nM). In all cases, after pre-RC 
formation the additional proteins were added and incubated for the indicated time points. 
The reaction omitting the pre-RC proteins (-pre-RC) was incubated for 1 minute. Lanes 9-12 
show a dilution series representing % of total protein (40 nM), which were added into the 
reactions. All experiments in this figure were performed by Herrera. 
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This experiment provides evidence that Cdc45 is recruited as a consequence of 
Sld3, Sld2 and DDK action, given that Cdc45 could not be found in a complex with 
the pre-RC (Figure 5.2). An extensive discussion of these results from the point of 
view of Cdc45 recruitment will be found in Chapter 7.  
The outcome of these assays, however, is suggesting that a trimeric complex 
between Sld3, Sld2 and Sld7 could form in solution, given that Sld7 blocked the 
recruitment of Sld3 and Sld2 to the pre-RC (Figure 6.14, panel B) and also that Sld3, 
Sld2 and Sld7 are released from the pre-RC in a synchronous manner (Figure 6.14, 
panel C). 
It was tested whetherSld7 could interact with Sld3, Sld2 and Cdc45 in a similar 
fashion. The interaction of Sld7 with Sld3 was already described by the Araki lab 
(Tanaka et al, 2011a; Tanaka et al, 2011b) in vivo and with the two hybrid system. 
Sld2 and Sld7 were found to interact in this study (Figure 6.6) whereas the physical 
binding of Sld7 to Cdc45 was never reported.  
The direct interaction of Sld7 with the other proteins was therefore tested. 
MBP-Sld3, GST-Sld2 and GST-Cdc45 were used to immunoprecipitate in vitro 
transcribed and translated Sld7, similarly to what was described in the previous 
chapters. 
It was found that both Sld3 and Sld2 are immunoprecipitated very well by Sld7 
(Figure 6.15, panels A and B respectively), whereas Cdc45 is interacting but to a 
lesser extent (Figure 6.15, panel C). 
 
 
Figure 6.15: Interaction analysis of Sld7 with Sld3, Sld2 and Cdc45 
A) In vitro transcribed and translated Sld7 interacts with Sld3. MBP-Sld3 (400 ng) and an 
equimolar amount of MBP, immobilized on magnetic beads, were incubated with 35S labeled 
in vitro transcribed and translated Sld7, washed, separated by SDS-PAGE and analyzed by 
autoradiography. B) In vitro transcribed and translated Sld7 interacts with Sld2. GST-Sld2 
(400 ng) and an equimolar amount of GST, immobilized on magnetic beads, were incubated 
with 35S labeled in vitro transcribed translated Sld7, washed, separated by SDS-PAGE and 
analyzed by autoradiography. C) GST-Cdc45 (400 ng) and an equimolar amount of GST, 
immobilized on magnetic beads, were incubated with 35S labeled in vitro transcribed and 
translated Sld7, washed, separated by SDS-PAGE and analyzed by autoradiography.  
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To test the possibility that Sld3, Sld2 and Sld7 could form dimeric or a trimeric 
complex in solution, the purified proteins were incubated with each other and cross-
linked with glutaraldehyde, similarly as previously described for the pre-RC complex 
(Evrin et al, 2013). 
Initially different concentrations of glutaraldehyde were tested in order to find an 
optimal condition for the treatment of the proteins analysed (Figure 6.16, panel A). 
For this experiment the four subunit GINS complex (containing Sld5, Psf1, Psf2 and 
Psf3) was used as a positive control to monitor the success of the crosslinking 
reaction (Figure 6.16, panel A, lanes 21-25). Sld3, Sld2 and Sld7 were analysed 
alone or all together, the samples were separated by SDS-PAGE and the proteins 
were visualized by silver staining. The experiment was then repeated under the best 
cross-linking condition (0.1% glutaraldehyde) for all protein combinations and 
analysed by Western Blot, probing with specific antibodies against the proteins 
tested (Figure 6.16, panels B-D). 
Sld5, Psf1, Psf2 and Psf3 are known to interact forming the GINS complex 
(Takayama et al, 2003) and they were successfully cross-linked here with 
concentrations of 0.1% glutaraldehyde and upwards (Figure 6.16, panel A, lane 24). 
A weak high molecular weight complex can be already detected at 0.02% (Figure 
6.16, panel A, lane 23), but then still uncross-linked subunits can be detected, 
suggesting that SDS can still denature the complex under those conditions. With 
higher concentrations of glutaraldehyde a large complex is detected. The addition of 
more glutaraldehyde results in a faster migration during SDS-PAGE, as the complex 
becomes stabilised in its very compact folded structure. 
When Sld3 was analysed by itself in the presence of the cross-linking agent, 
two species could be observed, one with a molecular weight below 77 kDa expected 
for Sld3 monomer, and another one with a molecular weight considerably higher 
than 77 kDa, but well below 200 kDa. This high molecular weight species could be 
possibly a Sld3 dimer. Once the samples were analysed by western blot using a 
specific antibody against Sld3 (Figure 6.16, panel B), it was possible to confirm that 
the species with a molecular weight similar to the 66 kDa marker was indeed Sld3 
(Figure 6.16 A, lane 9 and Figure 6.16 B, lane 4). No signal was instead detected for 
the higher molecular weight band observed in the silver staining gel (Figure 6.16, 
panel A, lane 9 in box), suggesting that either the epitope of Sld3 is masked in the 
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conformation of the dimer or that it was produced by contaminants present in the 
sample and it has nothing to do with Sld3. 
The Sld2 protein used for this experiment showed some contaminant bands 
derived from the purification process (Figure 6.16, panel A, lane 11) and the addition 
of glutaraldehyde did not appear to result in the formation of new species (Figure 
6.16 A, lanes 12-15). At the higher concentration of cross-linking reagent however a 
strong signal appeared, possibly due to a low molecular weight contaminant modified 
under these conditions. The western blot against Sld2 confirmed the absence of 
additional higher molecular weight species for the cross-linked sample compared to 
the untreated one (Figure 6.16 C, compare lane 5 to 2). 
Sld7 was analysed in the same way and upon addition of glutaraldehyde, the 
appearance of a new high molecular weight species was detected in the silver 
stained gel (Figure 6.16 A, lanes 19 and 20), likely belonging to a Sld7 dimer. The 
identity of the complex was therefore confirmed by western blot (Figure 6.16 D, lanes 
6). 
The possible formation of dimers between two proteins, as well as the 
formation of a trimeric complex, was tested next. 
The combination of Sld3 and Sld7 was tested first. No signal was detected with the 
Sld3 antibody, neither at the size of cross-linked Sld3 alone nor at a higher molecular 
weight (Figure 6.16 B, lane 7). For the same condition Sld7 antibody showed a 
reduction of the signal at the molecular weight of cross-linked Sld7 and the 
appearance of several high molecular weight species (Figure 6.16 D, lane 7). This 
suggests that the two proteins are indeed forming a complex which could be a 
Sld3/Sld7 dimer or some form of a multimer. Moreover, the absence of the Sld3 
signal suggests that the epitope for Sld3 antibody is hidden in this structure. 
When Sld3 and Sld2 were cross-linked together, the signal detected for cross-linked 
Sld3 alone disappeared and a new high molecular weight band was detected instead 
(Figure 6.16 B, lane 8), possibly due to a Sld3/Sld2 dimer. The analysis with Sld2 
antibody revealed two bands, which were absent in the sample of Sld2 cross-linked 
by itself. One complex weighs putatively around 80 kDa therefore it is unlikely to be 
Sld3/Sld2. The other signal is detected at very high molecular weight and it could 
either indicate an aggregate stuck in the well of the gel or a multimer of Sld2. 
Unfortunately this data does not conclusively indicate the nature of the complexes 
detected. 
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The combination of Sld2 and Sld7 was then tested. No new species were 
detected with the anti Sld2 antibody in comparison with the sample containing Sld2 
alone (Figure 6.16 C, compare lane 9 to 5). The western blot against Sld7 revealed 
instead a very different profile compared to the sample containing only Sld7 (Figure 
6.16 D, compare lane 9 to 6). In this case the signal belonging to Sld7 monomer 
reappears and several new higher molecular weight bands can be observed as well 
(two main signals and two weak above 66 kDa). This data suggests that Sld2 is 
indeed interacting with Sld7 or, alternatively, Sld2 induces Sld7 multimerisation. It is 
not possible to state that the two proteins form a dimeric complex because no signal 
was detected in the Sld2 western blot but, once again, the epitope for the antibody 
could be masked. It is quite likely though that Sld7 is in a complex either with other 
Sld7 molecules or with Sld2. 
Finally the combination of Sld3, Sld2 and Sld7 was analysed. The silver 
staining reveals the formation of a new species at a molecular weight higher than 
116 kDa (the trimer has an estimated size of 160 kDa) (Figure 6.16 A, lane 4). The 
western blot for Sld3 reveals no signal at all (Figure 6.16 B, lane 10), similar to what 
was observed for the sample with Sld3 and Sld7 (Figure 6.16 B, lane 7), suggesting 
that a complex was formed and that the epitope for Sld3 was hidden in this 
conformation. The western blot with Sld2 antibody (Figure 6.16 C, lane 10) showed a 
profile which was very similar to the one of the sample containing Sld3 and Sld2 
(Figure 6.16 C, lane 8) with an additional band around 116 kDa. The analysis with 
anti Sld7 antibody showed a similar profile as with Sld7 and Sld2, but the signal was 
attenuated (Figure 6.16 D, lane 9) and a signal at higher molecular weight was 
detected, at a molecular weight of 116 kDa, similarly to what observed with Sld2 
antibody (Figure 6.16 C, lane 10). 
These data unfortunately are not sufficient to prove the formation of a trimeric 
complex in solution but strongly suggest that Sld3, Sld2 and Sld7 have the potential 
to associate with one another in different ways. 
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Figure 6.16: Sld3, Sld2 and Sld7 cross-linked in solution 
A) 100 ng of Sld3 and equimolar amount of Sld2, Sld7 and GINS were incubated for 10 min 
on ice followed by 5 minutes at 24°C while shaking before the addition of glutaraldehyde (5 
fold dilution: 0.004-0.02-0.1-0.5%) for 5 min at 4°C. The samples were analysed by SDS-
PAGE followed by silver staining. Asterisks indicate full length proteins, boxes indicated high 
molecular weight species. B-C-D) 100 ng of Sld3 and equimolar amount of Sld2, Sld7 and 
GINS were incubated with 0.1% glutaraldehyde as described for panel A. The samples were 
analysed by SDS-PAGE followed by western blot against Sld3 (B), Sld2 (C) and Sld7 (D). 
Molecular weights: Sld3 77 kDa, Sld2 52 kDa, Sld7 29 kDa; subunit of GINS: Sld5 34 kDa, 
Psf1 24 kDa, Psf2 25 kDa, Psf3 22 kDa. 
 
 
 
To prove conclusively that a trimeric complex is formed, other techniques need to be 
employed such as gel filtration or glycerol / sucrose gradient sedimentation, or 
immunoprecipitation of the complex using one of the proteins and probing for the 
other two.  
 
6.4 DDK phosphorylation of the proteins involved 
In this section, the role of DDK in modifying factors involved in Cdc45 
recruitment to the pre-RC was investigated. 
The activity of DDK in initiation of replication has been reported in vivo in several 
papers (Francis et al, 2009; Gros et al, 2014; Heller et al, 2011; Jackson et al, 1993; 
On et al, 2014; Randell et al, 2010; Sheu & Stillman, 2006; Sheu & Stillman, 2010), 
as well as the specific requirement of DDK for stable Cdc45 recruitment to the 
origins (Heller et al, 2011), which is consistent with the observations presented here 
(Figure 6.1, panel C). 
So far the post-translational modification of MCM2-7 by DDK was extensively 
studied (Francis et al, 2009; Gros et al, 2014; On et al, 2014; Randell et al, 2010; 
Sheu & Stillman, 2006; Sheu & Stillman, 2010) but not much is known on DDK 
dependent phosphorylation of other replication factors. For this reason, a kinase 
assay was performed employing purified proteins. The purified proteins involved in 
Cdc45 recruitment to the pre-RC (Sld3, Sld2 and Sld7) were incubated with 
increasing amounts of DDK at 27°C in the presence of γ-32P-ATP and analysed by 
silver staining and autoradiography. 20 nM of DDK, the highest concentration used in 
the assay, was tested by itself as well and served as negative control to identify the 
signal caused by autophosphorylation of Dbf4 (Lee et al, 2012).  
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Among the proteins tested, only Sld3 appeared to incorporate radioactive ATP 
upon addition of increasing amounts of DDK, specifically at the concentrations of 5 
nM (lane 6) and 20 nM (lane 7) (Figure 6.17, panel A), where the band is additionally 
upshifted. In addition, a weak signal was detected for all DDK concentrations and 
even in the absence of kinase.  
 
 
Figure 6.17: DDK phosphorylation assay for Sld3, Cdc45, Sld2 and Sld7 
40 ng of (A) Sld3, (B) Cdc45, (C) Sld2, and (D) Sld7 were incubated with no DDK (lanes 1 
and 8) or with a 4 fold dilution (0.02 to 20 nM) of DDK (lanes 2-7) for 15 min at 27°C in the 
presence of γ-32P-ATP. The samples were separated by SDS-PAGE and analysed by silver 
staining and autoradiography. Lane 9 contains 20 nM of DDK in the absence of additional 
proteins.  
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Cdc45 as well exhibited a weak signal even in the absence of DDK, indicating that 
the protein was incorporating could incorporate γ-32P-ATP by autophosphorylation or 
due to a contamination, but no change was observed upon addition of DDK (Figure 
6.17, panel B). Sld2 and Sld7 did not show any incorporation of γ-32P-ATP (Figure 
6.17, panels C and D respectively), indicating that these proteins cannot be 
phosphorylated by DDK under these conditions. 
DDK promotes the recruitment of Cdc45 to the pre-RC. Most likely DDK functions 
here by phosphorylating Mcm2, Mcm4 and Mcm6 of the loaded MCM2-7 double-
hexamer, but it will be interesting to further explore the role of the newfound 
modification on Sld3 in this respect.  
 
6.5 Discussion 
The work described in this chapter started with the finding by a colleague, 
who showed that the recruitment of Cdc45 to the pre-RC is in vitro not only 
dependent on Sld3 and DDK, as previously described (Heller et al, 2011; Kamimura 
et al, 2001; Kanemaki & Labib, 2006), but also on Sld2 (Figure 6.1). Sld2 was never 
shown to have a role for Cdc45 recruitment. The only function proposed for this 
protein was in fact to bind Dpb11 upon CDK phosphorylation (Tanaka et al, 2007b; 
Zegerman & Diffley, 2007) and take part in the transient pre-LC complex (Muramatsu 
et al, 2010) together with Dpb11, GINS and Polε to facilitate the formation of the 
CMG. This intriguing finding led to an extensive investigation in order to obtain a 
substantial model of Cdc45 recruitment to the pre-RC. The work of Heller and 
colleagues (Heller et al, 2011) in fact appears to contradict this discovery. Heller 
employed an extract based system to assemble protein complexes, which depends 
on the overexpression of Sld2, Sld3, Cdc45 and Dpb11. Using this system they 
observed a DDK and Sld3 requirement for Cdc45 recruitment to the pre-RC, but the 
depletion of Sld2 had no effect on Cdc45. It is possible to argue that the 
overexpression of these limiting factors in the S-phase extract used by Heller is 
responsible for this discrepancy. Under these conditions the requirement of Sld2 
could be bypassed by the large number of Sld3 and/or Cdc45 molecules available 
for interaction with limited pre-RC complexes Indeed, overexpression of Cdc45 by 
itself is sufficient to bypass a Sld3 temperature sensitive allele (Kamimura et al, 
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2001; Tanaka et al, 2007b), indicating that overexpression of these factors could 
cause synthetic effects.  
A number of experiments were therefore performed in order to analyse how Sld2 
could function for Cdc45 recruitment to the pre-RC. No evidence was available that 
Sld2 would interact directly with the pre-RC at any point of the cell cycle, therefore 
the pre-RC reconstitution assay was used to determine whether Sld2 could interact 
with the pre-RC in vitro. It was observed that Sld2 can be recruited to the pre-RC 
rapidly and stably in the absence of additional factors (Figure 6.2 panel A). 
These data in combination with the observation by the Kaplan lab, that 
showed Sld2 interaction with MCM2-7 in the context of purified proteins in 
solution(Bruck et al, 2011), prompted us to study which MCM2-7 subunit is 
interacting with Sld2. Cdc45 in fact cannot bind neither the pre-RC alone nor the pre-
RC/Sld3 complex so it appears reasonable to think that Sld2 either directly bridges 
the interaction of Cdc45 or produces a conformational change on the pre-RC/Sld3 
complex to facilitate the binding. Sld2 was therefore expected to interact with Mcm2 
(subunit of interaction of Sld3 and Cdc45) or an adjacent subunit of MCM2-7 in order 
to be able to exert this function. GST-Sld2 was therefore used to immunoprecipitate 
in vitro transcribed and translated MCM2-7 subunits (Figure 6.2, panel C) and indeed 
it was found that it interacted weakly but specifically with Mcm2, similarly as 
observed for Sld3 (Figure 4.8, lane 8) and Cdc45 (Figure 5.5, lane 8). 
The simultaneous binding of three proteins to a single Mcm subunit, namely 
Mcm2, appears difficult for spatial reasons and it is more reasonable to speculate 
that the binding site for these three proteins is only partially formed by Mcm2 and 
additionally involves one or more adjacent subunits. 
In this regard it is interesting to note that Herrera observed competitive Sld2 and 
Sld3 interactions with the pre-RC (Herrera, Tognetti et al, under revision). Both 
proteins appeared to be efficiently recruited in the first case but, when added in 
combination, their signal, and especially that of Sld2, was decreased (Figure 6.3, 
panel A, compare lane 2 and 3 with 4). This suggested that the two proteins cannot 
be stably recruited to the pre-RC. However, upon addition of DDK and Cdc45, the 
pre-RC undergoes an apparent conformational change (Figure 6.1), as now a stable 
complex was observed. Indeed, Cdc45 could stabilise the complex, perhaps bridging 
some interactions. Interestingly, Herrera also found that DDK could negate 
competitive Sld2 and Sld3 interactions to the pre-RC and induce formation of a 
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stoichiometric pre-RC/Sld2/Sld3 complex (Figure 6.3, panel B). To determine how 
this could happen, the binding site for Sld2 on Mcm2 was mapped, finding that Sld2 
was precipitating the C-terminal Mcm2 (Figure 6.4), contrary to what observed for 
Sld3 (interaction with the N-terminus, Figure 4.9). 
This result indicates that Sld3 and Sld2 do not compete for the binding site on Mcm2, 
but that the interaction of Sld3 with the Mcm2 N-terminus causes an hindrance that 
impairs Sld2 binding to the C-terminus. The N-termini of the MCM2-7 subunits are 
unstructured regions and therefore it seems possible to think that this region could 
be flexible and assume, upon Sld3 binding, a folding that would obstruct the Sld2 
binding site at the C-terminus. A model was drawn where DDK dependent 
phosphorylation of MCM2-7 could produce a conformational change in the complex 
allowing Sld2 binding site on Mcm2 to be exposed again (Figure 6.5). The DDK 
dependent regulation of the simultaneous binding of Sld3 and Sld2 to the pre-RC 
could therefore represent a quality control mechanism that ensures strictly regulated 
Cdc45 recruitment to the pre-RC. Several mechanisms are in fact functioning during 
initiation of replication to prevent origin firing in case of suboptimal condition. Sld3, 
for example, was shown to be inactivated by Rad53 mediated phosphorylation in 
presence of DNA damage (Zegerman & Diffley, 2010). Additional structural studies 
would be extremely helpful to prove this model. Indeed samples of the double-
hexamer incubated with part or all the proteins involved in Cdc45 recruitment (Sld3, 
Sld2, DDK, Sld7) were sent for analysis by electron microscopy to the Li group, but 
unfortunately they have not been analysed yet.  
Moreover, the interaction of Sld2 with the other components of the Cdc45-
containing complex was carried out. No data was available in the literature on Sld2 
interaction with Sld3 and Sld7, while an in vivo analysis by Muramatsu and 
colleagues (Muramatsu et al, 2010) indicated that Sld2 and Cdc45 do not interact. 
Sld2 was instead reported to interact with Dpb11, upon CDK dependent 
phosphorylation (Zegerman & Diffley, 2007). 
GST-Sld2 was used to immunoprecipitate Sld3, Sld7 and Cdc45. Dpb11 was also 
tested in order to verify if the two proteins could interact in vitro in the absence of 
CDK phosphorylation (Figure 6.6). This assay revealed two new interactions 
between Sld2 and Sld3 and Sld2 and Sld7 (Figure 6.6, lanes 5 and 7 respectively). 
Furthermore, it was also confirmed that Sld2 and Cdc45 cannot interact (Figure 6.6, 
lane 10) and, surprisingly, a weak interaction was found with Dpb11, even in the 
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absence of CDK (Figure 6.6, lane 12). The fact that Sld2 and Cdc45 do not interact 
directly raises the question how Sld2 can function for Cdc45 recruitment. A 
conclusive answer could not be found during the course of this study, but it appears 
reasonable to speculate that Sld2 interaction with the pre-RC remodels the MCM2-7 
double-hexamer, making it suitable for Cdc45 binding. Once again the structural 
studies will help to prove or rule out this hypothesis.  
The newfound interaction between Sld3 with Sld2 was confirmed (Figure 6.7) and 
studied in more detail at this point. Using MBP-Sld3 to immunoprecipitate in vitro 
transcribed and translated domains of Sld2 it was found that all truncations 
containing the amino acids 250-327, appeared to bind (Figure 6.8, lanes 15, 23 and 
25), while the very N-terminal region of Sld2 did not interact with Sld3 (fragments 1-
148 and 1-249, Figure 6.8, lanes 11 and 13 respectively). Unfortunately some 
unspecific signal was also detected for the MBP control in some cases (lanes 14, 22 
and 24), affecting the quality of this result. A fungal alignment (Appendix III) was 
performed for Sld2 and a limited number of residues within the minimal region 
comprised between amino acids 250-327 were found to be highly conserved. These 
amino acids could be mutated in the future in order to produce a version of Sld2 
which is defective for the interaction with Sld3. 
During this project however it appeared reasonable to take advantage of the 
peptides containing conserved regions of Sld3 used to map Mcm2 and Cdc45 
interactions (described in paragraph 4.5 and 5.3). Sld3 peptides were therefore used 
to immunoprecipitate in vitro transcribed and translated proteins and for five of the 
peptides interactions were detected. These five peptides corresponded to amino 
acids 170-195 (CR1b), 196-226 (CR2), 249-287 (CR3a), 286-311 (CR3b) and 333-
355 (CR4) of Sld3, while peptides CR1a (152-175), CR5 (384-419) and CR6 (518-
546) did not show any interaction (Figure 6.9). Peptide CR3a (aa 249-287) in 
particular appeared to interact very well with Sld2, therefore its sequence was 
analysed in greater detail. The conserved residues were identified starting from the 
sequence alignment of Sanchez-Pulido and colleagues (Sanchez-Pulido et al, 2010). 
In the region comprising amino acids 259-287 a cluster of highly conserved residues 
can be found (Figure 6.10, panel A). Moreover, the secondary structure of the 
sequence was predicted (Figure 6.10, panel B) and a helical wheel projection of the 
sequence corresponding to CR3a was performed (Figure 6.10, panel C). The most 
conserved residues obtained from the sequence alignment were clustered in four 
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groups based on their characteristics and proximity in the helical projection and 
subsequentlymutated following the strategy adopted by Frigola and collegues(Frigola 
et al, 2013), as described in paragraph 6.1. 
The indicated mutations were produced in the context of the CR3a peptide to 
compare to results to wild type CR3a. The assay showed that mut1 
(R269E_E270R_Q274A_E280R) and mut3 (L273E_L277E_L248E) suppressed very 
strongly the interaction with Sld2 (Figure 6.11, lanes 4 and 6 respectively compared 
to lane 3). Mut3 did not alter the binding compared to the wild type (Figure 6.11, 
compare lanes 5 and 3) and mut4 showed a slightly reduced signal (Figure 6.11, 
compare lanes 7 and 3).  
The generation of a mutant version of Sld3, which is defective for Sld2 
interaction, could be an extremely valuable tool in order to clarify the mechanism of 
recruitment of the initial replicative factors to the pre-RC. Furthermore, for the 
purpose of this study, and the observed Sld2 requirement for Cdc45 recruitment to 
the pre-RC, the mutant could conclusively prove the proposed model. 
It was decided to test these mutations in vivo and, in order to perform a 
comprehensive in vivo analysis, mutants in CR1b and CR2 were also produced 
following the same strategy. The peptides covering these two regions in fact 
appeared to interact with Mcm2 and Cdc45 (Figure 4.22 and 5.7 respectively) and so 
it was attempted to produce mutants that are defective for their binding. The peptide 
for CR3b interacted with Mcm2 (Figure 4.22) but the region is devoid of well 
conserved residues that could be mutated (see Appendix III) therefore it was decided 
to focus on the other regions during this analysis.  
To test these Sld3 mutants in vivo it was decided to use the Sld3-7td strain 
developed by the Labib lab (Kanemaki & Labib, 2006). Sld3-7 is a mutated version of 
Sld3 that reduces the ability of MCM2-7 and Cdc45 to interact during initiation 
(Kamimura et al, 2001). Cells with this mutation grow well at 24°C, but show reduced 
growth at 37°C, therefore this mutant version of Sld3 was combined with the heat-
inducible degron cassette (Kanemaki et al, 2003; Sanchez-Diaz et al, 2004) 
producing a strain that grows similarly to the control strain at 24°C and exhibits 
severe growth defect at 37°C (Kanemaki & Labib, 2006). The addition of the degron 
cassette to wild type Sld3 on the contrary does not prevent growth at 37°C 
(Kanemaki & Labib, 2006) . The degron cassette allows efficient proteolysis of the 
protein fused to it via recognition by Ubr1, which is targeted by a ubiquitin-
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conjugating enzyme (Dohmen et al, 1994). Ubr1 overexpression is under control of 
the galactose-inducible promoter (Labib et al, 2000) and the proteolysis is more 
efficient at high temperatures (Sanchez-Diaz et al, 2004).  
The use of this strain allows the analysis of the Sld3 mutations in the absence of its 
wild type copy. For the expression of the mutant versions of Sld3 a yeast centromere 
plasmid was chosen and it has both a replication origin and a centromere sequence. 
It is propagated as low-copy-number, autonomously replicating, stably segregated 
plasmid (Stearns et al, 1990) 
Sld3-7td transformed with the empty vector that does not express any protein was 
used as a negative control. Sld3-7td was also transformed with the plasmid 
containing non modified SLD3 gene to verify that the wild type Sld3 can effectively 
rescue the lethality conferred by the degradation of the endogenous protein. 
The strains were grown at the permissive and restrictive temperature while the Ubr1 
expression was repressed or induced (Figure 6.13). 
All strains analysed appeared to grow similarly well at the permissive temperature, 
while Ubr1 expression was inhibited. A slightly reduced number of colonies was 
observed in case of the strains expressing CR1b mut, CR2 mut and CR3a mut1 in 
comparison to the other strains. This could suggest that these mutant versions of 
Sld3 are slowing down the growth of the cells even in the presence of wild the type 
Sld3 protein, thus exerting a dominant lethal effect. 
At the permissive temperature, but with Ubr1 expressed, a growth defect was 
observed for the strains expressing CR1b mut, CR2 mut and CR3a mut1, indicating 
a dominant effect on cell growth for these mutants, whereas the controls and CR3a 
mut3 did not show lethality.  
When the strains were analysed at the restrictive temperature with inactivated Ubr1, 
they all appeared to grow. Strains expressing CR1b mut, CR2 mut and CR3a mut1 
showed slightly reduced growth, consistent with what observed at the permissive 
temperature. 
At the restrictive temperature with Ubr1 expression, when all endogenous Sld3 is 
degraded, only the strain transformed with the plasmid containing wild type Sld3 
could grow. This indicates that the lethal effect of the degron (observed for the 
control strain transformed with the empty vector) can effectively be rescued by the 
addition of Sld3 and also, importantly, that all mutants analysed are defective for the 
complementation, meaning that they do not function like wild type Sld3.  
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Unfortunately this experiment alone does not prove that the growth defect 
observed is indeed due to disruption of one of the interactions studied in this project, 
which was described in this and the previous chapters.  
Therefore an experiment was attempted to identify the influence of the mutations on 
the chromatin binding of replication proteins. For this experiment cells were arrested 
in G1-phase and synchronously released in S-phase followed by chromatin 
fractionation of the samples (similarly to what previously reported (Kanemaki & 
Labib, 2006; Sheu & Stillman, 2006)). Unfortunately the arrest and release 
conditions for the Sld3-7td strain as well as the chromatin fractionation required 
some optimisation, and a conclusive result was not obtained in the timeframe of this 
project. It remains a very promising experiment to perform in the future in order to 
identify how the mutations affect complex formation in vivo and if the results are 
confirming the model. 
Alternatively, the overexpression and purification of these mutant versions of 
Sld3 was initiated during this study, but the lengthy process of clone isolation, culture 
expansion, protein expression and purification could not be completed on time. The 
purified mutants should be employed in in vitro tests for direct interaction with the 
binding partners (MCM2-7, Cdc45 and Sld2) and in pre-RC reconstitution assays in 
order to conclusively prove their efficacy. In the case that one or more mutants would 
produce the hoped outcome, it would be interesting to separate the individual 
mutations that were present in each of the mutants tested. 
The obtained data suggested that Sld3, Sld2 and Sld7 could form a trimeric 
complex in solution. In fact Herrera found that, in the presence of DDK, Sld3 together 
with Sld2 could interact only transiently with the pre-RC and they were rapidly 
displaced from the complex (Figure 6.14 A). It was also found that the addition of 
Sld7 to this reaction would result in inhibited recruitment of Sld3, Sld2 and Sld7 to 
the pre-RC (Figure 6.14 B), suggesting that these three proteins could form a 
complex in solution that would impede the interaction with the pre-RC proteins. 
Finally, it was observed that the recruitment of Sld3, Sld2 and Sld7 in the presence 
of Cdc45 was much more stable. Over time Sld3, Sld2 and Sld7 would get displaced 
from the complex, leaving only Cdc45 at this point stably recruited (Figure 6.14 C).  
To test the possibility that Sld3, Sld2 and Sld7 could form dimeric or trimeric 
complexes in solution, the purified proteins were cross-linked with glutaraldehyde as 
previously described (Evrin et al, 2013). The data obtained with this assay are 
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interesting (Figure 6.16) and in summary they suggest that Sld3 could form a dimer 
(species revealed by silver staining but not by western blot) and it shows 
conclusively that Sld7 can form a dimer (species revealed by western blot at a higher 
molecular weight compared to the non cross-linked sample). When Sld3 and Sld7 
were cross-linked together a signal that could correspond to a dimer or a multimer of 
Sld3 and Sld7 was detected by an anti-Sld7 western blot. Unfortunately, the Sld3 
antibody did not confirm this finding, but this is likely due to epitope masking. The 
combination of Sld3 and Sld2 also showed a different profile compared to the 
proteins cross-linked by themselves, suggesting that a complex could form but a 
high molecular weight species could not be detected with neither of the antibodies. 
Sld7, when added together with Sld2, showed a different profile compared to the 
proteins crosslinked by themselves but once again the Sld2 antibody did not confirm 
a complex. Finally, when all three proteins were cross-linked together a signal could 
be detected by silver staining for a complex with a molecular weight higher than 116 
kDa (the trimer has an estimated size of 160 kDa). Unfortunately Sld3 antibody did 
not confirm the identity of this complex nor could Sld2 and Sld7 antibody reveal the 
formation of a complex containing both proteins. 
In conclusion, this assay is not sufficient to prove the formation of a trimeric 
complex in solution, but strongly suggests that Sld3, Sld2 and Sld7 can associate 
with one another in different ways. This method was used because it allows a rapid 
analysis of complex formation and it requires a very limited amount of protein. It has 
however a big limitation: the recognition of the proteins after cross-linking can be 
difficult due to epitope masking. Other techniques can be employed for the same 
purpose, such as separation via gel filtration or glycerol / sucrose gradient 
sedimentation, or immunoprecipitation of the complex using one of the proteins and 
probing for the other two.  
To conclude the analysis presented in this chapter, the role of DDK in the 
modification of the factors involved in Cdc45 recruitment to the pre-RC was 
investigated. 
The activity of DDK in initiation of replication has been extensively studied in vivo 
(Francis et al, 2009; Gros et al, 2014; Heller et al, 2011; Jackson et al, 1993; On et 
al, 2014; Randell et al, 2010; Sheu & Stillman, 2006; Sheu & Stillman, 2010), as well 
as the specific requirement of DDK for Cdc45 stable recruitment to the origins (Heller 
et al, 2011), and this effect appeared confirmed in vitro (Figure 6.1 C). 
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The post-translational modifications of MCM2-7 by DDK have been broadly studied 
(Francis et al, 2009; Gros et al, 2014; On et al, 2014; Randell et al, 2010; Sheu & 
Stillman, 2006; Sheu & Stillman, 2010) but little is known on phosphorylation of other 
components of the complex studied by DDK. For this reason, a kinase assay was 
performed using purified Sld3, Sld2, Sld7 and Cdc45. Among the proteins tested, 
only Sld3 appeared to incorporate radioactive ATP upon addition of increasing 
amounts of DDK (Figure 6.17 A). This is consistent with what recently reported by 
Mattarocci and colleagues (Mattarocci et al, 2014), where Sld3, similarly to Mcm4, 
appeared to be target of DDK phosphorylation during G1-phase. It will be interesting 
to further characterise this modification and understand if it plays a role in the 
mechanism of recruitment/release of Sld3 to the pre-RC.  Cdc45, instead, exhibited 
a weak signal even in the absence of DDK, indicating that the protein could 
incorporate γ-32P-ATP, but no increase was observed upon addition of DDK. This 
differs from what previously reported by Nougarede and colleagues (Nougarede et 
al, 2000). Sld2 and Sld7 did not show any γ-32P-ATP incorporation. The role of DDK 
on Sld3 phosphorylation will deserve to be better investigated because it could affect 
initiation of replication even though it appears more plausible that the contribution of 
DDK to the recruitment of Cdc45 is exerted by the phosphorylation of the MCM2-7 
loaded double-hexamer. In vitro kinase assays are prone to non-specific 
phosphorylation events, therefore this result would need to be confirmed. An 
analysis of the sequence of Sld3 should be performed to look for residues that could 
be phosphorylated by DDK, as well as a mass spec analysis to determine whether a 
Sld3 sample treated with DDK would show new modifications. 
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Chapter 7 – Summary and conclusions 
 
The large genomes of eukaryotic cells are replicated from multiple replication 
origins during S-phase of the cell cycle. Ensuring that each origin is efficiently 
activated once and only once during each S-phase is crucial for maintaining the 
integrity of the genome. This is achieved by a two-step mechanism (Diffley et al, 
1994). First, in late mitosis and early G1-phase, a large complex of initiator proteins 
(pre-RC), assembles at origins. Second, in early S-phase, when cells have 
committed to DNA replication and cell division kinases are activated, the pre-RC is 
transformed into the pre-IC. After the unwinding of origin DNA, the DNA synthesis 
machinery is loaded on ssDNA. Once the pre-IC starts forming, the pre-RC 
disassembles, and its reassembly is prevented until the next G1. As a result, each 
origin is used once, and only once, per cell cycle (Morgan, 2007). Re-initiation from 
any origin would lead to unbalanced gene dosage and long-lived, potentially fragile 
replication forks whereas the use of an insufficient number of origins would leave 
regions of the genome unreplicated before mitosis, generating loss of genetic 
information (Diffley, 2011). 
DNA replication is a fundamental, conserved and still poorly defined process. 
This project intended to contribute to its understanding through the in vitro and in 
vivo analysis of the transition from pre-RC formation to CMG assembly in S. 
cerevisiae.  
 
7.1 Analysis of the interactions occurring during pre-RC formation 
This work started with the study of the protein-protein interactions involved in 
pre-RC formation. Very little was in fact known on how the ORC/Cdc6 complex, 
formed onto replicative origins, how ORC could contact MCM2-7/Cdt1, with the 
exceptions that Orc6 was shown to be required for the recruitment of Cdt1 (Chen et 
al, 2007) and that the C-terminus of Cdt1 binds MCM2-7 whilst the N-terminus is 
required to load pre-RC complexes that are competent for CMG formation (Takara & 
Bell, 2011). 
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A series of experiments presented in chapter 3 aimed to identify new regions 
of interaction that could provide additional information on pre-RC formation and 
complement the ongoing research of other lab members on the subject. 
Employing bait proteins to immunoprecipitate in vitro transcribed and translated 
binding partners it was found that MCM2-7 appears to interact exclusively with the 
Orc2 subunit of ORC, even though it is entirely possible that other subunits also 
contribute to the binding site. It was also found that isolated MCM2-7 and Cdc6 do 
not directly contact one another suggesting that an interaction does not occur or that 
MCM2-7 has to be in a different conformation (which could be achieved after a first 
contact with the DNA or ORC). Cdt1, regardless of its interaction with MCM2-7, 
could not produce a change in structure to allow Cdc6 interaction.  
An interaction between Orc6 and Cdt1 was observed, consistent with what was 
previously reported (Chen et al, 2007). 
It was also shown that MCM2-7 does not interact with the C-terminal domains 
of Orc1-5 and Cdc6, neither in absence nor presence of Cdt1, consistent with the 
model proposed by Sun and colleagues (Sun et al, 2013) where this part of the ORC 
subunits contact DNA, but are distal to MCM2-7. The relation between MCM2-7 and 
ORC was further analysed in the context of the MCM2-7ΔC6 mutant, which has a 
defective Cdt1 binding domain, showing no significant difference compared with the 
wild type consistent with what was previously reported (Fernandez-Cid et al, 2013), 
where this mutant is still capable of interacting with Cdt1, indicating that MCM2-7 has 
more than one binding site for Cdt1. 
Additionally, Cdt1 interacted with the full length Orc2, consistent with the 
literature (Asano et al, 2007; Chen et al, 2007). Surprisingly the assay also showed 
an interaction between Cdt1 and Cdc6 which has not been observed before and will 
need further exploration. 
A number of different Orc2 truncations were examined for binding to Cdt1 and 
indicated that the putative binding site must be in the central portion of Orc2, in the 
AAA+ region, with a minimum fragment comprising amino acids 225-461.  
Taking this data together with the structure proposed by Sun and colleagues (Sun et 
al, 2013), it appears possible that the surface of contact between MCM2-7 and ORC 
involves Orc2, and also that Cdt1 and Orc2 can interact with each other, and this 
interaction is potentially important for initial ORC/Cdc6/Cdt1/MCM2-7 complex 
formation. More work needs to be done in order to understand the interaction of Cdt1 
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with Cdc6, because the two proteins seem to be located far away one from the other, 
at least in the structure of the OCCM. This interaction could be however important 
during the recruitment of the second MCM2-7 hexamer for the formation of the 
double-hexamer.  
Overall the results obtained in this part of the study provide some interesting 
contributions to the understanding of the pre-RC formation process. Additional 
analysis is required to better comprehend the complicated and dynamic structure of 
the pre-RC complex and the newfound interaction surfaces could significantly 
facilitate this work. 
 
7.2 Analysis of the interaction of Sld3 with the pre-RC 
Sld3 is believed to be one of the first factors recruited to the pre-RC with an 
essential role in assembling the pre-IC and CMG (Kamimura et al, 2001; Kanemaki 
& Labib, 2006). Therefore the study proceeded with the analysis of this crucial step 
in initiation of DNA replication. 
The recruitment of Sld3 to the pre-RC was investigated in vitro with purified 
proteins, given that all previous data on the subject had been produced through in 
vivo studies (Kamimura et al, 2001; Kanemaki & Labib, 2006; Tanaka et al, 2007b; 
Zegerman & Diffley, 2007) or employing yeast extracts that were used for in vitro 
assembly and DNA replication assays (Heller et al, 2011). An in vitro study has in 
fact the advantage of being able to distinguish the contribution of each individual 
factor involved in the process and can provide conclusive details on the molecular 
mechanisms. 
A lot of efforts were made in order to reconstitute the recruitment of Sld3 to 
the pre-RC employing the reconstituted system developed by Evrin and colleagues 
(Evrin et al, 2009) but they were not effective because of the intrinsic characteristic 
of Sld3 and its unspecific charge-mediated interaction with the streptavidin beads 
used in the assay. A successful recruitment of Sld3 to the pre-RC was however 
obtained with the use of a novel method for the reconstitution of the pre-RC in 
solution (Herrera, Tognetti et al, under revision). It was shown that Sld3 is in fact 
able to interact with the pre-RC in an almost stoichiometric fashion and in the 
absence of additional factors. This finding appears in contradiction with the literature, 
where Sld3 was only recruited to the pre-RC upon DDK phosphorylation (Heller et al, 
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2011) and in a Cdc45 dependent manner (Kamimura et al, 2001). It seems 
reasonable to argue that the initial recruitment can be independent from other factors 
but it is too weak to be detected in in vivo studies, whereas it can still be sensed 
using a more sensitive in vitro assay. Alternatively, it appears possible that other 
replication factors could bind to Sld3 and regulate its association with the pre-RC in 
vivo. In vitro the contribution of Cdc45 and DDK to the Sld3/pre-RC interaction was 
observed, which resulted in an enhanced recruitment of Sld3 to the pre-RC, as it was 
shown in chapter 6. 
The interaction of Sld3 with MCM2-7 was analysed in great detail: Sld3 can 
bind the MCM2-7 hexamer in solution as well as the Mcm2 subunit. 
Mcm2 is part of the putative “gate”, which is thought to promote opening of MCM2-7 
for the entry/exit of the DNA during helicase activation (Bochman & Schwacha, 2007; 
Bochman & Schwacha, 2008; Bochman & Schwacha, 2010; Costa et al, 2011; 
Samel et al, 2014; Sun et al, 2013) and it is shown to interact with Cdc45 in the CMG 
structure (Costa et al, 2011; Ilves et al, 2010). Sld3, which is known to interact with 
Cdc45 (Bruck & Kaplan, 2011a; Kamimura et al, 2001; Kanemaki & Labib, 2006), is 
therefore positioned in a suitable place to interact with both Mcm2 and Cdc45 and to 
modify the gate for helicase activation. 
The binding site was mapped to the residues 200-250 of Mcm2. Several 
attempts were made to produce mutant versions of MCM2-7 which were defective 
for Sld3 binding and they included a series of deletion mutants for the N-terminus of 
Mcm2 that were tested in vitro and in vivo as well as the design of hybrid versions of 
MCM2-7 where part of the yeast Mcm2 N-terminus was substituted with the human 
counterpart. This last strategy was designed after the finding that Sld3 cannot 
interact with the N-terminus of human Mcm2, suggesting that this surface of 
interaction has diverged among species. Unfortunately all these versions of MCM2-7 
appeared to be unable to form a stable hexamer or did not produce any effect when 
analysed in vivo. Taken together these findings indicate that first 250 amino acids at 
the N-terminus of Mcm2 play an important role in the stability of the complex and are 
likely required for essential protein-protein interactions. 
Unfortunately this data did not validate in a conclusive way the hypothesis that Sld3 
is interacting with the region 200-250 of Mcm2, therefore it was decided to focus on 
the residues in this region of Mcm2 that differ between yeast and human and could 
be potentially crucial for the binding. A series of point mutations were produced, 
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which were tested in the context of in vitro transcribed and translated Mcm2 N-
terminus in order to facilitate the screen and overcome the issue of protein instability. 
Three amino acids on Mcm2 (T233, S239 and H248) were identified for their role in 
the interaction with Sld3. It cannot be excluded that these amino acids are only 
contributing to the creation of the binding site for Sld3 and that other binding sites 
are required, but they provide an excellent starting point for a future analysis of this 
interaction. 
An alternative approach was used to study the binding site on Sld3.  For this 
purpose, the sequence of Sld3 was analysed for its conservation and secondary 
structure prediction to identify stretches that could support protein-protein 
interactions. A series of peptides were designed to cover those interesting regions 
and tested for interaction with Mcm2, identifying the most important regions of Sld3 
as 170-195 (CR1b), 196-226 (CR2) and 286-311 (CR3b). This strategy was 
significantly faster and more promising than the ones adopted for the analysis of the 
binding site on Mcm2. The mutated CR1b and CR2 were then tested in vivo 
employing a temperature sensitive degron strain (Sld3-7td), as described in 
paragraph 6.2. The mutants in Sld3 were unable to rescue the lethality caused by 
the degradation of the endogenous proteins, demonstrating that they are not 
functional.  
Unfortunately it was not possible during the timeframe of this project to prove 
conclusively that their deficiency is due to the disrupted interaction with Mcm2. 
Nevertheless, the data obtained on Sld3/Mcm2 interaction during this analysis is a 
substantial advancement to the knowledge on the matter and will provide excellent 
preliminary data for future work. 
 
7.3 Analysis of the interaction of Cdc45 with the pre-RC and Sld3 
After the successful reconstitution of a pre-RC complex containing Sld3 
(chapter 4), the recruitment of Cdc45 was explored in vitro. Both bead and gel 
filtration based methods were used for this purpose but no interaction with the pre-
RC was detected when Cdc45 was added by itself. The contribution of Sld3 and 
DDK was therefore tested since, according to the literature (Heller et al, 2011; 
Kamimura et al, 2001; Kanemaki & Labib, 2006), these factors are required for 
Cdc45 recruitment but, once again, no recruitment was detected. The discrepancy of 
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these results could be explained with the fact that all previous work was performed in 
vivo or using yeast extracts. These experimental sets are in fact not fully controllable 
and mechanisms of compensation could take part without being able to detect them. 
Another reason could be that an interaction occurs in vivo but that something 
abrogates a stable complex formation in this particular work. 
Cdc45 and MCM2-7 are in fact both components of the CMG and their 
interaction is suggested in several publications (Bruck & Kaplan, 2011a; Costa et al, 
2011; Gambus et al, 2006; Gambus et al, 2009; Ilves et al, 2010; Kamimura et al, 
2001; Kanemaki & Labib, 2006; Moyer et al, 2006; Sheu & Stillman, 2006; Zou & 
Stillman, 1998; Zou & Stillman, 2000). Their direct interaction was therefore tested 
but the two purified proteins did not bind to each other in solution. This result 
indicates that isolated MCM2-7 is not in the correct conformation to support Cdc45 
binding and suggests that a conformational change has to occur as a consequence 
of another event (i.e. DNA encircling, phosphorylation or other protein interaction). 
Furthermore, it was shown that Cdc45 interacts with the Mcm2 subunit of MCM2-7. 
This is consistent with the structure proposed by Costa and colleagues (Costa et al, 
2011) and with the finding that MCM2-7/Cdc45/Sld3 can form a trimeric complex in 
solution (Bruck & Kaplan, 2011a), given that Sld3 also interacts with Mcm2.  
It was not possible during this project to further map the binding site, probably 
because of technical limitation conferred by the use of GST-tagged proteins, but the 
interaction of Cdc45 with Sld3 was analysed instead. The binding of Cdc45 to Sld3 is 
commonly accepted and it has been shown both in vivo and in vitro (Bruck & Kaplan, 
2011a; Bruck & Kaplan, 2011b; Kamimura et al, 2001; Kanemaki & Labib, 2006; 
Tanaka et al, 2007b; Tanaka et al, 2011b), therefore it was attempted to map the 
binding site in Sld3 and to identify point mutants that are defective for this interaction. 
It was found that fragments comprising amino acids 333-456 of Cdc45 could 
be immunoprecipitated by Sld3. Moreover, using the peptide strategy, three regions 
of Sld3 were identified to interact with Cdc45: CR1b (aa 170-195), CR2 (aa 196-226) 
and CR3a (aa 249-287). The conserved residues in these regions were mutated and 
their effect tested in vivo (paragraph 6.2). All strains produced a phenotype. As 
described for Mcm2, this result cannot conclusively prove that the mutated residues 
are essential and sufficient to support the interaction but provide some useful 
insights into the complex formation. 
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7.4 Analysis of Cdc45 recruitment to the pre-RC 
Herrera showed that the recruitment of Cdc45 to the pre-RC is not only 
dependent on Sld3 and DDK as previously described (Heller et al, 2011; Kamimura 
et al, 2001; Kanemaki & Labib, 2006), but also on Sld2, therefore this final part of the 
study was a collaboration aimed to analyse in detail how Sld2 could function in this 
process . 
Firstly, it was shown that Sld2 can be rapidly recruited to the pre-RC and is stably 
bound in the absence of additional factors. 
Sld2 interaction with MCM2-7 in the context of purified proteins in solution 
was suggested (Bruck et al, 2011) and, given that Sld2 appears required for Cdc45 
recruitment, together with Sld3, the subunits of contact on MCM2-7 was analysed, 
observing an interaction with Mcm2. The proximity of Sld3, Cdc45 and Sld2 with the 
single Mcm2 subunit appears sterically difficult and it is more reasonable to think that 
the binding site for these three proteins is only partially formed by Mcm2 and 
additionally involves adjacent subunits. 
Moreover, Herrera found that Sld2 and Sld3 by themselves were efficiently 
recruited to the pre-RC but, when added in combination, their binding, and especially 
the binding of Sld2, was decreased. Interestingly, it was also found that DDK could 
alter this interaction and induce cooperative binding, however this complex was only 
short-lived. This suggested that the two proteins cannot be stably recruited 
simultaneously in the absence of additional factors and indicated that either the pre-
RC undergoes a conformational change in the presence of Cdc45 and DDK or that 
Cdc45 stabilises the complex, perhaps bridging some interactions. 
When the Sld2 binding site on Mcm2 was mapped it was found, surprisingly, that it 
involved the C-terminus of Mcm2, contrarily to the N-terminus required for Sld3 
interaction. This result indicates that Sld3 and Sld2 do not compete for the binding 
site on Mcm2, with Sld3 getting a better chance of interaction, but that the interaction 
of Sld3 with the Mcm2 N-terminus could induce a hindrance that impairs Sld2 
binding to the C-terminus. The regulation of the simultaneous interaction of Sld3 and 
Sld2 to the pre-RC could therefore be an additional DDK induced quality control 
mechanism to strictly regulate Cdc45 recruitment to the pre-RC. 
The interaction analysis of Sld2 with the other components of the Cdc45-
containing complex was carried out in order to understand its functional role. Sld2 
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and Cdc45 did not show any binding, consistent with what reported by Muramatsu 
and colleagues (Muramatsu et al, 2010). However, two other new interactions were 
identified: Sld3/Sld2 and Sld2/Sld7. 
It was not possible during this study to conclusively state how Sld2 can facilitate 
Cdc45 recruitment given that they do not interact directly, but it appears reasonable 
to speculate that Sld2 interaction with the pre-RC remodels the MCM2-7 double-
hexamer, making the complex suitable for Cdc45 binding. Structural analysis will 
help to prove or rule out this hypothesis. 
The newfound interaction between Sld3 and Sld2 was studied in more detail, 
identifying a minimal binding region in Sld2 that comprised amino acids 250-327. 
Using a peptide approach, a region of Sld3 involved in the binding of Sld2 was also 
identified (CR3a, aa 249-287). The most conserved residues in this region were 
mutated and two sets of modifications suppressed the interaction 
(R269E_E270R_Q274A_E280R and L273E_L277E_L248E). Interestingly, helical 
wheel analyses showed that both sets of mutants where located on the same side of 
a predicted alpha helix, suggesting that they both affect the same interaction surface. 
These mutants were subsequently analysed in vivo and it was found that they were 
defective for the complementation of a temperature sensitive degron strain.  
Because this result by itself cannot prove that the growth defect is due to the 
disruption of the interaction between Sld3 and Sld2, the effect of the mutations on 
the chromatin binding of Cdc45 was tested, but these experiments were not 
completed in the timeframe of this study.  
Herrera found that Sld3 and Sld2 could be recruited to the pre-RC in the 
presence of DDK, but then they were rapidly displaced from the complex. The 
addition of Sld7 to this reaction did supress the recruitment of Sld3, Sld2 and Sld7 
but their binding in the presence of Cdc45 was much stabilised compared to what 
was observed for Sld3 and Sld2 alone. Over time Sld3, Sld2 and Sld7 would get 
displaced from the complex, leaving only Cdc45 stably recruited. This data suggests 
that Sld3, Sld2 and Sld7 could form a complex in solution, which is not competent for 
the interaction with the pre-RC proteins. Cross-linking experiments with 
glutaraldehyde were performed in order to characterise the potential Sld2/Sld3/Sld7 
complex, but despite several indications of dimers and trimer formation, no 
conclusive result could be obtained due to detection problems. This data suggests 
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that a more detailed analysis with different techniques such as gel filtration or 
glycerol or sucrose gradient sedimentation is required. 
To conclude this analysis, the role of DDK in modifying factors involved in 
Cdc45 recruitment to the pre-RC was investigated and it was found that only Sld3 
was phosphorylated by DDK. This observation will require further characterisation, it 
would be interesting to understand if this modification plays a role in the mechanism 
of recruitment/release of Sld3 to the pre-RC. 
Taken together, the results presented in chapter 6 and summarised in this 
paragraph, allowed us to draw a model for the recruitment of Cdc45 to the pre-RC 
(Figure 7.1).  
The pre-RC is formed on origin DNA and its final product is the MCM2-7 double-
hexamer, which represents a basis for pre-IC formation. Sld2, Sld3 and Sld7 all 
interact with each other in solution and could form a complex (Figure 7.1 A). When 
Sld3 and Sld2 are added to the pre-RC in the absence of additional factors, these 
proteins competes for pre-RC binding, possibly because the binding of Sld3 to the 
flexible N-terminus of Mcm2 produces an obstruction for Sld2 interaction with its 
binding to the C-terminus of Mcm2 (Figure 7.1 B), alternatively Sld3 acts as an 
allosteric negative inhibitor of Sld2. DDK activity alters these interactions and 
promotes cooperative Sld2/Sld3-pre-RC complex formation, most likely producing a 
conformational change that alters the spatial arrangement of Mcm2 (Figure 7.1 C).  
In the absence of Cdc45, the Sld2/Sld3-pre-RC complex becomes rapidly 
destabilized, suggesting that this reaction functions as a quality control step to 
redistribute Sld2 and Sld3 to sites of preferred complex formation (Figure 7.1 D). 
When Cdc45 is present, a Cdc45/Sld2/Sld3/Sld7-pre-RC complex is formed (Figure 
7.1 E). Over time Sld3, Sld2 and Sld7 become destabilized from this complex. The 
release of these factors could allow the CDK dependent binding of Dpb11 or allow 
GINS interaction and CMG formation. 
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Figure 7.1: Summary of the Cdc45 recruitment process 
The MCM2-7 double-hexamer is the landing platform for complex formation during S-phase. 
A) Sld2, Sld3 and Sld7 could interact with each other in solution. B) Sld2 and Sld3 compete 
in the absence of DDK for pre-RC interactions.  C) DDK promotes cooperative Sld2/Sld3-
pre-RC binding, but this complex is only short lived. Sld7 destabilizes this complex even 
further. D) In the absence of Cdc45 Sld2/Sld3/Sld7 cannot form a stable complex with the 
pre-RC and these limiting factors can be redirected to other locations where Cdc45 can 
induce complex assembly. E) Cdc45 recruitment to the pre-RC depends on Sld2, Sld3 and 
DDK and Cdc45 greatly stabilizes the unstable Sld2/Sld3/Sld7-pre-RC complex. After 
prolonged incubations Sld2/Sld3/Sld7 dissociate off and reveal a stable Cdc45/pre-RC 
complex.  
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7.5 Technical advancements 
This study highlighted many of the difficulties that can be encountered during 
the analysis of protein-protein interactions. Firstly, it underlined how problematic the 
identification of the minimal binding site can be. Secondly, it showed that the 
manipulation of large protein complexes can result in their instability and consequent 
loss of function due to structural reasons independent of the analysis performed. 
Thirdly, it revealed that the process of identification of an interaction, mapping of the 
binding site, mutation of the putative residues involved and test of the mutants can 
be challenging to achieve in a limited amount of time. 
Nevertheless, several important advancements were achieved during this 
project, both from a scientific and from a technical point of view. The issues 
encountered with the GST-tagged MCM2-7 subunits (paragraph 4.2) required to 
identify an alternative method for the mapping on the binding site. The use of in vitro 
transcribed and translated proteins was an important technical break-through, as it 
allowed the detection of specific interactions in a rapid process. This system, even 
though already used for the same purpose, was never employed before in such a 
systematic way. Moreover, the analysis of the interface between MCM2-7 and Sld3 
required an extensive amount of work and did not end with a definitive result but was 
undoubtedly useful to explore several different approaches for the variation of a 
putative binding site: deletion mutants, hybrid mutants and point mutants were 
analysed, producing a useful set of data for further studies. 
Finally, the use of peptides for the study of protein-protein interactions based 
on sequence analysis was a fairly uncommon approach in the field but it generated 
remarkably relevant results in a very limited time frame, which will be certainly used 
in the future for similar work by the group. 
 
7.6 Conclusions 
From a scientific point of view, the data produced during this study represent 
a considerable advancement in the field of DNA replication. Previous work had 
demonstrated that Sld3 functions in Cdc45 recruitment (Kamimura et al, 2001; 
Kanemaki & Labib, 2006). Additionally, Sld3 together with Sld2 represent the 
essential targets of CDK during S-phase and their phosphorylation enables binding 
of Dpb11, which promotes GINS recruitment, CMG formation and activation of the 
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replicative helicase (Muramatsu et al, 2010; Tanaka et al, 2007b; Zegerman & 
Diffley, 2007). An EM structure of the CMG has shown that Cdc45 and GINS contact 
MCM2-7 at the Mcm2/5 interface (Costa et al, 2011), a putative exit gate for ssDNA 
during helicase activation. However, if other factors besides Sld3 are involved in 
Cdc45 loading was not known prior to this study. Moreover, how Sld3 and others 
factors bind to the MCM2-7 helicase was also not known. Previous studies, exploring 
mechanism in Cdc45 recruitment to the replication origin, were based on in vivo 
experiments or extract based systems. However, these systems do not allow the 
analysis of individual components during complex formation or more complex 
reaction mechanisms. The extract based system (Heller et al, 2011) has the 
limitation that several factors involved in the process are overexpressed, which could 
alter complex assembly, e.g. it was shown that high-copy CDC45 suppressed the 
growth defect conferred by some temperature sensitive mutants of Sld3 (Kamimura 
et al, 2001) and, additionally, overexpression of Cdc45 or Dpb11 can bypass the 
requirement of CDK dependent phosphorylation of Sld3 (Tanaka et al, 2007b). 
Finally, the extract based system did not allow so far a detailed analysis of each 
component or more complex reaction mechanisms.  
The reconstitution of Cdc45 loading with purified proteins was a breakthrough, 
as it allowed a much more detailed analysis of complex assembly than previous 
systems, and described Sld2 as Cdc45 loading factor. The detailed analysis of 
protein interactions identified that the Mcm2 subunit of the MCM2-7 hexamer 
acquires a central role in Cdc45 recruitment, representing the landing pad for Sld2, 
Sld3 and Cdc45. This is particularly interesting, as Mcm2 is a substrate for DDK 
phosphorylation, which is essential for Cdc45 recruitment and, since Mcm2 is also 
part of a putative gate for DNA entry/exit. During helicase activation it is thought that 
the MCM2-7 ring must open at the Mcm2/5 interface and that one strand of DNA 
becomes extruded.  Indeed, while the double-hexamer encircles dsDNA and has no 
helicase activity, the CMG encircles ssDNA and functions as a processive helicase. 
Currently it is unknown how the MCM2-7 ring opens during helicase activation; 
however the data obtained here in collaboration with my colleague suggests that 
DDK dependent conformational changes in Mcm2 promote cooperative interactions 
in Sld3/Sld2, which in turn allows Cdc45 recruitment and loading. Interestingly, in the 
absence of Cdc45, Sld3, Sld2 and Sld7 fail to form a stable complex with the pre-
RC, suggesting that these limiting factors can be redistributed to other sites of 
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preferred complex formation. These redundant mechanisms of regulation guarantee 
that DNA replication is initiated only when the cell can support it, preventing helicase 
activation in case of suboptimal conditions. Such a highly controlled system is 
necessary to ensure that the DNA is correctly copied and no mistakes can be 
introduced, leading to genome instability (Green et al, 2010). In this sense, the 
investigation of the process of DNA replication is crucial for future therapeutic 
applications. All pre-RC proteins, as well as Sld3 and Cdc45, have a human 
homologue and it is reasonable to expect that the function of Sld2 is also conserved. 
Mutations on these proteins have been found in cancer and other human 
syndromes, indicating that the information acquired studying the process of 
replication in vitro or in species other than human could provide critical advancement 
in the understanding and treatment of human conditions. 
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Appendix I - Tables 
 
Table I. Plasmids 
Name Gene Plasmid Reference 
pCS372 ARS1 pUC19 (Evrin et al, 2009) 
pCS160 Cdc6 pGEX-6P-1 (Speck et al, 2005) 
pCS178 Cdt1 pGEX-6P-1 (Evrin et al, 2009) 
pCS14 Mcm2/Mcm7 pESC-LEU (Evrin et al, 2009) 
pCS479 Mcm2/Mcm7-MBP pESC-LEU Samel and Speck, unpublished 
pCS524 Mcm2Δ1-250/Mcm7 pESC-LEU This study 
pCS558 FLAG-Mcm2/Mcm7 pESC-LEU This study 
pCS572 FLAG-Mcm2Δ1-200/Mcm7 pESC-LEU This study 
pCS573 FLAG-Mcm2Δ1-238/Mcm7 pESC-LEU This study 
pCS574 FLAG-Mcm2Δ1-251/Mcm7 pESC-LEU This study 
pCS508 hMcm2 pESC-HIS Schlott and Speck, unpublished 
pCS576 FLAG-hMcm2(1-200) scMcm2(222-868)/Mcm7 pESC-LEU This study 
pCS577 FLAG-hMcm2(1-232) scMcm2(254-868)/Mcm7 pESC-LEU This study 
pCS15 Mcm6/Mcm4 pESC-TRP (Evrin et al, 2009) 
pCS496 Mcm6ΔC6/Mcm4 pESC-TRP (Fernandez-Cid et al, 2013) 
pCS232 Mcm3-HA/Mcm5 pESC-URA (Evrin et al, 2009) 
pCS319 Mcm2(1-322)-GST pGEX-6P-1 C-term This study 
pCS320 Mcm3(1-192)-GST pGEX-6P-1 C-term This study 
pCS321 Mcm4(1-340)-GST pGEX-6P-1 C-term This study 
pCS322 Mcm5(1-174)-GST pGEX-6P-1 C-term This study 
pCS323 Mcm6(1-302)-GST pGEX-6P-1 C-term This study 
pCS324 Mcm7(1-253)-GST pGEX-6P-1 C-term This study 
pCS313 Cdc7/MBP-Dbf4 pESC-TRP Herrera, Tognetti et al, under revision 
pCS245 MBP-HIS-Myc-Sld3 pESC-HIS Herrera, Tognetti et al, under revision 
pCS609 Sld3 wt + natural promoter pRC416 This study 
pCS610 Sld3 CR1b mut + natural promoter pRC416 This study 
pCS611 Sld3 CR2 mut + natural promoter pRC416 This study 
pCS612 Sld3 CR3a mut1 + natural promoter pRC416 This study 
pCS614 Sld3 CR3a mut3 + natural promoter pRC416 This study 
pCS8 Cdc45-FLAG pESC-HIS Herrera, Tognetti et al, under revision 
pCS241 Cdc45-FLAG pESC-LEU Herrera, Tognetti et al, under revision 
pCS242 Cdc45-FLAG pESC-TRP Herrera, Tognetti et al, under revision 
pCS243 Cdc45-FLAG pESC-URA Herrera, Tognetti et al, under revision 
pCS229 Cdc45-GST pGEX-6P-1 C-term Herrera, Tognetti et al, under revision 
pSC290 GST-Sld2 pGEX-6P-1 Herrera, Tognetti et al, under revision 
pSC486 GST-Sld7 pGEX-6P-1 Herrera, Tognetti et al, under revision 
pSC300 GST-Dpb11 pGEX-6P-1 Herrera, Tognetti et al, under revision 
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Table II. Oligonucleotides for cloning 
 
Name Full name  Final product Sequence 
oCS1941 Mcm2Δ1-250_F Mcm2Δ1-250/Mcm7 
GGATGGCTTTGGACTCCATGGATCCGGGG
TTT 
oCS1942 Mcm2Δ1-250_R Mcm2Δ1-250/Mcm7 
AAACCCCGGATCCATGGAGTCCAAAGCCAT
CC 
oCS1859 FLAG link BamHI_F FLAG-Mcm2/Mcm7 
[PHOS]GATCC ATG 
GATTATAAAGATGATGATGATAAA 
GGTGGTAGAGCTAATGGTAATAAT G 
oCS1860 FLAG link BamHI_R FLAG-Mcm2/Mcm7 
[PHOS]GATCC 
ATTATTACCATTAGCTCTACCACC 
TTTATCATCATCATCTTTATAATC CAT G 
oCS2136 FLAG_Mcm2 Δ1-200_F FLAG-Mcm2Δ1-200/Mcm7 
CTAATGGTAATAATGGATCCATG 
CCTAATGTCTCAAGAACTATTGC 
oCS2137 FLAG_Mcm2 Δ1-200_R FLAG-Mcm2Δ1-200/Mcm7 
GCAATAGTTCTTGAGACATTAGG 
CATGGATCCATTATTACCATTAG 
oCS2182 FLAG_Mcm2 Δ1-238_F FLAG-Mcm2Δ1-238/Mcm7 
GCTAATGGTAATAATGGATCCATG 
TCTGAATCTTTGGAGGTTAATTAT 
oCS2183 FLAG_Mcm2 Δ1-238_R FLAG-Mcm2Δ1-238/Mcm7 
ATAATTAACCTCCAAAGATTCAGA 
CATGGATCCATTATTACCATTAGC 
oCS2184 FLAG_Mcm2 Δ1-251_F FLAG-Mcm2Δ1-251/Mcm7 
GGTAATAATGGATCCATG 
TCCAAAGCCATCCTGGCA 
oCS2185 FLAG_Mcm2 Δ1-251_R FLAG-Mcm2Δ1-251/Mcm7 
TGCCAGGATGGCTTTGGA 
CATGGATCCATTATTACC 
oCS2158 SbfI_FLAG_hMcm2_F hybrid plasmids 
CAGTTGATCCTGCAGGATGGATTATAAAGA
TGATGATGATAAAGGTGGTAGAGCTAATGG
TAATAAT ATG GCA TCC AGC CCG GC 
oCS2159 AsiSI_hMcm2_232R 
FLAG-hMcm2(1-200) 
scMcm2(222-868)/Mcm7 
TCAGTCACGAT GCGATCGC CTC CCT GGC 
TGC CAA GTC C 
oCS2160 AsiSI_hMcm2_200R 
FLAG-hMcm2(1-232) 
scMcm2(254-868)/Mcm7 
TCAGTCACGAT GCGATCGC GCT GTC GAC 
GTG AGT GCG C 
oCS1364 Mcm2_F Mcm2(1-322)-GST 
CAGTTGAT GC ATGC TA 
ATGTCTGATAATAGAAGACGTAGACGTG  
oCS1365 Mcm2 322_R Mcm2(1-322)-GST 
TCAGTCACGAT GCGGCCGC 
AGGGAAGACTCCTGTTCTTCTTGT 
oCS1366 Mcm3_F Mcm3(1-192)-GST 
CAGTTGAT GC ATGC TA 
ATGGAAGGCTCAACGGGATTT  
oCS1367 MCM3 192_R Mcm3(1-192)-GST 
TCAGTCACGAT GCGGCCGC 
TGGCCTGACCAACGAAGTCTTA 
oCS1368 Mcm4_F Mcm4(1-340)-GST 
CAGTTGAT GC ATGC TA 
ATGTCTCAACAGTCTAGCTCTCCAA  
oCS1369 MCM4 340_R Mcm4(1-340)-GST 
TCAGTCACGAT GCGGCCGC 
AGGGATAACCGGAGTTGATCT 
oCS1370 Mcm5_F Mcm5(1-174)-GST 
CAGTTGAT GC ATGC TA 
ATGTCATTTGATAGACCGGAAA  
oCS1371 Mcm5 174_R Mcm5(1-174)-GST 
TCAGTCACGAT GCGGCCGC 
GGAAGATAAAACTGACGTGGATATT 
oCS1372 Mcm6_F Mcm6(1-302)-GST 
CAGTTGAT GC ATGC TA 
ATGTCATCCCCTTTTCCAGCT  
oCS1373 Mcm6 306_R Mcm6(1-302)-GST 
TCAGTCACGAT GCGGCCGC 
TGGACGGACCTCAGATGTTCTT 
oCS1374 Mcm7_F Mcm7(1-253)-GST 
CAGTTGAT GC ATGC TA 
ATGAGTGCGGCACTTCCAT  
oCS1375 Mcm7 253_R Mcm7(1-253)-GST 
TCAGTCACGAT GCGGCCGC  
TGGTTTGACATCAGAAACTCTGG 
oCS2187 Sld3promoter_Fwd Sld3 wt+natural promoter CCTCCCCAAGAGCTCAGTTC 
oCS2188 Sld3_BamHI_Rev Sld3 wt+natural promoter 
CGCGCG GGA TCC CTA CTA TGT GGA TTC 
TGG AGC AAA TAA AC 
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Table III. Oligonucleotides for in vitro transcription and translation 
 
Code Name Sequence Reference 
oCS1711 Orc1_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GCAAAAACGTTGAAGGATTTAC 
Gardenal and Speck, 
unpublished 
oCS1712 Orc1_788_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCTCATGTAATTACGTTTATGACGC 
Gardenal and Speck, 
unpublished 
oCS1713 Orc1_Rev_End 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
TAA ATT TCT CAA TGT CTC ATC C 
Gardenal and Speck, 
unpublished 
oCS1714 Orc2_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CTAAATGGGGAAGACTTTG 
Gardenal and Speck, 
unpublished 
oCS1715 Orc2_505_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AGTGGTGCTGAAGGTGCG 
This study 
oCS1771 Orc2_91_Rev+4Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CAT CCT ATC AGT TAA TTC TTC 
CTG TAT C 
This study 
oCS1772 Orc2_92_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG ATC AAG AAG GAT GAG AAA GAT 
ACA ATT 
This study 
oCS1773 Orc2_125_Rev+4Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CAT GTT GTT AGA AGT CTT GCT 
TTC C 
This study 
oCS1774 Orc2_125_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AAG CAG GTG ATG GAA AAG ACG 
This study 
oCS1775 Orc2_225_Rev+2Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT  TTT ATT TTT CGG TAC AGG GGT TG 
This study 
oCS1776 Orc2_226_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AAG CTC TAC CAA ACT TCG GAA 
AC 
This study 
oCS1779 Orc2_311_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
TTG AGT CAA TTC AAA CCA ATA CTG G 
This study 
oCS1780 Orc2_311_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GGA TTC TCC TTA TTA TTT TAT 
GGT G 
This study 
oCS1781 Orc2_319_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
TAC ACC ATA AAA TAA TAA GGA GAA TCC 
This study 
0CS1782 Orc2_320_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GGT TCG AAA CGT AAT TTT TTG 
GAA G 
This study 
oCS1783 Orc2_350_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
TTG TAA TTC ATT CTC ATA AGC CAG 
This study 
oCS1784 Orc2_351_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CAA AAC AAA CCT GTA AAT TCC 
ATC C 
This study 
oCS1785 Orc2_429_Rev+3Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT  CAT ACC ATC CAG ATT ATG CAC TAC 
AAG 
This study 
oCS1786 Orc2_430_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CCT AGC ATA AGG AAA AAC ACT 
TTT C 
This study 
oCS1787 Orc2_461_Rev+2Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT  CAT AGC GTA AAT GTG GTC TGT AGA G 
This study 
oCS1788 Orc2_462_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CCG CTC CTC TGG GAC AAC 
This study 
oCS1789 Orc2_504_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
GCT GGT ATC GCT TTT ACC CAT C 
This study 
oCS1716 Orc2_Rev_End 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
TAG AGT ATT TAA AAC GGT TTT CAG 
Gardenal and Speck, 
unpublished 
oCS1717 Orc3_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AGCGACCTTAACCAATC 
Gardenal and Speck, 
unpublished 
oCS1718 Orc3_493_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AGT TGG GAG CAG GTG CTG 
Gardenal and Speck, 
unpublished 
oCS1719 Orc3_Rev_End 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
AAT TCC TCT CCA GAC AC 
Gardenal and Speck, 
unpublished 
oCS1720 Orc4_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG ACT ATA AGC GAA GCT CGT C 
Gardenal and Speck, 
unpublished 
oCS1721 Orc4_384_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCCGATTTAGAGTTAGCCATTTTG 
Gardenal and Speck, 
unpublished 
oCS1722 Orc4_Rev_End AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA Gardenal and Speck, 
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CAG TTG TGT CCA GGA GTA G unpublished 
oCS1723 Orc5_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AATGTGACCACTCCGG 
Gardenal and Speck, 
unpublished 
oCS1724 Orc5_342_Fwd+2M 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG ATG ATG 
GAACCTAGATACGATGCGAG 
Gardenal and Speck, 
unpublished 
oCS1725 Orc5_Rev_End 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA 
TTC GTG AAT ATC GCT GAA G 
Gardenal and Speck, 
unpublished 
oCS1726 Orc6_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCC ATG CAA CAA GTC CAA C 
Gardenal and Speck, 
unpublished 
oCS1727 Orc6_Rev_End 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
TAA AGG TTC TGT TAA TGC CAA ATC 
Gardenal and Speck, 
unpublished 
oCS1728 Cdt1_Fwd 
ACTGATCT AATACGACTCACTATAGGG CAT 
CCACCATG AGT GGC ACA GCT AAT AG 
Gardenal and Speck, 
unpublished 
oCS1730 Cdt1_Rev_End 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA 
ATC TTG TTG TTT TGA TTT GTG 
Gardenal and Speck, 
unpublished 
oCS1731 Cdc6_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCAGCTATACCAATAACTCC 
Gardenal and Speck, 
unpublished 
oCS1732 Cdc6_400_Fwd+2M 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG ATG ATG 
AATTCTACGAGAACGAGGATAGC 
Gardenal and Speck, 
unpublished 
oCS1733 Cdc6_Rev_End 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
GTG AAG GAA AGG TTT CAA AAT TG  
Gardenal and Speck, 
unpublished 
oCS1670 Mcm2_Fwd  
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCTGATAATAGAAGACGTAGAC 
This study 
oCS1799 Mcm2_50_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GAC GAT AAT GAA GTT GAC GAT G 
This study 
oCS1801 Mcm2_101_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CAACAAGAACTATCTTTAAGCGAAC 
This study 
oCS1803 Mcm2_151_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AGA CGA AGA AGG AGA AGG CAG 
This study 
oCS1805 Mcm2_200_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CAACCTAATGTCTCAAGAACTATTG  
This study 
oCS1673 Mcm2_322_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GGG GTG GTG ACA AGA AGA AC  
This study 
oCS1784 Mcm2_666_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AAT GTT AGT TTG ACC GAG CCT 
ATT 
This study 
oCS1800 Mcm2_200_Rev+1Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT TTG TGT TAT CCA TTC CGA GTA AC 
This study 
oCS1843 Mcm2_218_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
ATA TTC CAG CAG GAA TGA TTT TAA C 
This study 
oCS1845 Mcm2_227_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
ATA TAC AGA ACG ACC CGT TTC ATC 
This study 
oCS1847 Mcm2_241_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
AGA TTC AGA ATT CAT TTC ACC TAA TG 
This study 
oCS2174 Mcm2_250_Rev+3Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
CTC 
This study 
oCS1804 Mcm2_300_Rev+2Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT AAA ATC AGA GAT TCT TAC GTG AAT 
TTC 
This study 
oCS1672 Mcm2_332_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CCC AGT GAC GCG TAC TAG 
This study 
oCS1806 Mcm2_350_Rev+3Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT TGG GCC CAA AAT GGA GCC A 
This study 
oCS1783 Mcm2_665_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CTG AGC TAA AGG CAA GGT TGA A 
This study 
oCS1785 Mcm2_Rev_end 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
GTG ACC CAA GGT ATA AAT TGC  
This study 
oCS2060 hMcm2_1Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GCA TCC AGC CCG GCC C 
This study 
oCS2061 hMcm2_232_ Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA 
TGC CAA GTC CTC ATA GTT CAC 
This study 
oCS2174 Mcm2_250_ R232S_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
CTC CAA AGA TTC AGA ATT CAT TTC ACC TAA 
TGT AGA AAT ACG 
This study 
oCS2175 Mcm2_250_ E243V_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
AAC CAA AGA TTC AGA ATT CAT TTC ACC TAA 
TGT TCT AAT ACG 
This study 
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oCS2176 
Mcm2_250_ R232S+ 
E243V_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
AAC CAA AGA TTC AGA ATT CAT TTC ACC TAA 
TGT AGA AAT ACG  
This study 
oCS2177 Mcm2_250_ E243K_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
TTT CAA AGA TTC AGA ATT CAT TTC ACC TAA 
TG 
This study 
oCS2178 
Mcm2_250_T233D+S239R_Re
v 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
CTC CAA AGA TTC TCT ATT CAT TTC ACC TAA 
ATC TCT AAT ACG TGC ACC  
This study 
oCS2179 
Mcm2_250_ T233A+S239A 
_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
CTC CAA AGA TTC AGC ATT CAT TTC ACC TAA 
AGC TCT AAT ACG TGC ACC  
This study 
oCS2180 Mcm2_250_ERH_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA ATC TTC ATA ATT AAC 
CTC CAA AGA TTC AGA ATT CAT CTT ACC TAA 
TGT TCT AAT ACG TGC ACC  
This study 
oCS2189 Mcm2_250_ T233D_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
CTC CAA AGA TTC AGA ATT CAT TTC ACC TAA 
ATC TCT AAT ACG TGC ACC 
This study 
oCS2190 Mcm2_250_ S239R_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
CTC CAA AGA TTC TCT ATT CAT TTC ACC TAA 
TGT TCT AAT ACG TGC ACC 
This study 
oCS2191 Mcm2_250_E236K_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TCT ATA ATT AAC 
CTC CAA AGA TTC AGA ATT CAT CTT ACC TAA 
TGT TCT AAT ACG TGC ACC 
This study 
oCS2192 Mcm2_250_R247E_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA GTG TTC ATA ATT AAC 
CTC CAA AGA TTC AGA ATT CAT TTC ACC TAA 
TGT TCT AAT ACG TGC ACC 
This study 
oCS2193 Mcm2_250_ H248D_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT CGC TAA ATC TCT ATA ATT AAC 
CTC CAA AGA TTC AGA ATT CAT TTC ACC TAA 
TGT TCT AAT ACG TGC ACC 
This study 
oCS1667 Mcm3_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GAAGGCTCAACGGGATTTG 
This study 
oCS1669 Mcm3_Rev_end 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA 
GAC TCT CCA AAC TTT ATC G 
This study 
oCS1677 Mcm4_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCTCAACAGTCTAGCTCTCCAA 
This study 
oCS1678 Mcm4_Rev_end 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA 
GAC ACG GTT ATT CAG GCG  
This study 
oCS1681 Mcm5_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCATTTGATAGACCGGAAATATAC 
This study 
oCS1682 Mcm5_Rev_end 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA 
TAC ACC ACT TCT GTA AAT ATT C 
This study 
oCS1685 Mcm6_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCATCCCCTTTTCCAGC 
This study 
oCS1686 Mcm6_Rev_end 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
GCT GGA ATC CTG TGG TTC  
This study 
oCS1689 Mcm7_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AGTGCGGCACTTCCATC 
This study 
oCS1690 Mcm7_Rev_end 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TCA 
AGC GTC TTG TAG ATC GAT ATC AG 
This study 
oCS1784 Cdc45_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TAT TAT GGA ATC AGC CAG TTT 
AG  
This study 
oCS1896 Cdc45_164_Rev+3Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT  TTC AAG CAA TTT ATA GTA TGC 
TTC TTT TTG 
This study 
oCS1897 Cdc45_165_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CTG GAC GAG GAG AGT GGT G 
This study 
oCS1898 Cdc45_332_Rev+4Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT CAT  CAT  AGA ATG CCT CAG TAA 
GAA AAG G 
This study 
oCS1899 Cdc45_333_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCA TTG TAC GAC AGT TTT TAT 
TAT TCT AAC 
This study 
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oCS1900 Cdc45_517_Rev+1Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT TTT CTT CTC CAA TAT AGC AAC CCC 
This study 
oCS1901 Cdc45_518_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TTA ATC AAG CAT TTA AGA ATT 
TAT AGA TTA TG 
This study 
oCS1902 Cdc45_650_Rev+2Met 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
CAT CAT TAA CAA TCC ACT CAA GGT CAG C 
This study 
oCS1785 Cdc45_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA TTA 
TAA CAA TCC ACT CAA GGT C 
This study 
oCS1766 Sld3_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GAA ACA TGG GAA GTC ATA G 
This study 
oCS1767 Sld3_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA  CTA 
TGT GGA TTC TGG AGC AAA TA 
This study 
oCS2040 Sld7_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCA CGG AAA TTA TGC ACA CTA 
AAT TTT 
This study 
oCS2041 Sld7_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
CAT TCA TGA TTT GGT AAA GAG CTT CAG 
This study 
oCS2041 Dpb11_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG AAG CCC TTT CAA GGA ATA AC 
This study 
oCS2043 Dpb11_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
TCA AGA ATC TAA TTC CTT TGT CTG 
This study 
oCS2044 Sld2_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TAC TCA TTT GAA CTG GAC AAA 
TTG 
This study 
oCS2045 Sld2_148_Rev+1M 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
CAT TGG TTC CGC CAC TAA CGT AC 
This study 
oCS2046 Sld2_149_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG ATA TCC AGT GTG AAA CGC CAA 
TTA 
This study 
oCS2047 Sld2_327_Rev+3M 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
CAT CAT CAT AAA TAT GTC CTT CAC AAC TTT 
TGG 
This study 
oCS2048 Sld2_328_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG CAA GAG GAT GAT GAT AAT GAT 
GAT AG 
This study 
oCS2049 Sld2_Rev+4M 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
CAT CAT CAT CAT TCA CCT TCT TCC CCA TCG 
TC 
This study 
oCS2052 Sld2_76_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG GAC GAA GTC GTA GAG ATA GG 
This study 
oCS2053 Sld2_249_Rev+1M 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
CAT AAT ATC CGC TTG ATC CTT TGA GG 
This study 
oCS2054 Sld2_250_Fwd 
ACTGATC TAATACGACTCACTATAGGG CAT 
CCACCATG TCA ACT TCA TTT AGT CCG TCT 
CC 
This study 
oCS2055 Sld2_365_Rev+3M 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
CAT CAT CAT CTC GGT TTC TGG ATC ATT GTC 
This study 
oCS2050 Sld2_Rev 
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA CTA 
TCA CCT TCT TCC CCA TCG TC 
This study 
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Table IV. Peptides 
 
Name Sld3 aa Mutations Sequence 
CR1a  152-175 wt DYYSDPKEYIESKYYDALFSIHTP 
CR1b 170-195 wt FSIHTPLAYFVKSNLVRLKNTCRTKY 
CR2 196-226 wt GSDSYKIAYQAMLQKFLLSIVQFKDRHDNRL 
CR3a 249-287 wt IQDENKNSSTIADLCVVLKSREIKLQILLLLEIIGLNDL 
CR3b 286-311 wt DLDWNFRDFEKKYKLKLKKRSLNLTK 
CR4 333-355 wt ITTSLDYCEQLDLYLDRACILDI 
CR5 384-419 wt KSKEASLVGFINYVLIPYFNKKVPHAVEFIIQKLKG 
CR6 518-546 wt RTKSDLTMNHLQKRQFSVSDLSTTRVPNS 
CR3a_mut1  249-287 R269E_E270R_Q274A_E280R IQDENKNSSTIADLCVVLKSERIKLAILLLLRIIGLNDL 
CR3a_mut2  249-287 K267D_K272D IQDENKNSSTIADLCVVLDSREIDLQILLLLEIIGLNDL 
CR3a_mut3  249-287 L273E_L277E_L284E IQDENKNSSTIADLCVVLKSREIKEQILELLEIIGENDL 
CR3a_mut4  249-287 I275K_L278E_I282K IQDENKNSSTIADLCVVLKSREIKLQKLLELEIKGLNDL 
 
 
Table V. Antibodies 
 
Antibody name Antigen Peptide Sequence 
 
Source 
Cdc6 Cdc6 - mouse Santacruz (SC53218) 
ORC1 ORC1 - mouse (Bell et al, 1995) 
MCM2 MCM2 - mouse (Zou & Stillman, 2000) 
Sld3 (318) Sld3 CTKKGLVRRRSKKKTSE rabbit Speck lab 
Sld3 (426) Sld3 CKLKGPSMRPKRALKKVND rabbit Speck lab 
Sld2 Sld2 CRKRPKRRKVIRRLRDNDPETE rabbit Speck lab 
Sld7 Sld7 THRDELKRISMGSGEEVS   rabbit Speck lab 
Dpb11 Dpb11 CGSIQDKKRTASLEKPMRRQTRNQTKE rabbit Speck lab 
FLAG FLAG epitope - mouse Sigma (A8592) 
MBP MBP - mouse NEB (E8032L) 
GST GST - mouse Pierce (P08263) 
HA HA - mouse Sigma (H3663) 
Anti-mouse gamma chain - goat Sigma (A 3673) 
Anti-mouse kappa light chain - goat Millipore (AP200P) 
Anti-rabbit IgG - goat Sigma (A 6154) 
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Table VI. Published protein-protein interactions 1 
 
Interaction Binding involves Method Reference 
    
pre-RC proteins    
    
ORC - Cdc6 Orc1 and Orc2, Cdc6 FL Two-hybrid (Huo et al, 2012) 
    
Orc6 - Cdt1 Orc6 aa 1-185, 270-435; Cdt1 FL Purified proteins (Chen et al, 2007) 
 Full-length proteins Purified proteins (Chen et al, 2007) 
    
Cdc6 - Mcm3 Full-length proteins Purified proteins (Sun et al, 2013) 
    
Cdt1 - MCM2-7 Cdt1 aa 1-312, MCM2-7 FL Purified proteins (Fernandez-Cid et al, 2013) 
 Cdt1 aa 306-604, MCM2-7 FL Purified proteins (Fernandez-Cid et al, 2013) 
 Cdt1 aa 472-604, MCM2-7 FL Purified proteins (Takara & Bell, 2011) 
    
pre-IC proteins    
    
MCM2-7 - DDK Mcm4 and Cdc7 Purified proteins (Sheu & Stillman, 2006) 
 Mcm2 aa 204-278, DDK  Purified proteins (Bruck & Kaplan, 2009) 
 Mcm2 and Dbf4 Purified proteins (Ramer et al, 2013) 
 Mcm5 and Cdc7 Purified proteins (Ramer et al, 2013) 
    
MCM2-7 - Sld3 Full-length proteins Purified proteins (Bruck & Kaplan, 2011a) 
    
Sld3 - Sld7  
 
Sld3 aa 60-120, Sld7 FL 
Two-hybrid and purified 
proteins 
(Tanaka et al, 2011b) 
    
Sld3 - Cdc45 Full-length proteins Two-hybrid (Kamimura et al, 2001) 
 Sld3 aa 150-430, Cdc45 FL Two-hybrid (Tanaka et al, 2011b) 
 Full-length proteins Two-hybrid (Zegerman & Diffley, 2010) 
 Full-length proteins Purified proteins 
(Bruck & Kaplan, 2011a; Bruck & 
Kaplan, 2013) 
    
Cdc45 - MCM2-7 Full-length proteins Purified proteins (Bruck & Kaplan, 2011a) 
    
Sld3 - Dpb11 Sld3 aa 527-668, Dpb11 FL Two-hybrid (Tanaka et al, 2007b) 
 Full-length proteins Two-hybrid (Zegerman & Diffley, 2010) 
 Full-length proteins Purified proteins (Bruck et al, 2011) 
 Full-length proteins  Purified proteins (Wang et al, 2012) 
    
Cdc45 - GINS Full-length proteins Purified proteins (Bruck & Kaplan, 2011a) 
    
Cdc45 - Rad53 Full-length proteins 
Two-hybrid and purified 
proteins 
(Aucher et al, 2010) 
    
Sld2 - MCM2-7 Full-length proteins Purified proteins (Bruck et al, 2011) 
    
Dpb11 - Sld2 Full-length proteins Two-hybrid (Kamimura et al, 1998) 
 Full-length proteins Two-hybrid (Tak et al, 2006) 
    
Dpb11 – Pol ε Dpb11 FL and Dpb2 FL Two-hybrid (Edwards et al, 2002) 
    
Dpb11 - GINS Dpb11 FL and Psf1 FL Two-hybrid (Takayama et al, 2003) 
    
Sld2 – Pol ε Sld2 FL and Dpb2 FL Purified proteins (Muramatsu et al, 2010) 
    
Pol ε - GINS Dpb2 FL and Sld5 FL Purified proteins (Muramatsu et al, 2010) 
    
GINS - Ctf4 Full-length proteins Purified proteins (Tanaka et al, 2009) 
 Full-length proteins Purified proteins (Gambus et al, 2009) 
    
Pol α - Ctf4 Pol1 FL and Ctf4 FL Two-hybrid (Zhou & Wang, 2004) 
 Full-length proteins Two-hybrid (Gambus et al, 2009) 
    
Mcm10 - MCM2-7 Mcm10 FL and Mcm2 FL Two-hybrid (Merchant et al, 1997) 
 Mcm10 FL and Mcm2 FL Two-hybrid (Lee & Hurwitz, 2000) 
 Mcm10 FL and Mcm3 FL Two-hybrid (Liachko & Tye, 2009) 
 Mcm10 FL and Mcm6 FL Two-hybrid (Merchant et al, 1997) 
 Mcm10 FL and Mcm6 FL Two-hybrid (van Deursen et al, 2012) 
 
                                               
1
 As in Tognetti, Riera and Speck, submitted 
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Table VII. Orthologs of replication factors 1 
 
S. cerevisiae S. pombe Metazoa Function 
ORC (Orc1-6) ORC (Orp1-6) ORC Origin Recognition Complex, pre-RC component 
Cdc6 Cdc18 Cdc6 ATP-binding protein, pre-RC component 
Cdt1 Cdt1 Cdt1 DNA replication licensing factor, pre-RC component 
MCM2-7 MCM2-7 MCM2-7 Replicative DNA helicase, pre-RC and CMG component 
- - Geminin DNA licensing inhibitor 
? ? GEMC1 Required for recruitment of Cdc45 to chromatin 
? ? DUE-B  Required for recruitment of Cdc45 to chromatin 
Sld3 Sld3 Treslin/Ticrr  Required for DNA helicase activation and pre-IC formation 
Sld7 ? MTBP?  Non-essential factor, interacts with Sld3/Treslin 
Cdc45 Cdc45/Sna41 Cdc45 Required for pre-IC formation, CMG component 
Sld2 Drc1 RecQ4/ RecQL4?  Required for helicase activation and pre-IC formation,  
pre-LC component 
Dpb11 Cut5/Rad4 TopBP1/Cut5/Mus101 Loads Pol  and GINS into pre-IC, pre-LC component 
GINS GINS  GINS  CMG and pre-LC component 
Pol  Pol   Pol   Leading strand polymerase, pre-LC component 
MCM10 MCM10  MCM10  Required for CMG activation 
RPA RPA  RPA  Single-stranded DNA binding protein 
Ctf4 Mcl1  AND-1  Required for sister chromatid cohesion; interacts with Polα 
PCNA PCNA  PCNA  Sliding clamp of DNA polymerases 
Kinases involved in DNA replication 
Dbf4 Dfp1/Him1 Dbf4 DDK regulatory subunit 
Cdc7 Hsk1 Cdc7 DDK catalytic subunit 
Clb5  Cig2 Cyclin E Cyclin involved in S phase, CDK regulatory subunit 
Cdc28  Cdc2 Cdc2/Cdk2 CDK catalytic subunit 
Mec1 Rad3 ATR Genome integrity checkpoint protein kinase 
Rad53 Cds1 Chk2 DNA damage response protein kinase 
 
The replicative factors whose association with origins is kinases independent are shown in 
grey; the factors that associate in a DDK dependent manner are shown in red and in purple 
are shown the factors that require both DDK and CDK. No colour is shown whenever the 
kinase requirement has not been directly determined.  
 
 
 
 
 
 
 
                                               
1
 As in Tognetti, Riera and Speck, submitted 
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Appendix II - Secondary structure predictions 
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Appendix III - Alignments  
 
Alignment of S. cerevisiae / human Mcm2 
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Alignment of S. cerevisiae / S. pombe Mcm2 
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Alignment of S. cerevisiae / S. pombe Sld3 
 
 
 
 
sc
sc
sp
sc
sp
sp
sp
sp
sp
196 
 
Alignment of S. cerevisiae / human Cdc45 
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Fungal alignment of Mcm2 
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Fungal alignment of Sld3 
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Fungal alignment of Cdc45 
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Fungal alignment of Sld2 
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Multiple alignment of Sld3 (Sanchez-Pulido et al, 2010) 
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